"","pathway","pval","padj","ES","NES","nMoreExtreme","size","leadingEdge"
"1","A tetrasaccharide linker sequence is required for GAG synthesis",0.802307521633015,0.980533241832259,0.313254223652454,0.426989356861442,3615,24,"AGRN, B3GALT6, B3GAT1, B3GAT2, B3GAT3, B4GALT7, BCAN, BGN, CSPG4, CSPG5, DCN, GPC1, GPC3, GPC4, GPC5, GPC6, HSPG2"
"2","ABC transporter disorders",0.836948662328272,0.980533241832259,-0.57811900727494,-0.748173155466707,4629,72,"UBB, OS9, PSMB2"
"3","ABC transporters in lipid homeostasis",0.192478695813264,0.980533241832259,-0.983583489681051,-1.34014909118102,1038,16,"ABCA2"
"4","ABC-family proteins mediated transport",0.554201527828301,0.980533241832259,-0.714337638440204,-0.962128371530958,3046,96,"ABCB10, UBB, OS9, PSMB2, ABCA2, ABCC5"
"5","ADP signalling through P2Y purinoceptor 1",0.557006252298639,0.980533241832259,-0.960522788203753,-1.24954126139805,3028,20,"GNB1, MAPK14"
"6","ADP signalling through P2Y purinoceptor 12",0.13387573964497,0.980533241832259,-0.988340146083227,-1.32955282475088,723,17,"GNB1"
"7","APC-Cdc20 mediated degradation of Nek2A",0.229517190929042,0.980533241832259,-0.979823032578094,-1.25204418666947,1254,22,"UBB, BUB3"
"8","APC/C-mediated degradation of cell cycle proteins",0.4457111834962,0.980533241832259,-0.808324785522667,-1.05545270430199,2462,77,"PTTG1, UBB, CUL1, PSMB2, BUB3"
"9","APC/C:Cdc20 mediated degradation of Cyclin B",0.029828760817529,0.629804462055302,-0.99718517525635,-1.30944653241863,161,19,"UBB"
"10","APC/C:Cdc20 mediated degradation of Securin",0.533908976434611,0.980533241832259,-0.797682129327946,-1.01129546559006,2967,62,"PTTG1, UBB, PSMB2"
"11","APC/C:Cdc20 mediated degradation of mitotic proteins",0.506486486486487,0.980533241832259,-0.798777351354437,-1.02121238005828,2810,67,"PTTG1, UBB, PSMB2, BUB3"
"12","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1",0.507927927927928,0.980533241832259,-0.797676819325339,-1.01980538356437,2818,67,"PTTG1, UBB, PSMB2"
"13","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint",0.896495956873315,0.980533241832259,-0.546833954484377,-0.69822151216238,4988,66,"UBB, PSMB2, BUB3"
"14","ATF4 activates genes in response to endoplasmic reticulum  stress",0.783849557522124,0.980533241832259,0.449527967798631,0.618670783169107,3542,23,"ASNS, ATF3, ATF4, ATF6, CEBPB, CEBPG, DCP2, DDIT3, DIS3, EXOSC1, EXOSC2, EXOSC3, EXOSC4, EXOSC5, EXOSC7, EXOSC8, EXOSC9"
"15","AUF1 (hnRNP D0) binds and destabilizes mRNA",0.871752951861944,0.980533241832259,-0.57175285946628,-0.707517517185639,4798,51,"UBB, HSPA8, PSMB2"
"16","AURKA Activation by TPX2",0.873674752920036,0.980533241832259,-0.559746766376109,-0.714709155205349,4861,66,"YWHAG, DYNLL1, AKAP9, PCM1, SDCCAG8"
"17","Abortive elongation of HIV-1 transcript in the absence of Tat",0.441814159292035,0.980533241832259,0.970704565261111,1.33594925485245,1996,23,"NCBP2, CTDP1"
"18","Acetylcholine Neurotransmitter Release Cycle",0.586923576531717,0.980533241832259,0.57406733131342,0.887510523609405,2710,15,"RIMS1, CHAT"
"19","Activated NOTCH1 Transmits Signal to the Nucleus",0.384712914327115,0.980533241832259,-0.966932725199544,-1.18416654211402,2123,31,"UBB, NEURL1, MIB1, ITCH"
"20","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins",0.502529815684857,0.980533241832259,-0.798775999583099,-1.02305209131028,2780,68,"PTTG1, UBB, PSMB2, BUB3"
"21","Activation of ATR in response to replication stress",0.0388596331941166,0.719288660551397,-0.993760483059376,-1.20712533088768,213,35,"ORC3"
"22","Activation of BAD and translocation to mitochondria",0.602078371941979,0.980533241832259,0.526135336946907,0.81340745747509,2780,15,"YWHAZ, AKT1"
"23","Activation of BH3-only proteins",0.821532316630356,0.980533241832259,-0.600465472618703,-0.741050999493232,4524,28,"YWHAG, DYNLL1"
"24","Activation of G protein gated Potassium channels",0.631375437304364,0.980533241832259,-0.872187401069041,-1.14530660532079,3428,19,"GNB1, KCNJ6"
"25","Activation of GABAB receptors",0.77214907386744,0.980533241832259,0.599613358833248,0.786595110588155,3459,31,"ADCY1, KCNJ4, ADCY2"
"26","Activation of HOX genes during differentiation",0.684717426858077,0.980533241832259,-0.737222266476335,-0.906436574288388,3767,48,"CTCF, CREBBP, RBBP7"
"27","Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon",0.233790292701,0.980533241832259,-0.980604767980526,-1.3360905326329,1261,16,"UBB"
"28","Activation of Matrix Metalloproteinases",0.558562459406798,0.980533241832259,0.65949531190724,1.01958254313061,2579,15,"MMP16, COL18A1"
"29","Activation of NF-kappaB in B cells",0.823126801152738,0.980533241832259,-0.595139530352052,-0.755395585764462,4569,63,"UBB, CUL1, PSMB2, CHUK"
"30","Activation of NMDA receptors and postsynaptic events",0.746208742194469,0.980533241832259,0.615820343971725,0.823450690916236,3345,71,"NRG1, ADCY1, PPM1E, RPS6KA2, CREB1, CASK"
"31","Activation of anterior HOX genes in hindbrain development during early embryogenesis",0.684717426858077,0.980533241832259,-0.737222266476335,-0.906436574288388,3767,48,"CTCF, CREBBP, RBBP7"
"32","Activation of gene expression by SREBF (SREBP)",0.759555879140881,0.980533241832259,-0.687973268213048,-0.838916897143423,4172,41,"ACACA, CREBBP, HMGCR"
"33","Activation of kainate receptors upon glutamate binding",0.621016208340922,0.980533241832259,-0.891361770013313,-1.10990465732445,3409,26,"GNB1, NCALD"
"34","Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",0.968380883154643,0.985120736573921,-0.487311234678297,-0.599163571503737,5328,48,"EIF4E, EIF4A2"
"35","Activation of the pre-replicative complex",0.0482320942883046,0.800979872881356,-0.993762575452716,-1.21990328173324,265,30,"ORC3"
"36","Acyl chain remodelling of PC",0.132112924569916,0.980533241832259,0.989390657774601,1.3757746709216,598,22,"PLA2G3, PLA2G4E"
"37","Acyl chain remodelling of PE",0.132112924569916,0.980533241832259,0.989390657774601,1.3757746709216,598,22,"PLA2G3, PLA2G4E"
"38","Acyl chain remodelling of PS",0.439486286460601,0.980533241832259,0.971453461100315,1.44028654899751,2018,17,"OSBPL10, PLA2G4E"
"39","Adherens junctions interactions",0.778684907325684,0.980533241832259,0.549403479040494,0.73801070564162,3528,27,"CDH12, AFDN"
"40","Adrenaline,noradrenaline inhibits insulin secretion",0.117197452229299,0.980533241832259,-0.988334674175382,-1.25114559087726,643,24,"GNB1"
"41","Aggrephagy",0.639573372563442,0.980533241832259,-0.864866518082433,-1.12510230180653,3477,20,"UBB, DYNLL1"
"42","Amine ligand-binding receptors",0.751223854027592,0.980533241832259,0.604613733905579,0.8032632820834,3375,28,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, DRD1, DRD3, DRD4, DRD5, HRH1, HRH2, HRH3, HTR1A, HTR1B, HTR1F, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7"
"43","Amino acid transport across the plasma membrane",0.667917034421889,0.980533241832259,0.692632780042384,0.930409846771139,3026,27,"SLC6A15"
"44","Amino acids regulate mTORC1",0.515959376133478,0.980533241832259,-0.861260524060016,-1.06395389098476,2844,50,"ATP6V0C, ATP6V0B, ATP6V1C1, SESN1, ATP6V1H"
"45","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal",0.939373750832778,0.980533241832259,0.50258069667764,0.689733436818854,4229,86,"CKAP5, RANBP2, DYNC1I2, AHCTF1"
"46","Amplification of signal from the kinetochores",0.939373750832778,0.980533241832259,0.50258069667764,0.689733436818854,4229,86,"CKAP5, RANBP2, DYNC1I2, AHCTF1"
"47","Amyloid fiber formation",0.868286445012788,0.980533241832259,-0.580802066620083,-0.709746501083138,4752,44,"UBB, ITM2B, TSPAN5"
"48","Anchoring of the basal body to the plasma membrane",0.499454545454545,0.980533241832259,-0.752534846757781,-1.00750860793629,2746,92,"AHI1, YWHAG, DYNLL1, AKAP9, PCM1, SDCCAG8"
"49","Antigen Presentation: Folding, assembly and peptide loading of class I MHC",0.404779547980734,0.980533241832259,-0.969115058093089,-1.32043560915652,2184,16,"SEC23A"
"50","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers",0.157325684024713,0.980533241832259,0.986454771005163,1.32509932937539,712,27,"TRPC1, AHCYL1"
"51","Antigen processing-Cross presentation",0.95737558580674,0.985120736573921,0.494447468831738,0.672295421512589,4289,81,"PSMA1, CTSS, PSMB3, PSMD14, PSME4, PSMD9"
"52","Antigen processing: Ubiquitination & Proteasome degradation",0.424307036247335,0.980533241832259,-0.651200860140478,-1.0179698248932,2188,282,"HECTD2, UBB, FBXO10, CUL3, FBXW7, CUL1, MGRN1, FBXW4, FBXL7, PSMB2, UBE2O, UBR2, WWP1, UBE2K, TRIM9, UBR1, RNF111, ITCH, RNF217, RNF6"
"53","Antiviral mechanism by IFN-stimulated genes",0.704784342152954,0.980533241832259,-0.66464308324693,-0.857661651458151,3888,71,"UBB, EIF4E, NUP98, EIF4A2, ARIH1, NEDD4"
"54","Apoptosis",0.845220353417075,0.980533241832259,0.527078882731217,0.779715427275249,3969,156,"BCL2L1, PSMA1, NMT1, YWHAZ, PSMB3, PSMD14, PSME4, ADD1, PSMD9"
"55","Apoptotic cleavage of cellular proteins",0.319215336602764,0.980533241832259,0.972555861235993,1.25490546039503,1431,37,"ADD1, ACIN1"
"56","Apoptotic execution phase",0.561381074168798,0.980533241832259,-0.857200816315226,-1.04750880733919,3072,44,"PAK2, DNM1L"
"57","Apoptotic factor-mediated response",0.618532149815977,0.980533241832259,0.454673366834171,0.702926949260476,2856,15,"APAF1, APIP, AVEN, BAK1, BAX, C1QBP, CASP3, CASP7, CASP9"
"58","Aquaporin-mediated transport",0.663921655909192,0.980533241832259,0.71483634583974,0.921248872900606,2982,39,"ADCY1, ADCY2"
"59","Arachidonic acid metabolism",0.00365363536719035,0.629804462055302,-0.999127282491944,-1.22094450698506,19,44,"PTGDS"
"60","Asparagine N-linked glycosylation",0.756902877003283,0.980533241832259,-0.544568232389081,-0.845598537720672,3919,267,"UBB, SEC23A, ST3GAL5, OS9, DYNLL1, ST6GALNAC3, TUSC3, SPTBN2, ARF4, MAN1A2, PREB, COPA, UGGT1"
"61","Assembly Of The HIV Virion",0.510188958873657,0.980533241832259,-0.962878584829804,-1.3119383091676,2753,16,"UBB, PPIA, FURIN"
"62","Assembly and cell surface presentation of NMDA receptors",0.794782925939438,0.980533241832259,-0.578266889763831,-0.735695256555074,4356,23,"CAMK2A, GRIN2B, CAMK2G"
"63","Assembly of collagen fibrils and other multimeric structures",0.50277346350122,0.980533241832259,0.832334697576111,1.07368628727192,2265,43,"CTSS, BMP1"
"64","Assembly of the pre-replicative complex",0.812826517744551,0.980533241832259,-0.602184107712619,-0.765487583614322,4511,64,"UBB, ORC3, PSMB2"
"65","Association of TriC/CCT with target proteins during biosynthesis",0.0749682337992376,0.906512436285034,-0.987987383397087,-1.1987794351475,412,39,"FBXW7, FBXW4, XRN2"
"66","Asymmetric localization of PCP proteins",0.598233597692862,0.980533241832259,-0.759561102594065,-0.960148675465371,3318,61,"PRICKLE1, UBB, PSMB2, DVL2"
"67","Attenuation phase",0.191171105435972,0.980533241832259,-0.982704297110679,-1.25023739518595,1047,23,"UBB, HSP90AB1, HSPA8, CREBBP"
"68","Autodegradation of Cdh1 by Cdh1:APC/C",0.921767475552336,0.980533241832259,-0.530930483209545,-0.66807147101591,5089,59,"UBB, PSMB2"
"69","Autodegradation of the E3 ubiquitin ligase COP1",0.936943485371616,0.980533241832259,-0.518935633024765,-0.638046704318098,5155,48,"UBB, PSMB2"
"70","Autophagy",0.405780989438577,0.980533241832259,-0.767796072371551,-1.05837208893681,2189,112,"PRKAG2, UBB, HSP90AB1, ATG4B, DYNLL1, HSPA8"
"71","Axon guidance",0.75049504950495,0.980533241832259,0.529434292712785,0.861187850211037,3789,471,"ROBO2, UNC5C, TYROBP, PSMA1, EPHA10, GFRA1, TREM2, PAK6, PAK3, RPS6KA2, PSMB3, TRPC1, CREB1, CLTA, LAMC1, TRPC4, ETF1, RNPS1, PSMD14, PSME4, CHL1, RHOA, PSMD9, NCBP2"
"72","B-WICH complex positively regulates rRNA expression",0.137325854894156,0.980533241832259,-0.98437080762007,-1.20385292940039,758,32,"SF3B1"
"73","BBSome-mediated cargo-targeting to cilium",0.378342832091188,0.980533241832259,0.974529123935921,1.36814686151006,1725,21,"LZTFL1, ARL6"
"74","BMAL1:CLOCK,NPAS2 activates circadian gene expression",0.772536878528501,0.980533241832259,-0.661656770939659,-0.823880893618777,4241,26,"CREBBP, CLOCK"
"75","Base Excision Repair",0.116386925795053,0.980533241832259,0.983418367346939,1.26857509401537,526,44,"PNKP, ACD"
"76","Base-Excision Repair, AP Site Formation",0.752773668639053,0.980533241832259,-0.423921227004506,-0.570274987886849,4070,17,"UNG, TINF2, TERF2IP, TERF2, TERF1, TDG, SMUG1, POT1, OGG1, NTHL1, NEIL3, NEIL2, NEIL1, MUTYH, MPG, MBD4"
"77","Basigin interactions",0.500182415176943,0.980533241832259,-0.963196353154119,-1.22541857521194,2741,23,"PPIA, SLC7A6"
"78","Beta-catenin independent WNT signaling",0.28018691588785,0.980533241832259,-0.801501827640238,-1.13734832497426,1498,137,"PRICKLE1, UBB, AGO2, ROR1, PRKG1, CLTC, GNB1, PSMB2, DVL2, CAMK2A"
"79","Beta-catenin phosphorylation cascade",0.676099259904223,0.980533241832259,0.361187428801179,0.535500068917471,3105,17,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, FRAT1, FRAT2, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"80","Bile acid and bile salt metabolism",0.557388009806106,0.980533241832259,0.829254783505547,1.0925498003055,2500,30,"CYP7B1, ABCB11"
"81","Binding and Uptake of Ligands by Scavenger Receptors",0.0726543347448184,0.906512436285034,0.99215291750503,1.3071693928738,325,30,"APOE, HBA1, ALB"
"82","Biological oxidations",0.670407943017483,0.980533241832259,0.600709985422776,0.876070972370544,3105,139,"CYP7B1, COMT, ABHD10"
"83","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",0.281679942070963,0.980533241832259,-0.909605496020389,-1.18560028903919,1555,76,"ST3GAL5, ST6GALNAC3, ST3GAL3"
"84","Blood group systems biosynthesis",0.564191383416324,0.980533241832259,0.637277476578086,0.985233675687956,2605,15,"ST3GAL4, B3GALT1"
"85","Branched-chain amino acid catabolism",0.622620870706629,0.980533241832259,0.672680137822304,0.970312516601259,2845,19,"ACAT1, ACAD8"
"86","Budding and maturation of HIV virion",0.191039883445638,0.980533241832259,-0.981762102722274,-1.22246922277116,1048,26,"UBB, PPIA"
"87","Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA",0.646394439617724,0.980533241832259,0.460198338247119,0.695295022783258,2975,16,"AKT1, DCP1A, DCP2, DIS3, EXOSC1, EXOSC2, EXOSC3, EXOSC4, EXOSC5, EXOSC7, EXOSC8, EXOSC9"
"88","C-type lectin receptors (CLRs)",0.825965824665676,0.980533241832259,-0.561248147514288,-0.779343737459703,4446,119,"UBB, PDPK1, CUL1, PSMB2, CREBBP, CHUK, PAK2"
"89","CD209 (DC-SIGN) signaling",0.690564393113968,0.980533241832259,0.487304697513952,0.711891846178949,3168,18,"PAK3, RAF1"
"90","CD28 co-stimulation",0.857142857142857,0.980533241832259,-0.578011580787643,-0.705018739984977,4745,33,"PDPK1, PAK2"
"91","CD28 dependent PI3K/Akt signaling",0.102231163130944,0.980533241832259,-0.990146132189301,-1.26523532060578,558,22,"PDPK1"
"92","CDK-mediated phosphorylation and removal of Cdc6",0.9392632524708,0.980533241832259,-0.518916455007583,-0.662575227690415,5226,66,"UBB, PSMB2"
"93","CDT1 association with the CDC6:ORC:origin complex",0.830493110949964,0.980533241832259,-0.60219365929582,-0.752279183482701,4580,55,"UBB, ORC3, PSMB2"
"94","CLEC7A (Dectin-1) signaling",0.804984537020193,0.980533241832259,-0.582983169744614,-0.782331898925719,4424,94,"UBB, PDPK1, CUL1, PSMB2, CHUK"
"95","COPI-dependent Golgi-to-ER retrograde traffic",0.746152453376788,0.980533241832259,-0.627297303088175,-0.820866512599152,4120,78,"ARF4, KIF3A, KIF3B, KIF21A, COPA, STX18, KIF5A"
"96","COPI-independent Golgi-to-ER retrograde traffic",0.59815784720968,0.980533241832259,-0.884949902848584,-1.07940097775542,3311,33,"GALNT2, DYNLL1, RAB6B"
"97","COPI-mediated anterograde transport",0.923954372623574,0.980533241832259,-0.520907940510344,-0.68164789232615,5102,78,"DYNLL1, SPTBN2, ARF4, COPA"
"98","COPII-mediated vesicle transport",0.857591388203633,0.980533241832259,0.559099042308077,0.73275954103537,3823,60,"LMAN2L, TBC1D20, TFG, SEC23IP"
"99","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling",0.808592321755027,0.980533241832259,-0.618775674596426,-0.76551402925282,4422,27,"RASGRF1, PDPK1, CAMK2A, GRIN2B, CAMK2G"
"100","CRMPs in Sema3A signaling",0.668331885317116,0.980533241832259,0.313940632538193,0.474320181347592,3076,16,"CDK5, CDK5R1, CRMP1, DPYSL2, DPYSL3, DPYSL4, DPYSL5, FES, FYN, GSK3B, NRP1, PLXNA1, PLXNA2, PLXNA3, PLXNA4"
"101","CTLA4 inhibitory signaling",0.783209118807541,0.980533241832259,0.244597014353701,0.343391109925157,3572,21,"AKT1, AKT2, AKT3, CD80, CD86, CTLA4, FYN, LCK, LYN, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E, PTPN11"
"102","Ca-dependent events",0.642105263157895,0.980533241832259,0.738842463988622,0.959661396117195,2866,33,"ADCY1, CREB1, ADCY2"
"103","Ca2+ pathway",0.25685740236149,0.980533241832259,-0.963383499059393,-1.20490845266519,1413,56,"AGO2, PRKG1, GNB1, CAMK2A, GNAO1"
"104","CaM pathway",0.638473555010042,0.980533241832259,0.738844344766533,0.969243497526356,2860,31,"ADCY1, CREB1, ADCY2"
"105","Calmodulin induced events",0.638473555010042,0.980533241832259,0.738844344766533,0.969243497526356,2860,31,"ADCY1, CREB1, ADCY2"
"106","Calnexin/calreticulin cycle",0.46933575978162,0.980533241832259,-0.964735854116385,-1.2212715406813,2578,24,"UBB, OS9, UGGT1"
"107","Cap-dependent Translation Initiation",0.74990899162723,0.980533241832259,-0.618384597100571,-0.821073994922409,4119,87,"EIF4E, EIF5, EIF4A2"
"108","Carboxyterminal post-translational modifications of tubulin",0.264524328249818,0.980533241832259,-0.975523068669528,-1.20391992217895,1456,28,"TUBB2A"
"109","Cardiac conduction",0.0729753139887397,0.906512436285034,0.920349815420108,1.31940112635075,336,119,"KCNIP4, KCND2, SLC8A3, TRPC1, KCNJ4, ATP1A1"
"110","Cargo concentration in the ER",0.78381992422554,0.980533241832259,0.579546668525212,0.763557364466745,3516,30,"LMAN2L, MIA3, CD59"
"111","Cargo recognition for clathrin-mediated endocytosis",0.390616475722859,0.980533241832259,-0.802462240319671,-1.07921395197748,2147,95,"UBB, CLTC, TFRC, SH3GL1, DVL2"
"112","Cargo trafficking to the periciliary membrane",0.669157856361648,0.980533241832259,-0.757079287557254,-0.928563681814059,3670,47,"ARF4"
"113","Caspase activation via extrinsic apoptotic signalling pathway",0.78233231039018,0.980533241832259,0.245679047810558,0.344910182718046,3568,21,"APPL1, CASP3, CASP8, CASP9, CD14, CFLAR, DAPK1, DAPK2, DAPK3, DCC"
"114","Cdc20:Phospho-APC/C mediated degradation of Cyclin A",0.896117900790798,0.980533241832259,-0.546835310411984,-0.697453582453388,4985,65,"UBB, PSMB2, BUB3"
"115","Cell Cycle Checkpoints",0.760174971472043,0.980533241832259,-0.550499516337945,-0.842136561342617,3996,234,"UBB, ORC3, YWHAG, SUMO1, DYNLL1, CENPP, PSMB2, BUB3, NUP98"
"116","Cell Cycle, Mitotic",0.204357474278798,0.980533241832259,-0.694958295590423,-1.14019314124407,1012,424,"PTTG1, UBB, HSP90AB1, ORC3, YWHAG, CUL1, DYNLL1, FBXL7, ARPP19, AKAP9, CENPP, PSMB2, PPP2R2A, CCND2, BUB3, LPIN2, NUP98, PCM1, MAX, SDCCAG8"
"117","Cell death signalling via NRAGE, NRIF and NADE",0.75858330321648,0.980533241832259,-0.632670115814292,-0.814277190477501,4197,70,"UBB, ARHGEF12, ARHGEF11, ARHGEF7, ARHGEF18, FGD4"
"118","Cell junction organization",0.809843400447427,0.980533241832259,0.579682222816901,0.776460633607038,3619,72,"CDH12, SDK2, ACTN1, MPP5, FERMT2"
"119","Cell surface interactions at the vascular wall",0.26304347826087,0.980533241832259,0.81463719999417,1.15538269008164,1209,110,"ITGA4, SIRPA, SIRPG, CD47, ANGPT1"
"120","Cell-Cell communication",0.522542335605894,0.980533241832259,0.694346894779804,0.975837316979561,2375,104,"CDH12, TYROBP, KIRREL3, SIRPB1, SIRPA, SIRPG, SDK2, CASK, ACTN1, MPP5, CD47, FERMT2"
"121","Cell-cell junction organization",0.810008857395926,0.980533241832259,0.583206042345895,0.756040467415971,3657,47,"CDH12, SDK2, MPP5, AFDN"
"122","Cell-extracellular matrix interactions",0.405734144222415,0.980533241832259,0.973197534173144,1.47036472203029,1867,16,"ACTN1, FERMT2, ARHGEF6"
"123","Cellular Senescence",0.441138181141901,0.980533241832259,-0.744984201092864,-1.031739209914,2371,117,"UBB, SCMH1, RBBP7, MAPK14"
"124","Cellular response to heat stress",0.31008174386921,0.980533241832259,-0.849497971712622,-1.1388866945392,1706,93,"CRYAB, UBB, HSP90AB1, HSPA8, HSPA4, CREBBP, HSPA9, ST13, NUP98, CAMK2A, CAMK2G"
"125","Cellular response to hypoxia",0.956270328876039,0.985120736573921,-0.504946058973867,-0.646722137247133,5291,68,"UBB, PSMB2, CREBBP, EGLN1"
"126","Cellular responses to external stimuli",0.179393939393939,0.980533241832259,-0.701722298205906,-1.15626616520356,887,444,"CRYAB, NR3C2, ATP6V0C, UBB, HSP90AB1, ATP6V0B, DYNLL1, HSPA8, DNAJA2, HSPA4, PSMB2, CREBBP, HSPA9, ST13, NUP98, CAMK2A, ATP6V1C1, SCMH1, EGLN1, CAMK2G, SESN1, TXNRD2, RBBP7"
"127","Cellular responses to stress",0.162865792129162,0.980533241832259,-0.708717484041365,-1.16701743749561,806,439,"CRYAB, NR3C2, ATP6V0C, UBB, HSP90AB1, ATP6V0B, DYNLL1, HSPA8, DNAJA2, HSPA4, PSMB2, CREBBP, HSPA9, ST13, NUP98, CAMK2A, ATP6V1C1, SCMH1, EGLN1, CAMK2G, SESN1, TXNRD2, RBBP7"
"128","Centrosome maturation",0.79477445288075,0.980533241832259,0.586079898404036,0.787970810812463,3558,76,"CKAP5, CDK11A, CDK11B, DYNC1I2, TUBGCP4, ODF2"
"129","Chaperone Mediated Autophagy",0.665987402741756,0.980533241832259,-0.70050956104198,-0.954456089841899,3594,16,"UBB, HSP90AB1, HSPA8"
"130","Chaperonin-mediated protein folding",0.171023965141612,0.980533241832259,-0.960433349034385,-1.25811304782307,941,79,"FBXW7, FBXW4, GNB1, XRN2, TUBB2A, GNAO1, PFDN1"
"131","Chemokine receptors bind chemokines",0.338543582199338,0.980533241832259,-0.972922252010724,-1.2656716872831,1840,20,"CX3CL1"
"132","Cholesterol biosynthesis",0.777679165742179,0.980533241832259,0.513895105749534,0.700478155217739,3504,24,"GGPS1, ACAT2"
"133","Chondroitin sulfate biosynthesis",0.0277838547363815,0.629804462055302,0.997654312713625,1.4390739557156,126,19,"CSGALNACT1, BCAN"
"134","Chondroitin sulfate/dermatan sulfate metabolism",0.00950276243093923,0.629804462055302,0.997650060427018,1.28959745541516,42,46,"CSGALNACT1, AGRN"
"135","Chromatin modifying enzymes",0.159513862514242,0.980533241832259,-0.817170363582777,-1.21704232116544,839,192,"DOT1L, NCOR2, KAT6B, KDM1A, BRD1, CREBBP, CLOCK, ATF7IP, DNMT3A, SMARCA4, HDAC2, KDM2A, RBBP7, AEBP2"
"136","Chromatin organization",0.159513862514242,0.980533241832259,-0.817170363582777,-1.21704232116544,839,192,"DOT1L, NCOR2, KAT6B, KDM1A, BRD1, CREBBP, CLOCK, ATF7IP, DNMT3A, SMARCA4, HDAC2, KDM2A, RBBP7, AEBP2"
"137","Chromosome Maintenance",0.248547567175018,0.980533241832259,-0.963445773417551,-1.20841794733223,1368,58,"CENPP, RBBP7"
"138","Cilium Assembly",0.255210306934445,0.980533241832259,-0.778540185159854,-1.14604692647735,1346,178,"AHI1, YWHAG, DYNLL1, AKAP9, TTC26, ARF4, KIF3A, KIF3B, IFT20, PCM1, SDCCAG8"
"139","Circadian Clock",0.421621621621622,0.980533241832259,-0.854282981367418,-1.09217462809407,2339,67,"UBB, CRTC3, CUL1, MEF2D, CREBBP, CLOCK, CRY2"
"140","Citric acid cycle (TCA cycle)",0.692765769739744,0.980533241832259,0.607998237819023,0.845438117879357,3140,22,"FAHD1, SDHA, OGDH, ACO2"
"141","Class A/1 (Rhodopsin-like receptors)",0.920927580307926,0.980533241832259,-0.503091087670182,-0.748301846182969,4844,190,"OPRM1, CX3CL1, SST, CCK"
"142","Class B/2 (Secretin family receptors)",0.931883537023724,0.980533241832259,-0.523199472590734,-0.6673075778907,5184,65,"GNB1, RAMP1, GLP2R"
"143","Class I MHC mediated antigen processing & presentation",0.423497267759563,0.980533241832259,-0.640618384980472,-1.01934128812545,2169,326,"HECTD2, UBB, FBXO10, CUL3, FBXW7, SEC23A, CUL1, MGRN1, FBXW4, FBXL7, PSMB2, UBE2O, CHUK, UBR2, WWP1, UBE2K, TRIM9, UBR1, RNF111, ITCH, RNF217, RNF6"
"144","Class I peroxisomal membrane protein import",0.730474732006126,0.980533241832259,0.283136801188011,0.408412805219087,3338,19,"ABCD1, ABCD2, ABCD3, ACBD5, ALDH3A2, ATAD1, FIS1, GDAP1, PEX12, PEX13, PEX14, PEX16, PEX19, PEX2, PEX26, PEX3, PXMP2, PXMP4"
"145","Clathrin-mediated endocytosis",0.218283582089552,0.980533241832259,-0.838653931647502,-1.18547590615914,1169,133,"UBB, CLTC, TFRC, HSPA8, SYNJ1, SH3GL1, DVL2, BIN1"
"146","Cleavage of the damaged pyrimidine",0.71279955415196,0.980533241832259,-0.416013400335008,-0.575956707218245,3836,15,"UNG, TINF2, TERF2IP, TERF2, TERF1, TDG, SMUG1, POT1, OGG1, NTHL1, NEIL3, NEIL2, NEIL1, MBD4"
"147","Cobalamin (Cbl, vitamin B12) transport and metabolism",0.127454612819563,0.980533241832259,-0.98874296435272,-1.34717896242708,687,16,"LMBRD1"
"148","Collagen biosynthesis and modifying enzymes",0.0441964285714286,0.774910714285714,0.986828842147705,1.29269722640747,197,59,"COL25A1, COLGALT1, ADAMTS14"
"149","Collagen chain trimerization",0.0766317665404322,0.916097936369712,0.990405260332797,1.2797424742008,343,36,"COL25A1, COL11A1"
"150","Collagen degradation",0.472426881000223,0.980533241832259,0.91372392793883,1.20844524577999,2115,29,"COL25A1, ADAM10"
"151","Collagen formation",0.215708212127993,0.980533241832259,0.908231885625738,1.22050620496518,963,74,"CTSS, COL25A1, COLGALT1, ADAMTS14"
"152","Complement cascade",0.479283314669653,0.980533241832259,0.893076083928209,1.15999104452478,2139,33,"C1QB, C1QA"
"153","Complex I biogenesis",0.796040925266904,0.980533241832259,0.597088901098038,0.777844265086699,3578,54,"NDUFS1, NDUFS4, ACAD9"
"154","Constitutive Signaling by AKT1 E17K in Cancer",0.763248952831907,0.980533241832259,-0.681027101237958,-0.848000415607782,4190,26,"PDPK1, CHUK"
"155","Constitutive Signaling by Aberrant PI3K in Cancer",0.55623168807753,0.980533241832259,0.732795424785666,0.969560964482358,2467,66,"NRG1, STRN"
"156","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants",0.0310363938666174,0.629804462055302,-0.99718536389224,-1.3233161215276,167,18,"UBB"
"157","Constitutive Signaling by NOTCH1 HD Domain Mutants",0.249674902470741,0.980533241832259,-0.97929648241206,-1.355803387454,1343,15,"UBB, NEURL1, MIB1"
"158","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants",0.866098930965755,0.980533241832259,-0.572778423693031,-0.717999516146413,4779,57,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, CREBBP, MIB1, HDAC9"
"159","Constitutive Signaling by NOTCH1 PEST Domain Mutants",0.866098930965755,0.980533241832259,-0.572778423693031,-0.717999516146413,4779,57,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, CREBBP, MIB1, HDAC9"
"160","Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase",0.600565955594253,0.980533241832259,0.658549179907841,0.976371554227918,2758,17,"ANAPC1, ANAPC10, ANAPC15, ANAPC16, ANAPC2, ANAPC4, ANAPC5, ANAPC7, CDC14A, CDC16, CDC20, CDC23, CDC26, CDC27"
"161","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding",0.428182313419285,0.980533241832259,-0.963233814156323,-1.1700444487952,2357,35,"GNB1, GNAO1"
"162","Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding",0.557825611090843,0.980533241832259,-0.960246698397801,-1.22166590140143,3057,23,"TUBB2A, PFDN1"
"163","Costimulation by the CD28 family",0.858360536815379,0.980533241832259,-0.577981389797048,-0.719299919228368,4732,53,"PDPK1, PAK2"
"164","Cristae formation",0.649977748108589,0.980533241832259,0.727686967745736,0.966772981263507,2920,28,"ATP5MG, APOO"
"165","Cross-presentation of soluble exogenous antigens (endosomes)",0.537016574585635,0.980533241832259,0.794437384486839,1.02691762388346,2429,46,"PSMA1, PSMB3, PSMD14, PSME4, PSMD9"
"166","Cyclin A/B1/B2 associated events during G2/M transition",0.183639705882353,0.980533241832259,-0.983443930558348,-1.2655658004325,998,21,"PPP2R2A"
"167","Cyclin A:Cdk2-associated events at S phase entry",0.815016322089227,0.980533241832259,-0.58583312287988,-0.768786672200016,4493,80,"UBB, CUL1, PSMB2, MAX"
"168","Cyclin D associated events in G1",0.106479796141245,0.980533241832259,-0.983220350359085,-1.19894217354399,584,41,"UBB, CUL1, PPP2R2A, CCND2"
"169","Cyclin E associated events during G1/S transition",0.816042006156075,0.980533241832259,-0.58583717994467,-0.766612769550688,4506,78,"UBB, CUL1, PSMB2, MAX"
"170","Cytochrome P450 - arranged by substrate type",0.0110963160230803,0.629804462055302,0.997965554543945,1.28685548998711,49,42,"CYP7B1, AHR"
"171","Cytosolic sensors of pathogen-associated DNA",0.175081729022884,0.980533241832259,-0.970038962783824,-1.20839834689181,963,54,"UBB, CREBBP, CHUK, LRRFIP1"
"172","Cytosolic sulfonation of small molecules",0.549264705882353,0.980533241832259,-0.961123399691668,-1.23684214915496,2987,21,"PODXL2"
"173","DAG and IP3 signaling",0.637093178778422,0.980533241832259,0.738838700918384,0.953336211408292,2857,37,"ADCY1, CREB1, ADCY2"
"174","DAP12 interactions",0.128838451268358,0.980533241832259,0.988331545064378,1.31305393204804,578,28,"TYROBP, TREM2, SIRPB1, B2M"
"175","DAP12 signaling",0.105903161618395,0.980533241832259,0.99068052296346,1.34336211985866,478,25,"TYROBP, TREM2, B2M"
"176","DARPP-32 events",0.0306457497263772,0.629804462055302,-0.996648119595093,-1.2679773077447,167,23,"PDE4A"
"177","DDX58/IFIH1-mediated induction of interferon-alpha/beta",0.523464395723863,0.980533241832259,-0.823157082878297,-1.03185867827986,2888,57,"UBB, CREBBP, CHUK, UBE2K, ITCH"
"178","DNA Damage Bypass",0.452159650082012,0.980533241832259,-0.940822075595799,-1.15224359512971,2480,45,"UBB, REV3L"
"179","DNA Damage Recognition in GG-NER",0.0143064107207533,0.629804462055302,-0.997181586364246,-1.21025704832357,78,38,"UBB"
"180","DNA Damage/Telomere Stress Induced Senescence",0.85014409221902,0.980533241832259,0.214305608566035,0.288804477807276,3834,26,"ACD, ASF1A, ATM, CABIN1, CCNA1, CCNA2, CCNE1, CCNE2, CDKN1A, CDKN1B"
"181","DNA Double Strand Break Response",0.691369264384559,0.980533241832259,-0.762962539040021,-0.926923013842314,3796,40,"UBB, SUMO1"
"182","DNA Double-Strand Break Repair",0.413355717216937,0.980533241832259,-0.749824838256863,-1.04916306288218,2215,125,"UBB, SUMO1, SUMO2"
"183","DNA Repair",0.171703561116458,0.980533241832259,-0.762121133206917,-1.18709030946803,891,272,"UBB, ASCC2, SUMO1, REV3L, SUMO2, RNF111"
"184","DNA Replication",0.658622609987006,0.980533241832259,-0.642108589698275,-0.890632776944983,3547,118,"UBB, ORC3, CUL1, PSMB2"
"185","DNA Replication Pre-Initiation",0.786673928830792,0.980533241832259,-0.602168162698158,-0.788806035562887,4332,79,"UBB, ORC3, PSMB2"
"186","DNA strand elongation",0.874804731086811,0.980533241832259,0.296532295928634,0.389002097222804,3919,31,"CDC45, DNA2, FEN1, GINS1, GINS2, GINS3, GINS4, LIG1, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, MCM8, PCNA, POLA1, POLA2, POLD1, POLD2, POLD4, PRIM1, PRIM2, RFC1, RFC2, RFC3, RFC4, RFC5, RPA1, RPA2, RPA3"
"187","Deactivation of the beta-catenin transactivating complex",0.752586676347795,0.980533241832259,-0.705774996586522,-0.856355623530439,4145,39,"UBB, TLE4"
"188","Deadenylation of mRNA",0.671754321441707,0.980533241832259,-0.793032636692228,-1.03165381743346,3652,20,"EIF4E, CNOT6L, CNOT4, EIF4A2"
"189","Deadenylation-dependent mRNA decay",0.964126559714795,0.985120736573921,0.478054195621375,0.620477815674944,4326,50,"LSM7, CNOT7"
"190","Death Receptor Signalling",0.583131632843046,0.980533241832259,-0.66855101191465,-0.937238455310081,3131,127,"UBB, ARHGEF12, MADD, ARHGEF11, ARHGEF7, ARHGEF18, CHUK, SPPL2A, FGD4, HDAC2"
"191","Dectin-1 mediated noncanonical NF-kB signaling",0.833333333333333,0.980533241832259,-0.59514657643798,-0.746472530270052,4589,58,"UBB, CUL1, PSMB2, CHUK"
"192","Defective B3GALT6 causes EDSP2 and SEMDJL1",0.703203312268468,0.980533241832259,0.327033909663584,0.477756062892997,3226,18,"AGRN, B3GALT6, BCAN, BGN, CSPG4, CSPG5, DCN, GPC1, GPC3, GPC4, GPC5, GPC6, HSPG2"
"193","Defective B3GALTL causes Peters-plus syndrome (PpS)",0.0311310190369541,0.629804462055302,0.996243375595358,1.29399209614334,138,33,"ADAMTS17, ADAMTS1"
"194","Defective B3GAT3 causes JDSSDHD",0.703203312268468,0.980533241832259,0.327033909663584,0.477756062892997,3226,18,"AGRN, B3GAT3, BCAN, BGN, CSPG4, CSPG5, DCN, GPC1, GPC3, GPC4, GPC5, GPC6, HSPG2"
"195","Defective B4GALT7 causes EDS, progeroid type",0.703203312268468,0.980533241832259,0.327033909663584,0.477756062892997,3226,18,"AGRN, B4GALT7, BCAN, BGN, CSPG4, CSPG5, DCN, GPC1, GPC3, GPC4, GPC5, GPC6, HSPG2"
"196","Defective CFTR causes cystic fibrosis",0.856753812636166,0.980533241832259,-0.578133876284659,-0.725134067052834,4718,58,"UBB, OS9, PSMB2"
"197","Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)",0.530908279401919,0.980533241832259,0.853935297694805,1.12022409112498,2378,31,"NUP93, RANBP2, AAAS"
"198","Defects in vitamin and cofactor metabolism",0.177395757132407,0.980533241832259,-0.983912052553962,-1.25726924621567,969,22,"ACACA, LMBRD1, MCCC1"
"199","Degradation of AXIN",0.937908496732026,0.980533241832259,-0.518931375250755,-0.643141499391038,5165,52,"UBB, PSMB2"
"200","Degradation of DVL",0.860697420995278,0.980533241832259,-0.576951528391606,-0.718720896678548,4738,54,"UBB, CUL3, PSMB2, DVL2"
"201","Degradation of GLI1 by the proteasome",0.873277737490936,0.980533241832259,-0.568491263868885,-0.710177095355713,4816,55,"UBB, CUL1, PSMB2, ITCH"
"202","Degradation of GLI2 by the proteasome",0.86158038147139,0.980533241832259,-0.576870733523253,-0.721495046983865,4742,56,"UBB, CUL1, PSMB2"
"203","Degradation of beta-catenin by the destruction complex",0.778462654097172,0.980533241832259,-0.60654317494801,-0.798429719976462,4293,82,"UBB, CUL1, PSMB2, TLE4"
"204","Degradation of the extracellular matrix",0.222074468085106,0.980533241832259,0.878999575289114,1.2058804428064,1001,85,"CTSS, COL25A1, LAMC1, MMP16, A2M"
"205","Deposition of new CENPA-containing nucleosomes at the centromere",0.489535941765241,0.980533241832259,-0.963529096272459,-1.21974389038719,2689,24,"CENPP, RBBP7"
"206","Depyrimidination",0.71279955415196,0.980533241832259,-0.416013400335008,-0.575956707218245,3836,15,"UNG, TINF2, TERF2IP, TERF2, TERF1, TDG, SMUG1, POT1, OGG1, NTHL1, NEIL3, NEIL2, NEIL1, MBD4"
"207","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models",0.55393331880584,0.980533241832259,0.798909409800412,1.16710776147662,2541,18,"PRDX1, APP"
"208","Detoxification of Reactive Oxygen Species",0.510363271673724,0.980533241832259,0.873822890064736,1.15126863665082,2289,30,"PRDX1, ATOX1"
"209","Deubiquitination",0.753526496378193,0.980533241832259,-0.555556414935359,-0.844399901355627,3952,221,"UBB, USP47, PSMB2, SMAD7, ASXL1"
"210","Disassembly of the destruction complex and recruitment of AXIN to the membrane",0.304829339143065,0.980533241832259,-0.972974785407725,-1.20077501552859,1678,28,"DVL2"
"211","Diseases associated with N-glycosylation of proteins",0.635317115551694,0.980533241832259,0.511223532564996,0.772386921421792,2924,16,"ALG1, ALG11, ALG12, ALG14, ALG2, ALG3, ALG6, ALG8, ALG9, B4GALT1"
"212","Diseases associated with O-glycosylation of proteins",0.0868983957219251,0.980533241832259,0.982467925035266,1.2785929804219,389,53,"ADAMTS17, LARGE1, ADAMTS1"
"213","Diseases associated with glycosaminoglycan metabolism",0.505349977708426,0.980533241832259,0.854960334567202,1.10316994121657,2266,37,"EXT1, ACAN"
"214","Diseases associated with glycosylation precursor biosynthesis",0.68741837178929,0.980533241832259,0.316838200803339,0.469747463052684,3157,17,"CTSA, DHDDS, DOLK, DPM2, DPM3, GALE, GALK1, GFPT1, GLB1, DPM1, GNE, MPI, NEU1, NUS1, PGM1, PMM2"
"215","Diseases associated with the TLR signaling cascade",0.258636615555145,0.980533241832259,-0.978890229191797,-1.29903753945925,1399,18,"CHUK"
"216","Diseases of Immune System",0.258636615555145,0.980533241832259,-0.978890229191797,-1.29903753945925,1399,18,"CHUK"
"217","Diseases of carbohydrate metabolism",0.651331280565115,0.980533241832259,-0.833348183750908,-1.02057052306887,3595,31,"UBB"
"218","Diseases of glycosylation",0.0190229139645482,0.629804462055302,0.964057837711053,1.38623833421027,87,122,"ADAMTS17, LARGE1, EXT1, ACAN"
"219","Diseases of metabolism",0.926355724168712,0.980533241832259,0.509774613437489,0.693135591182492,4150,81,"CYP7B1, GALNS, ABCA3"
"220","Diseases of signal transduction",0.571710396527915,0.980533241832259,-0.584942540743321,-0.939095740903493,2897,350,"MAML3, SPRED2, UBB, PTPN12, NEURL1, FGFR1, FBXW7, SPRED1, ZMYM2, NCOR2, OS9, PDPK1, CUL1, AKAP9, IQGAP1, PSMB2, CREBBP, FXR1, MIB1, CHUK, HDAC9, CAMK2A, LRRFIP1, MYO18A, CAMK2G, FGFR2, ZFYVE9, NF1, HDAC2"
"221","Disorders of transmembrane transporters",0.543724609792602,0.980533241832259,0.649845301526852,0.955865028988516,2542,149,"SLC1A3, PSMA1, NUP93, PSMB3, SLC4A4, RANBP2, PSMD14, PSME4, VCP, PSMD9"
"222","Dopamine Neurotransmitter Release Cycle",0.661504424778761,0.980533241832259,0.674081396273961,0.927716394142911,2989,23,"RIMS1, CASK, APBA1"
"223","Downregulation of ERBB2 signaling",0.814430714916152,0.980533241832259,0.500908597813643,0.672867795413349,3690,27,"NRG1, AKT1"
"224","Downregulation of SMAD2/3:SMAD4 transcriptional activity",0.409656181419166,0.980533241832259,-0.96842740313715,-1.2374825453112,2239,22,"UBB, NCOR2, SKIL, RNF111"
"225","Downregulation of TGF-beta receptor signaling",0.426151884902568,0.980533241832259,-0.966273300254794,-1.20318289641819,2339,26,"UBB, PMEPA1, SMAD7, ZFYVE9"
"226","Downstream TCR signaling",0.820987654320988,0.980533241832259,-0.583004314085786,-0.763702484119186,4521,79,"UBB, PDPK1, CUL1, PSMB2, CHUK"
"227","Downstream signal transduction",0.89760348583878,0.980533241832259,-0.286346566523605,-0.353388194658977,4943,28,"STAT6, STAT5B, STAT3, STAT1, SRC, SOS1, RASA1, RAPGEF1, PTPN11, PLCG1, PIK3R2, PIK3R1, PIK3CB, PIK3CA, PDGFRB, PDGFRA, PDGFB, PDGFA, NRAS, NCK2, NCK1"
"228","Downstream signaling events of B Cell Receptor (BCR)",0.757690915671372,0.980533241832259,-0.620923216420199,-0.810757135834741,4186,77,"UBB, CUL1, PSMB2, PPIA, CHUK"
"229","Downstream signaling of activated FGFR1",0.0389728646876707,0.719288660551397,-0.994904116937106,-1.23883337846458,213,26,"FGFR1"
"230","Downstream signaling of activated FGFR2",0.415589145875068,0.980533241832259,-0.966943811184122,-1.20401780232091,2281,26,"FGFR2"
"231","Downstream signaling of activated FGFR3",0.843487778183145,0.980533241832259,-0.313199705034524,-0.398465728242634,4623,23,"SOS1, SHC1, PTPN11, PLCG1, PIK3R1, PIK3CA, NRAS, KRAS, HRAS, GRB2, GAB1, FRS3, FRS2, FGFR3, FGF9, FGF5, FGF4, FGF23, FGF20, FGF2, FGF18, FGF16, FGF1"
"232","Downstream signaling of activated FGFR4",0.843487778183145,0.980533241832259,-0.313199705034524,-0.398465728242634,4623,23,"SOS1, SHC1, PTPN11, PLCG1, PIK3R1, PIK3CA, NRAS, KRAS, KLB, HRAS, GRB2, GAB1, FRS3, FRS2, FGFR4, FGF9, FGF4, FGF23, FGF20, FGF2, FGF18, FGF16, FGF1"
"233","Dual Incision in GG-NER",0.0114712308812819,0.629804462055302,-0.997181208053691,-1.21147522115442,62,40,"UBB"
"234","Dual incision in TC-NER",0.00396324986488921,0.629804462055302,-0.997176660392579,-1.26759630887635,21,64,"UBB"
"235","E2F mediated regulation of DNA replication",0.0647296800294226,0.906512436285034,-0.993766756032172,-1.29278824106824,351,20,"ORC3"
"236","E3 ubiquitin ligases ubiquitinate target proteins",0.607896652110626,0.980533241832259,-0.82431367920798,-1.0067359388015,3340,42,"UBB, SELENOS"
"237","ECM proteoglycans",0.093950808774651,0.980533241832259,0.983278490363307,1.27690870096041,423,49,"TNR, LAMC1, ACAN"
"238","EGFR downregulation",0.586094513851168,0.980533241832259,-0.918909634886014,-1.13062055540327,3236,29,"UBB, PTPN12, ARHGEF7, SH3GL1"
"239","EML4 and NUDC in mitotic spindle formation",0.936335403726708,0.980533241832259,0.502576072544835,0.693066773953207,4220,90,"CKAP5, RANBP2, DYNC1I2, AHCTF1"
"240","EPH-Ephrin signaling",0.971032975040991,0.985120736573921,-0.491699711679696,-0.653722378909895,5329,88,"EPHA3, CLTC, ARHGEF7, PAK2, LIMK2, GRIN2B"
"241","EPH-ephrin mediated repulsion of cells",0.918954827280779,0.980533241832259,0.5075946858024,0.658021514949091,4149,47,"EPHA10, CLTA, ADAM10"
"242","EPHB-mediated forward signaling",0.642857142857143,0.980533241832259,-0.829748839604805,-1.01108930312794,3554,34,"LIMK2, GRIN2B"
"243","ER Quality Control Compartment (ERQC)",0.48186337691033,0.980533241832259,-0.964747671067623,-1.26685145736717,2616,19,"UBB, OS9, UGGT1"
"244","ER to Golgi Anterograde Transport",0.83786701208981,0.980533241832259,0.539709650469949,0.778877988202506,3880,126,"LMAN2L, TMED9, MIA3, TBC1D20, DYNC1I2, TFG, ACTR10, SEC23IP"
"245","ER-Phagosome pathway",0.897255326832792,0.980533241832259,-0.544076926487473,-0.699020411460403,4968,69,"UBB, PSMB2, CHUK"
"246","ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression",0.497776954427566,0.980533241832259,-0.963548646475476,-1.3128512794593,2686,16,"HDAC2, RBBP7"
"247","ERK/MAPK targets",0.466242875931609,0.980533241832259,0.948683568834774,1.33186214284223,2126,21,"RPS6KA2, DUSP4"
"248","ESR-mediated signaling",0.172632363907532,0.980533241832259,-0.850512839631632,-1.21542541998783,925,144,"HSP90AB1, AGO2, KDM1A, PDPK1, GNB1, CREBBP"
"249","Effects of PIP2 hydrolysis",0.668921389396709,0.980533241832259,-0.825954848282947,-1.02182430539527,3658,27,"DGKZ, DGKB, MGLL, DGKD, DAGLB"
"250","Elastic fibre formation",0.446835443037975,0.980533241832259,-0.962766671139139,-1.17317799812834,2470,34,"FBLN2, FURIN"
"251","Elevation of cytosolic Ca2+ levels",0.71279955415196,0.980533241832259,-0.419966499162479,-0.581429640979862,3836,15,"TRPC7, TRPC6, TRPC3, STIM1, P2RX7, P2RX6, P2RX5, P2RX4, P2RX3, P2RX1, ORAI2, ORAI1, ITPR3, ITPR2, ITPR1"
"252","Endogenous sterols",0.0245022970903522,0.629804462055302,0.997967520417302,1.43952574451994,111,19,"CYP7B1, AHR"
"253","Endosomal Sorting Complex Required For Transport (ESCRT)",0.620315046170559,0.980533241832259,-0.880024255678468,-1.0827762327761,3425,29,"UBB"
"254","Energy dependent regulation of mTOR by LKB1-AMPK",0.399782135076253,0.980533241832259,-0.967125412970089,-1.19355614368836,2201,28,"PRKAG2, STRADA"
"255","Ephrin signaling",0.767411786440052,0.980533241832259,-0.496286877569479,-0.658598140095904,4153,18,"ARHGEF7, PAK2"
"256","Epigenetic regulation of gene expression",0.118310884601383,0.980533241832259,-0.962229852555039,-1.27762223182036,649,87,"SF3B1, TET3, DNMT3A, HDAC2, RBBP7, AEBP2"
"257","Estrogen-dependent gene expression",0.0382513661202186,0.719288660551397,-0.975327692525712,-1.28875835000739,209,85,"HSP90AB1, AGO2, KDM1A, CREBBP"
"258","Estrogen-dependent nuclear events downstream of ESR-membrane signaling",0.181296868107631,0.980533241832259,0.985923045984716,1.37095286223397,821,22,"CREB1, AKT1"
"259","Eukaryotic Translation Elongation",0.871919409965821,0.980533241832259,-0.562124635205044,-0.712657428038748,4846,62,"RPSA, RPS9, RPS8, RPS7, RPS5, RPS4X, RPS3A, RPS28, RPS27L, RPS27A, RPS25, RPS24, RPS21, RPS20, RPS19, RPS17, RPS16, RPS15A, RPS15, RPS14, RPS13, RPS12, RPS11, RPLP1, RPL8, RPL7A, RPL6, RPL5, RPL4, RPL3L, RPL38, RPL37A, RPL36, RPL35, RPL34, RPL32, RPL30, RPL3, RPL29, RPL28, RPL27, RPL26, RPL23, RPL22L1, RPL19, RPL18A, RPL18, RPL14, RPL13A, RPL12, RPL11, RPL10A, RPL10"
"260","Eukaryotic Translation Initiation",0.74990899162723,0.980533241832259,-0.618384597100571,-0.821073994922409,4119,87,"EIF4E, EIF5, EIF4A2"
"261","Eukaryotic Translation Termination",0.0730337078651685,0.906512436285034,0.980372386905962,1.29092176280025,324,63,"ETF1, APEH"
"262","Export of Viral Ribonucleoproteins from Nucleus",0.530908279401919,0.980533241832259,0.853935297694805,1.12022409112498,2378,31,"NUP93, RANBP2, AAAS"
"263","Extension of Telomeres",0.904761904761905,0.980533241832259,-0.421498592800039,-0.518609180926033,4996,29,"WRAP53, TERT, RUVBL2, RUVBL1, RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, PRIM2, PRIM1, POLE4, POLE3, POLE2, POLE, POLD4, POLD2, POLD1, POLA2, POLA1"
"264","Extra-nuclear estrogen signaling",0.820291419320022,0.980533241832259,-0.597122899450248,-0.757027966920592,4559,62,"PDPK1, GNB1"
"265","Extracellular matrix organization",0.157265674145523,0.980533241832259,0.79309133272961,1.2220836413615,749,238,"ITGA4, CTSS, COL25A1, TNR, COLGALT1, LAMC1, CASK, ACTN1, CD47, MMP16, A2M"
"266","FBXL7 down-regulates AURKA during mitotic entry and in early mitosis",0.816993464052288,0.980533241832259,-0.617466281581559,-0.765261475985875,4499,52,"UBB, CUL1, FBXL7, PSMB2"
"267","FCERI mediated Ca+2 mobilization",0.901053013798112,0.980533241832259,-0.25967581238504,-0.320473081446177,4962,28,"VAV3, VAV2, VAV1, TXK, TEC, SYK, SOS1, SHC1, PPP3R1, PPP3CB, PPP3CA, PLCG2, PLCG1, NFATC3, NFATC2, NFATC1, LYN, LCP2, LAT, ITPR3, ITPR2, ITPR1, ITK, GRB2, GRAP2"
"268","FCERI mediated MAPK activation",0.24001452432825,0.980533241832259,-0.977467811158798,-1.20631998251739,1321,28,"PAK2"
"269","FCERI mediated NF-kB activation",0.826314838243268,0.980533241832259,-0.583011352717317,-0.757651678968659,4571,74,"UBB, PDPK1, CUL1, PSMB2, CHUK"
"270","FGFR1 mutant receptor activation",0.362705667276051,0.980533241832259,-0.969288540199826,-1.19914858708836,1983,27,"FGFR1, ZMYM2, LRRFIP1, MYO18A"
"271","FGFR2 alternative splicing",0.44020412691369,0.980533241832259,0.970702601233575,1.32314155120317,1983,24,"NCBP2, GTF2F1"
"272","FGFR2 mutant receptor activation",0.582835415535035,0.980533241832259,-0.923862087299628,-1.13671402127403,3218,29,"FGFR2"
"273","FLT3 Signaling",0.666349266806323,0.980533241832259,-0.583991796700348,-0.891368118168248,3498,231,"SPRED2, UBB, CUL3, FGFR1, SPRED1, RASGRF1, PDPK1, SHC3, IQGAP1, PSMB2, SPTBN2, CAMK2A, GRIN2B, RASGEF1A, CAMK2G, FGFR2, NF1, PTPRA"
"274","FOXO-mediated transcription",0.887073347857662,0.980533241832259,-0.557846420089664,-0.699688186393888,4885,58,"YWHAG, CREBBP, HDAC2"
"275","FOXO-mediated transcription of cell cycle genes",0.68911019701234,0.980533241832259,0.27035175879397,0.417964963198648,3182,15,"BTG1, CCNG2, CDKN1A, CDKN1B, FOXG1, FOXO1, FOXO3, FOXO4, GADD45A"
"276","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.445456201056274,0.980533241832259,-0.965334584953735,-1.20201402815437,2445,26,"HDAC2"
"277","FRS-mediated FGFR1 signaling",0.0517400110476892,0.83731026498585,-0.994906507606729,-1.30645431640262,280,19,"FGFR1"
"278","FRS-mediated FGFR2 signaling",0.439154411764706,0.980533241832259,-0.966954889737918,-1.24434652651576,2388,21,"FGFR2"
"279","FRS-mediated FGFR3 signaling",0.69535846589671,0.980533241832259,0.391569494705804,0.572034564648316,3190,18,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF5, FGF9, FGFR3, FRS2, FRS3, GRB2, HRAS, KRAS"
"280","FRS-mediated FGFR4 signaling",0.69535846589671,0.980533241832259,0.391569494705804,0.572034564648316,3190,18,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF9, FGFR4, FRS2, FRS3, GRB2, HRAS, KLB, KRAS"
"281","Factors involved in megakaryocyte development and platelet production",0.655045871559633,0.980533241832259,-0.653042818607719,-0.892923273834131,3569,106,"KDM1A, KIF3A, KIF3B, KIF21A, HDAC2, KIF5A"
"282","Fanconi Anemia Pathway",0.0176139458870528,0.629804462055302,-0.997182153639718,-1.21128164953981,96,35,"UBB"
"283","Fatty acid metabolism",0.0576201201201201,0.853751638962907,-0.928683156603051,-1.33035025917167,306,148,"PTGDS, PRKAG2, ACACA, TECR"
"284","Fatty acyl-CoA biosynthesis",0.712058023572076,0.980533241832259,-0.764000310034693,-0.93785629332233,3926,30,"ACACA, TECR, HACD1"
"285","Fc epsilon receptor (FCERI) signaling",0.739365671641791,0.980533241832259,-0.598155331199629,-0.835716353980368,3962,124,"UBB, PDPK1, CUL1, PSMB2, CHUK, PAK2"
"286","Fcgamma receptor (FCGR) dependent phagocytosis",0.478174243796414,0.980533241832259,-0.782373219634495,-1.02941845042953,2639,81,"HSP90AB1"
"287","Fertilization",0.277982247239662,0.980533241832259,0.980033500837521,1.51513593970424,1283,15,"CD9, IZUMO4, ACR"
"288","Formation of ATP by chemiosmotic coupling",0.0790214332106517,0.934051098175343,0.993433835845896,1.53585291433615,364,15,"ATP5MG, ATP5F1A"
"289","Formation of Fibrin Clot (Clotting Cascade)",0.908775137111517,0.980533241832259,-0.217349516082165,-0.268892444617715,4970,27,"VWF, THBD, TFPI, SERPING1, SERPINE2, SERPIND1, SERPINC1, PRTN3, PROS1, PRCP, KNG1, KLKB1, GP9, GP5, GP1BB, FGG, F8, F5, F3, F2R, F2, F13B, F13A1, F12, F11"
"290","Formation of HIV elongation complex in the absence of HIV Tat",0.296205901930331,0.980533241832259,0.970665234610996,1.25212844660739,1334,43,"NCBP2, CCNH"
"291","Formation of HIV-1 elongation complex containing HIV-1 Tat",0.313442768411713,0.980533241832259,0.97066917242768,1.24954636263176,1412,41,"NCBP2, CCNH"
"292","Formation of Incision Complex in GG-NER",0.274977252047316,0.980533241832259,-0.968382895885078,-1.183314650501,1510,43,"UBB, SUMO1, SUMO2, RNF111"
"293","Formation of RNA Pol II elongation complex",0.198132088058706,0.980533241832259,0.970639613007256,1.26761639447144,890,56,"NCBP2, AFF4"
"294","Formation of TC-NER Pre-Incision Complex",0.00689154878491114,0.629804462055302,-0.997178746557399,-1.24099253802418,37,53,"UBB"
"295","Formation of a pool of free 40S subunits",0.0176181980374665,0.629804462055302,0.989777389199005,1.32349131198337,78,71,"EIF3A, EIF1AX"
"296","Formation of the Early Elongation Complex",0.382530795072788,0.980533241832259,0.970684913128061,1.2607949384684,1707,33,"NCBP2, CCNH"
"297","Formation of the HIV-1 Early Elongation Complex",0.382530795072788,0.980533241832259,0.970684913128061,1.2607949384684,1707,33,"NCBP2, CCNH"
"298","Formation of the beta-catenin:TCF transactivating complex",0.373664191269698,0.980533241832259,-0.96746931383728,-1.18482368225948,2062,31,"TLE4, CREBBP, SMARCA4"
"299","Formation of the cornified envelope",0.484386347131445,0.980533241832259,-0.962781652360515,-1.18819538892715,2667,28,"CAPNS1, FURIN"
"300","Formation of the ternary complex, and subsequently, the 43S complex",0.0628051486906347,0.892851573277672,0.989797288226608,1.27632268321208,282,42,"EIF3A, EIF1AX"
"301","Formation of tubulin folding intermediates by CCT/TriC",0.30676775147929,0.980533241832259,-0.975541111036655,-1.31233507510498,1658,17,"TUBB2A"
"302","G alpha (12/13) signalling events",0.916516082399711,0.980533241832259,-0.530391417251115,-0.682639534090764,5071,70,"ARHGEF12, GNB1, ARHGEF11, ARHGEF7, ARHGEF18, FGD4"
"303","G alpha (i) signalling events",0.620410703173615,0.980533241832259,0.584195219040532,0.908200173518653,2990,266,"APOE, ADCY1, NMT1, CREB1, CCL23, PSAP, NPY2R, GRM8"
"304","G alpha (q) signalling events",0.305960264900662,0.980533241832259,-0.769060497021848,-1.11336223636902,1616,159,"DGKZ, DGKB, ARHGEF25, GNB1, MGLL, DGKD, DAGLB, CCK"
"305","G alpha (s) signalling events",0.711111111111111,0.980533241832259,-0.59574564410329,-0.852583570144247,3807,146,"PDE4A, PDE10A, GNB1, PDE7A, RAMP1, ADCY8, GLP2R"
"306","G alpha (z) signalling events",0.659937888198758,0.980533241832259,0.7148359584698,0.920211228662331,2974,41,"ADCY1, ADCY2"
"307","G beta:gamma signalling through CDC42",0.13245646535754,0.980533241832259,-0.988340927365318,-1.34663118025206,714,16,"GNB1"
"308","G beta:gamma signalling through PI3Kgamma",0.597462302317028,0.980533241832259,-0.943424996550467,-1.22729879467894,3248,20,"PDPK1, GNB1"
"309","G beta:gamma signalling through PLC beta",0.13245646535754,0.980533241832259,-0.988340927365318,-1.34663118025206,714,16,"GNB1"
"310","G protein gated Potassium channels",0.631375437304364,0.980533241832259,-0.872187401069041,-1.14530660532079,3428,19,"GNB1, KCNJ6"
"311","G-protein activation",0.50625,0.980533241832259,-0.96333534419197,-1.2396886371194,2753,21,"GNB1, OPRM1, GNAO1"
"312","G-protein beta:gamma signalling",0.578793418647166,0.980533241832259,-0.943419553901782,-1.16714495031544,3165,27,"PDPK1, GNB1"
"313","G-protein mediated events",0.62577502214349,0.980533241832259,0.723091878457809,0.937381786332211,2825,47,"ADCY1, CREB1, ADCY2"
"314","G0 and Early G1",0.502918642831084,0.980533241832259,-0.962995240329825,-1.22516271108849,2756,23,"MAX, DYRK1A"
"315","G1 Phase",0.106479796141245,0.980533241832259,-0.983220350359085,-1.19894217354399,584,41,"UBB, CUL1, PPP2R2A, CCND2"
"316","G1/S DNA Damage Checkpoints",0.93613959345206,0.980533241832259,-0.518920720799459,-0.657883826966702,5203,62,"UBB, PSMB2"
"317","G1/S Transition",0.642737586014506,0.980533241832259,-0.646772687951616,-0.900545051539198,3455,121,"UBB, ORC3, CUL1, PSMB2, MAX"
"318","G1/S-Specific Transcription",0.8697766968826,0.980533241832259,0.185893395910158,0.252071319269093,3933,25,"CCNA1, CCNE1, CDC25A, CDC45, CDC6, DHFR, E2F1, E2F4, E2F5, E2F6, FBXO5, HDAC1, LIN37, LIN52, LIN54, LIN9"
"319","G2/M Checkpoints",0.72354694485842,0.980533241832259,-0.606750855259629,-0.846690128322559,3883,123,"UBB, ORC3, YWHAG, SUMO1, PSMB2"
"320","G2/M DNA damage checkpoint",0.803299492385787,0.980533241832259,-0.623881762057761,-0.77937264085341,4430,55,"YWHAG, SUMO1"
"321","G2/M Transition",0.783399658897101,0.980533241832259,-0.558272259358385,-0.816135669399577,4133,168,"UBB, HSP90AB1, YWHAG, CUL1, DYNLL1, FBXL7, AKAP9, PSMB2, PPP2R2A, PCM1, SDCCAG8"
"322","GAB1 signalosome",0.810781554449015,0.980533241832259,0.202211055276382,0.31261914719542,3744,15,"BTC, CSK, EGF, EGFR, EPGN, GAB1, GRB2, HBEGF, PAG1, PIK3CA, PIK3R1, PTPN11, PXN"
"323","GABA B receptor activation",0.77214907386744,0.980533241832259,0.599613358833248,0.786595110588155,3459,31,"ADCY1, KCNJ4, ADCY2"
"324","GABA receptor activation",0.611603188662533,0.980533241832259,0.734883129773612,0.952667401550393,2761,47,"ADCY1, ARHGEF9, KCNJ4"
"325","GABA synthesis, release, reuptake and degradation",0.720487714760761,0.980533241832259,-0.631611959937133,-0.838181464950558,3899,18,"HSPA8, STXBP1"
"326","GLI3 is processed to GLI3R by the proteasome",0.86158038147139,0.980533241832259,-0.576870733523253,-0.721495046983865,4742,56,"UBB, CUL1, PSMB2"
"327","GPCR ligand binding",0.873720795520371,0.980533241832259,-0.510291222042853,-0.791452673449849,4524,265,"GNB1, OPRM1, CX3CL1, RAMP1, SST, CCK, GLP2R"
"328","GPVI-mediated activation cascade",0.594242259641499,0.980533241832259,-0.908460486092889,-1.11776398935644,3281,29,"PDPK1"
"329","GRB2 events in ERBB2 signaling",0.0164537778739987,0.629804462055302,0.998592964824121,1.54382894956943,75,15,"NRG1, BTC"
"330","GTP hydrolysis and joining of the 60S ribosomal subunit",0.755116826661837,0.980533241832259,-0.618399087311109,-0.813667204130836,4168,81,"EIF4E, EIF5, EIF4A2"
"331","Gamma carboxylation, hypusine formation and arylsulfatase activation",0.488665447897623,0.980533241832259,-0.962851203647824,-1.19118468087179,2672,27,"DPH7, DHPS, FURIN"
"332","Gap junction trafficking",0.62856613560578,0.980533241832259,-0.817221357173919,-1.11347788022092,3392,16,"MYO6, CLTC"
"333","Gap junction trafficking and regulation",0.648623683724367,0.980533241832259,-0.817220081892406,-1.0844929622545,3510,18,"MYO6, CLTC"
"334","Gap-filling DNA repair synthesis and ligation in GG-NER",0.0245677888989991,0.629804462055302,-0.997184231697506,-1.26234835970075,134,24,"UBB"
"335","Gap-filling DNA repair synthesis and ligation in TC-NER",0.00414265129682997,0.629804462055302,-0.997176850171406,-1.26569140920685,22,63,"UBB"
"336","Gastrin-CREB signalling pathway via PKC and MAPK",0.192224152910513,0.980533241832259,0.985995711605468,1.48970096975184,884,16,"RPS6KA2, CREB1, CCKBR"
"337","Gene Silencing by RNA",0.719862642327851,0.980533241832259,-0.649514979095126,-0.844076383989939,3982,74,"AGO2, TSNAX, NUP98, DROSHA"
"338","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation",0.470237018273928,0.980533241832259,-0.962302119667293,-1.17686365418589,2598,32,"PPIA, HSPA9, PAK2, HNRNPA2B1"
"339","Generation of second messenger molecules",0.607321856613641,0.980533241832259,0.676788120447621,0.988703673482737,2786,18,"PAK3, CD101"
"340","Global Genome Nucleotide Excision Repair (GG-NER)",0.0810467017990187,0.943177624719207,-0.968297772093962,-1.27547382101352,445,83,"UBB, SUMO1, SUMO2, RNF111"
"341","Glucagon signaling in metabolic regulation",0.649966747949457,0.980533241832259,0.714838861211926,0.96333766255606,2931,26,"ADCY1, ADCY2"
"342","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion",0.627426083801923,0.980533241832259,-0.843099574959505,-1.02349783236205,3458,36,"GNB1, IQGAP1, ADCY8"
"343","Glucagon-type ligand receptors",0.442721634439985,0.980533241832259,-0.966213045518536,-1.22925653706359,2426,23,"GNB1, GLP2R"
"344","Gluconeogenesis",0.350896252036936,0.980533241832259,-0.969418550063711,-1.19276640257148,1937,29,"GOT2, MDH1"
"345","Glucose metabolism",0.735815602836879,0.980533241832259,0.605502932419013,0.830676333405342,3319,85,"NUP93, RANBP2, AAAS"
"346","Glutamate Neurotransmitter Release Cycle",0.499667184379854,0.980533241832259,0.903447051511033,1.23146711634143,2251,24,"SLC1A3, RIMS1, ARL6IP5"
"347","Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.384587488667271,0.980533241832259,-0.967270288397049,-1.18738240731301,2120,30,"MYO6, CAMK2A, EPB41L1, CAMK2G"
"348","Glutathione conjugation",0.296114742193174,0.980533241832259,-0.973511266094421,-1.2014371011392,1630,28,"GSTZ1, CHAC2"
"349","Glycerophospholipid biosynthesis",0.737580993520518,0.980533241832259,0.583084754724822,0.832094493293883,3414,115,"PLA2G3, PTDSS2, GPCPD1, OSBPL10, PLD3, PLA2G4E"
"350","Glycogen metabolism",0.0218539428155163,0.629804462055302,-0.997183854096822,-1.24167205853385,119,26,"UBB"
"351","Glycogen synthesis",0.0304662827419654,0.629804462055302,-0.997185929648241,-1.38057073176504,163,15,"UBB"
"352","Glycolysis",0.334229390681004,0.980533241832259,0.853893820414254,1.13711079335794,1491,69,"NUP93, RANBP2, AAAS"
"353","Glycosaminoglycan metabolism",0.365030674846626,0.980533241832259,0.765223171621799,1.08081797162807,1665,107,"CSGALNACT1, HS6ST3, HS3ST4, EXT1, ST3GAL4"
"354","Glycosphingolipid metabolism",0.1578125,0.980533241832259,0.982821097839216,1.26664002280987,706,38,"PSAP, ARSA"
"355","Glyoxylate metabolism and glycine degradation",0.748729121278141,0.980533241832259,-0.714842268657194,-0.882206557786222,4123,28,"GOT2"
"356","Golgi Associated Vesicle Biogenesis",0.498092643051771,0.980533241832259,-0.845146227395523,-1.05702851888289,2741,56,"CLTC, TFRC, HSPA8, PUM1, AP1M1"
"357","Golgi-to-ER retrograde transport",0.366907809311816,0.980533241832259,-0.788869914141034,-1.08580291159278,1977,111,"GALNT2, DYNLL1, RAB6B, ARF4, KIF3A, KIF3B, KIF21A, COPA, STX18"
"358","Growth hormone receptor signaling",0.793408212115633,0.980533241832259,-0.310995805981679,-0.408381903225503,4308,19,"STAT5B, STAT3, STAT1, SOCS3, SOCS2, SOCS1, SH2B1, PTPN6, PTPN1, PRLR, PRL, MAPK3, MAPK1, LYN, JAK2, IRS2, IRS1"
"359","HATs acetylate histones",0.563110307414105,0.980533241832259,-0.745749201330877,-0.970706433952547,3113,75,"KAT6B, BRD1, CREBBP, CLOCK, RBBP7"
"360","HCMV Early Events",0.919893190921228,0.980533241832259,0.517764712046523,0.678240252303483,4133,58,"NUP93, CREB1, RANBP2, DYNC1I2, AAAS"
"361","HCMV Infection",0.693181818181818,0.980533241832259,0.634538350095585,0.861010988807332,3110,80,"CEBPD, NUP93, CREB1, RANBP2, DYNC1I2, AAAS"
"362","HCMV Late Events",0.313279857397504,0.980533241832259,0.914452955736063,1.19007766089485,1405,53,"CEBPD, NUP93, RANBP2, AAAS"
"363","HDACs deacetylate histones",0.45494106980961,0.980533241832259,-0.963648558014755,-1.18293651562011,2508,30,"NCOR2, KDM1A, HDAC2, RBBP7"
"364","HDMs demethylate histones",0.490855888807608,0.980533241832259,-0.964003217589489,-1.23182920219564,2683,22,"KDM1A, KDM2A"
"365","HDR through Homologous Recombination (HRR)",0.00341480948957584,0.629804462055302,-0.997176470588235,-1.27183502694077,18,65,"UBB"
"366","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)",0.0589519650655022,0.861353711790393,-0.968819449121153,-1.29506360098099,323,91,"UBB, SUMO1, SUMO2"
"367","HDR through Single Strand Annealing (SSA)",0.953226976069616,0.985120736573921,-0.240519322247833,-0.29193641852195,5257,37,"WRN, TOPBP1, TOP3A, RPA3, RPA2, RPA1, RMI2, RMI1, RHNO1, RFC5, RFC4, RFC3, RFC2, RBBP8, RAD9B, RAD9A, RAD52, RAD51, RAD50, RAD17, RAD1"
"368","HIV Infection",0.984628342809012,0.986503825366744,0.47664611573851,0.726362985472586,4675,214,"PSMA1, NMT1, NUP93, PSMB3, RANBP2, PSMD14, PSME4, PSMD9, NCBP2"
"369","HIV Life Cycle",0.901172529313233,0.980533241832259,-0.518012044830594,-0.73773117248263,4841,140,"UBB, PPIA, NUP98, FURIN"
"370","HIV Transcription Elongation",0.313442768411713,0.980533241832259,0.97066917242768,1.24954636263176,1412,41,"NCBP2, CCNH"
"371","HIV Transcription Initiation",0.975756471017134,0.985120736573921,-0.266275317120281,-0.326588764089938,5352,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1L, TAF1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"372","HIV elongation arrest and recovery",0.927187103785546,0.980533241832259,-0.221184865604019,-0.270876877619602,5118,31,"TCEA1, SUPT5H, SUPT4H1, SUPT16H, SSRP1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, NELFE, NELFCD, NELFB, NELFA"
"373","HS-GAG biosynthesis",0.658833961427621,0.980533241832259,0.700957008956249,0.944630074273492,2971,26,"HS6ST3, HS3ST4, EXT1, AGRN"
"374","HS-GAG degradation",0.716254648873332,0.980533241832259,0.337472089848641,0.48678915040334,3273,19,"AGRN, GLB1, GLB1L, GPC1, GPC3, GPC4, GPC5, GPC6, GUSB, HPSE, HPSE2, HSPG2, IDS, IDUA"
"375","HSF1 activation",0.205694469793758,0.980533241832259,-0.980795137195502,-1.23184090433388,1126,25,"UBB, HSP90AB1"
"376","HSF1-dependent transactivation",0.367287859598335,0.980533241832259,-0.967467131741347,-1.18318029306588,2029,32,"CRYAB, UBB, HSP90AB1, HSPA8, CREBBP, CAMK2A, CAMK2G"
"377","HSP90 chaperone cycle for steroid hormone receptors (SHR)",0.55347739240966,0.980533241832259,-0.920794762976993,-1.11849354234368,3047,35,"NR3C2, HSP90AB1, DYNLL1, HSPA8, DNAJA2"
"378","Hedgehog 'off' state",0.958934517203108,0.985120736573921,0.493700730108914,0.683834411705664,4319,94,"ADCY1, PSMA1, PSMB3, PSMD14, PSME4, PSMD9"
"379","Hedgehog 'on' state",0.726565327542526,0.980533241832259,-0.64228463699727,-0.838649351339704,4014,77,"UBB, CUL3, PSMB2, SPOP, KIF3A, ITCH"
"380","Hedgehog ligand biogenesis",0.852606891574959,0.980533241832259,-0.578131753853433,-0.729657291778127,4725,60,"UBB, OS9, PSMB2"
"381","Hemostasis",0.332793522267206,0.980533241832259,-0.632857158313558,-1.05534899840572,1643,487,"DGKZ, DGKB, PDE10A, APLP2, PRKG1, TMSB4X, KDM1A, PDPK1, GNB1, PPIA, MGLL, DGKD, KIF3A, KIF3B, KIF21A, DAGLB, VTI1B, HDAC2, ACTN4, CLU, SLC7A6, MANF"
"382","Heparan sulfate/heparin (HS-GAG) metabolism",0.648570795479725,0.980533241832259,0.700928839482245,0.910242767090599,2926,49,"HS6ST3, HS3ST4, EXT1, AGRN"
"383","Hh mutants abrogate ligand secretion",0.858881220486742,0.980533241832259,-0.578138119436163,-0.720199058599554,4728,54,"UBB, OS9, PSMB2"
"384","Hh mutants that don't undergo autocatalytic processing are degraded by ERAD",0.858360536815379,0.980533241832259,-0.578139179867759,-0.71949628953911,4732,53,"UBB, OS9, PSMB2"
"385","Homologous DNA Pairing and Strand Exchange",0.963427947598253,0.985120736573921,-0.292225226780201,-0.356895251704077,5294,42,"XRCC3, XRCC2, WRN, TOPBP1, TOP3A, RPA3, RPA2, RPA1, RMI2, RMI1, RHNO1, RFC5, RFC4, RFC3, RFC2, RBBP8, RAD9B, RAD9A, RAD51D, RAD51C, RAD51B, RAD51AP1, RAD51, RAD50, RAD17, RAD1"
"386","Homology Directed Repair",0.0465878070973612,0.800979872881356,-0.96880684497743,-1.30595345159591,255,97,"UBB, SUMO1, SUMO2"
"387","Host Interactions of HIV factors",0.915351772786338,0.980533241832259,-0.517142685931835,-0.717299587387056,4930,118,"UBB, PACS1, PSMB2, PPIA, PAK2, NUP98, AP1M1"
"388","Host Interactions with Influenza Factors",0.492682926829268,0.980533241832259,0.853925493248052,1.10102254621702,2221,40,"NUP93, RANBP2, AAAS"
"389","IGF1R signaling cascade",0.290281329923274,0.980533241832259,-0.96703813104189,-1.18173121165893,1588,44,"FGFR1, PDPK1, FGFR2"
"390","IKK complex recruitment mediated by RIP1",0.664582567120265,0.980533241832259,-0.808769509825018,-1.0521258692643,3613,20,"UBB, CHUK"
"391","IRE1alpha activates chaperones",0.775186737110585,0.980533241832259,-0.658959140476205,-0.81172609477412,4254,49,"PREB"
"392","IRS-mediated signalling",0.31161266836549,0.980533241832259,-0.967044768105242,-1.17921761460999,1711,41,"FGFR1, PDPK1, FGFR2"
"393","IRS-related events triggered by IGF1R",0.297179253867152,0.980533241832259,-0.967040343693361,-1.18167411999982,1632,43,"FGFR1, PDPK1, FGFR2"
"394","ISG15 antiviral mechanism",0.726535759322645,0.980533241832259,-0.664662197927618,-0.844908813259827,4032,64,"UBB, EIF4E, NUP98, EIF4A2, ARIH1, NEDD4"
"395","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell",0.0271473075211393,0.629804462055302,0.990727052815482,1.29779212571188,121,58,"TYROBP, ITGA4, TREM2, B2M"
"396","Inactivation of APC/C via direct inhibition of the APC/C complex",0.243158284023669,0.980533241832259,-0.979762782282383,-1.31801422812954,1314,17,"BUB3"
"397","Inactivation, recovery and regulation of the phototransduction cascade",0.732859995562458,0.980533241832259,0.58612637643572,0.798934876585996,3302,24,"NMT1, CALM1"
"398","Infection with Mycobacterium tuberculosis",0.547362657419237,0.980533241832259,-0.960241367750587,-1.20602616180479,2998,25,"UBB, RAB7A, ATP6V1H"
"399","Infectious disease",0.81437125748503,0.980533241832259,-0.516960894960834,-0.836081647181748,4079,377,"UBB, HSP90AB1, NCOR2, CLTC, DYNLL1, PACS1, PSMB2, PPIA, PAK2, SH3GL1, SV2A, NUP98, AP1M1, RAB7A, RBBP7, FURIN"
"400","Inflammasomes",0.749122482911509,0.980533241832259,-0.551544957144041,-0.731928445767713,4054,18,"HSP90AB1"
"401","Influenza Infection",0.647084326902233,0.980533241832259,0.623570670206724,0.894541177299017,2984,120,"NUP93, CLTA, RANBP2, AAAS"
"402","Influenza Life Cycle",0.655606159184559,0.980533241832259,0.623580539805166,0.885472347975672,3022,111,"NUP93, CLTA, RANBP2, AAAS"
"403","Influenza Viral RNA Transcription and Replication",0.208928964152188,0.980533241832259,0.853856529072241,1.19886292537902,949,103,"NUP93, RANBP2, AAAS"
"404","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits",0.631375437304364,0.980533241832259,-0.872187401069041,-1.14530660532079,3428,19,"GNB1, KCNJ6"
"405","Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components",0.243158284023669,0.980533241832259,-0.979762782282383,-1.31801422812954,1314,17,"BUB3"
"406","InlB-mediated entry of Listeria monocytogenes into host cell",0.602823704254133,0.980533241832259,-0.873741916680905,-1.20966660421237,3244,15,"UBB, SH3GL1"
"407","Inositol phosphate metabolism",0.334883720930233,0.980533241832259,0.936605294423668,1.20822275740361,1511,45,"INPP4B, CALM1"
"408","Insertion of tail-anchored proteins into the endoplasmic reticulum membrane",0.586061051857301,0.980533241832259,-0.958914209115281,-1.24744866560756,3186,20,"SGTA, VAPA"
"409","Insulin processing",0.559591166271217,0.980533241832259,-0.959570901776735,-1.20518408237328,3065,25,"KIF5A"
"410","Insulin receptor recycling",0.628420284567676,0.980533241832259,-0.885828169935532,-1.12698754550964,3444,23,"ATP6V0C, ATP6V0B, ATP6V1C1"
"411","Insulin receptor signalling cascade",0.268319358366752,0.980533241832259,-0.96703149130464,-1.18607170576975,1471,47,"FGFR1, PDPK1, FGFR2"
"412","Integration of energy metabolism",0.630391264786169,0.980533241832259,-0.674049379544942,-0.908619833072404,3463,97,"PRKAG2, ACACA, GNB1, IQGAP1, STXBP1, ADIPOR2, ADCY8"
"413","Integrin cell surface interactions",0.135918003565062,0.980533241832259,0.977564317861221,1.27221138001367,609,53,"ITGA4, CD47, AGRN"
"414","Integrin signaling",0.656324146742106,0.980533241832259,-0.839632420536409,-1.05454597091406,3595,25,"PDPK1"
"415","Interaction between L1 and Ankyrins",0.541249317064287,0.980533241832259,-0.960439855169639,-1.19591921506447,2971,26,"SPTBN2, SCN1B, SCN1A"
"416","Interactions of Rev with host cellular proteins",0.519677996422182,0.980533241832259,0.853932030861391,1.1068409153271,2323,34,"NUP93, RANBP2, AAAS"
"417","Interactions of Vpr with host cellular proteins",0.519677996422182,0.980533241832259,0.853932030861391,1.1068409153271,2323,34,"NUP93, RANBP2, AAAS"
"418","Interconversion of nucleotide di- and triphosphates",0.389304617630955,0.980533241832259,-0.968555145826349,-1.21646794675548,2132,25,"CTPS2"
"419","Interferon Signaling",0.477945281965382,0.980533241832259,-0.704089214285281,-1.00273452474821,2567,140,"UBB, SUMO1, EIF4E, TRIM2, NUP98, CAMK2A, CAMK2G, EIF4A2, ARIH1, NEDD4"
"420","Interferon alpha/beta signaling",0.960065347612997,0.985120736573921,-0.272841781398254,-0.331053940653187,5288,39,"XAF1, TYK2, STAT2, STAT1, SOCS3, SOCS1, SAMHD1, RNASEL, PTPN6, PTPN11, PTPN1, PSMB8, OAS3, OAS2, OAS1, JAK1, ISG20, ISG15, IRF9, IRF7, IRF6, IRF5, IRF3, IRF2, IRF1, IP6K2, IFNAR2, IFNAR1, IFITM3, IFITM2, IFITM1, IFIT3, IFIT2, IFI35"
"421","Interferon gamma signaling",0.524146695715323,0.980533241832259,-0.821707651686179,-1.03064054164204,2886,58,"SUMO1, TRIM2, CAMK2A, CAMK2G"
"422","Interleukin receptor SHC signaling",0.803903516847726,0.980533241832259,-0.275697621508365,-0.362030346457352,4365,19,"SOS1, SHC1, PTPN6, PIK3R3, PIK3R2, PIK3R1, PIK3CD, PIK3CB, PIK3CA, JAK3, JAK2, JAK1, INPPL1, INPP5D, IL5, IL2, GRB2, GAB2"
"423","Interleukin-1 family signaling",0.973826519576033,0.985120736573921,0.48416820654854,0.689491679330144,4501,114,"IL1RAPL1, PSMA1, PSMB3, IL1R1, PSMD14, PSME4, TAB2, PSMD9"
"424","Interleukin-1 signaling",0.881507098653076,0.980533241832259,-0.538780758355412,-0.719291168039609,4842,90,"UBB, CUL1, PSMB2, CHUK"
"425","Interleukin-10 signaling",0.147396293027361,0.980533241832259,0.987125326895997,1.32600008345694,667,27,"IL12B, IL1R1"
"426","Interleukin-12 family signaling",0.300686904498117,0.980533241832259,0.938202914375472,1.21837249199849,1356,49,"IL12B, AIP"
"427","Interleukin-12 signaling",0.368736141906874,0.980533241832259,0.938202995501904,1.20968709699346,1662,40,"IL12B, AIP"
"428","Interleukin-17 signaling",0.673090778097983,0.980533241832259,-0.69935467551861,-0.887673239346055,3736,63,"UBB, CUL1, CHUK"
"429","Interleukin-2 family signaling",0.918855279840609,0.980533241832259,-0.302644646338323,-0.37063764107251,5072,31,"SYK, STAT5B, STAT4, STAT3, STAT1, SOS2, SOS1, SHC1, PTPN6, PTK2B, PIK3R3, PIK3R2, PIK3R1, PIK3CD, PIK3CB, PIK3CA, LCK, JAK3, JAK2, JAK1, INPPL1, INPP5D, IL5, IL21R, IL2, IL15RA, IL15, HAVCR2, GRB2"
"430","Interleukin-3, Interleukin-5 and GM-CSF signaling",0.0625139043381535,0.892851573277672,0.992284468299228,1.28358401723381,280,35,"YWHAZ, BLNK"
"431","Interleukin-37 signaling",0.0412352071005917,0.74094606261644,-0.996314413991825,-1.34028011379728,222,17,"PTPN12"
"432","Interleukin-4 and Interleukin-13 signaling",0.145665773011618,0.980533241832259,0.941258960270115,1.26998053095966,651,77,"IL12B, BCL2L1, CEBPD"
"433","Interleukin-6 family signaling",0.830648672181106,0.980533241832259,0.194334840416097,0.288122764353381,3815,17,"CBL, CNTFR, CRLF1, CTF1, IL11RA, IL31RA, IL6R, IL6ST, JAK1, JAK2, LIFR"
"434","Interleukin-7 signaling",0.435617956770737,0.980533241832259,-0.967363624179065,-1.28374114343084,2357,18,"SMARCA4"
"435","Intra-Golgi and retrograde Golgi-to-ER traffic",0.307955192709322,0.980533241832259,-0.753180641433618,-1.10486077492406,1621,174,"GALNT2, GOLGA1, VPS54, DYNLL1, RAB6B, ARF4, KIF3A, KIF3B, MAN1A2, KIF21A, COPA, STX18"
"436","Intra-Golgi traffic",0.644252108300044,0.980533241832259,0.720782740742606,0.929434110014399,2902,42,"STX16, MAN2A2, ARF1"
"437","Intracellular signaling by second messengers",0.981611570247934,0.986299304585317,0.475605043445751,0.742807660396253,4750,284,"NRG1, ADCY1, PSMA1, PSMB3, CREB1, STRN, PSMD14, PSME4, PSMD9"
"438","Intraflagellar transport",0.186203130688023,0.980533241832259,-0.975501711524263,-1.18953003961283,1022,41,"DYNLL1, TTC26, KIF3A, KIF3B, IFT20"
"439","Intrinsic Pathway for Apoptosis",0.666148032896199,0.980533241832259,0.692163843226472,0.896858540873583,2996,48,"BCL2L1, NMT1, YWHAZ, AKT1"
"440","Intrinsic Pathway of Fibrin Clot Formation",0.805398345668263,0.980533241832259,0.206605673831551,0.306315623837611,3699,17,"A2M, C1QBP, F11, F12, F2, F8, GP1BB, GP5, GP9, KLKB1, KNG1, PRCP, SERPINC1, SERPIND1, SERPINE2, SERPING1"
"441","Inwardly rectifying K+ channels",0.637670609645132,0.980533241832259,-0.872182166564025,-1.10410663578997,3503,24,"GNB1, KCNJ6"
"442","Ion channel transport",0.447313854853911,0.980533241832259,-0.705074174492141,-1.01811734411929,2372,156,"ATP6V0C, UBB, ATP6V0B, WNK2, TTYH1, WWP1, CAMK2A, ATP6V1C1, TRPM7, CAMK2G, UNC80"
"443","Ion homeostasis",0.529673260724606,0.980533241832259,0.794018541203812,1.02883488824137,2382,48,"SLC8A3, TRPC1, ATP1A1, ABCC9"
"444","Ion transport by P-type ATPases",0.765687341313021,0.980533241832259,-0.666568320238654,-0.823441848445471,4221,50,"CAMK2A, CAMK2G"
"445","Iron uptake and transport",0.386305848165638,0.980533241832259,-0.927955388083741,-1.15597393503835,2126,54,"ATP6V0C, UBB, ATP6V0B, CUL1, TFRC, ATP6V1C1"
"446","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1",0.381251353106733,0.980533241832259,0.974338358458961,1.50633122548568,1760,15,"TAB2, IKBKG"
"447","KSRP (KHSRP) binds and destabilizes mRNA",0.453735881841877,0.980533241832259,0.962724201903427,1.45454098866605,2088,16,"YWHAZ, AKT1"
"448","Keratan sulfate biosynthesis",0.687389380530973,0.980533241832259,0.637263390820029,0.877044965665491,3106,23,"ST3GAL4, ACAN"
"449","Keratan sulfate/keratin metabolism",0.726969292389853,0.980533241832259,0.637254579546432,0.846628477627476,3266,28,"ST3GAL4, ACAN"
"450","Keratinization",0.563988426441131,0.980533241832259,0.798374448890849,1.02890901599207,2533,39,"KRT12, CAPN1"
"451","Kinesins",0.460882192775458,0.980533241832259,-0.959734246023757,-1.16449834954792,2538,39,"KIF3A, KIF3B, KIF21A, KIF5A"
"452","L13a-mediated translational silencing of Ceruloplasmin expression",0.977668845315904,0.985923916214482,-0.487236434628131,-0.638252010300091,5384,79,"EIF4E, EIF4A2"
"453","L1CAM interactions",0.653265417500455,0.980533241832259,-0.666173394931338,-0.893968684033766,3590,94,"FGFR1, CLTC, HSPA8, SPTBN2, SCN1B"
"454","LDL clearance",0.680399039349714,0.980533241832259,-0.733693689666692,-0.973649155869401,3682,18,"CLTC, NCEH1"
"455","Lagging Strand Synthesis",0.786411342294237,0.980533241832259,-0.435027989516718,-0.571253871911275,4270,19,"RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, PRIM2, PRIM1, POLD4, POLD2, POLD1, POLA2, POLA1, PCNA"
"456","Laminin interactions",0.213938053097345,0.980533241832259,0.983240597975464,1.35320219067134,966,23,"LAMC1, COL18A1"
"457","Late Phase of HIV Life Cycle",0.905888930301901,0.980533241832259,-0.51803727431396,-0.729568245658679,4860,130,"UBB, PPIA, NUP98, FURIN"
"458","Late endosomal microautophagy",0.111895708853884,0.980533241832259,-0.987794245858762,-1.21537574150642,617,29,"UBB, HSPA8"
"459","Listeria monocytogenes entry into host cells",0.635159985288709,0.980533241832259,-0.873734349802725,-1.13663843792919,3453,20,"UBB, SH3GL1"
"460","Long-term potentiation",0.516541685046317,0.980533241832259,0.884333961025545,1.22969047125557,2341,22,"NRG1, ACTN2"
"461","Loss of Nlp from mitotic centrosomes",0.877499549630697,0.980533241832259,-0.559751023702589,-0.711547271128289,4870,64,"YWHAG, DYNLL1, AKAP9, PCM1, SDCCAG8"
"462","Loss of proteins required for interphase microtubule organization from the centrosome",0.877499549630697,0.980533241832259,-0.559751023702589,-0.711547271128289,4870,64,"YWHAG, DYNLL1, AKAP9, PCM1, SDCCAG8"
"463","Lysosome Vesicle Biogenesis",0.907027419647721,0.980533241832259,-0.528194906685808,-0.641600730131063,4994,35,"CLTC, HSPA8, AP1M1"
"464","M Phase",0.279177975959674,0.980533241832259,-0.699032308210292,-1.09931952516605,1439,295,"PTTG1, UBB, YWHAG, DYNLL1, ARPP19, AKAP9, CENPP, PSMB2, PPP2R2A, BUB3, LPIN2, NUP98, PCM1, SDCCAG8"
"465","MAP kinase activation",0.687250996015936,0.980533241832259,-0.69936033083425,-0.880007269814662,3794,59,"UBB, CUL1, CHUK"
"466","MAP2K and MAPK activation",0.760578661844485,0.980533241832259,-0.697659686963322,-0.850132248510492,4205,34,"IQGAP1"
"467","MAP3K8 (TPL2)-dependent MAPK1/3 activation",0.253982956650611,0.980533241832259,-0.979027070490485,-1.33394089319749,1370,16,"UBB, CUL1, CHUK"
"468","MAPK family signaling cascades",0.650983416891631,0.980533241832259,-0.58363860465512,-0.900245653400334,3375,255,"SPRED2, UBB, AGO2, CUL3, FGFR1, SPRED1, RASGRF1, SHC3, IQGAP1, PSMB2, SPTBN2, PAK2, CAMK2A, GRIN2B, RASGEF1A, CAMK2G, FGFR2, NF1, PTPRA"
"469","MAPK targets/ Nuclear events mediated by MAP kinases",0.41609092935146,0.980533241832259,0.961342798494103,1.26657681500469,1866,30,"RPS6KA2, CREB1, ATF1"
"470","MAPK1/MAPK3 signaling",0.713714285714286,0.980533241832259,-0.570092210282515,-0.864907859676924,3746,219,"SPRED2, UBB, CUL3, FGFR1, SPRED1, RASGRF1, SHC3, IQGAP1, PSMB2, SPTBN2, CAMK2A, GRIN2B, RASGEF1A, CAMK2G, FGFR2, NF1, PTPRA"
"471","MAPK6/MAPK4 signaling",0.828861493836113,0.980533241832259,-0.577180038593395,-0.759777235362723,4571,82,"UBB, AGO2, PSMB2, PAK2"
"472","MECP2 regulates neuronal receptors and channels",0.698962578732864,0.980533241832259,-0.605581035810952,-0.825114373403806,3772,16,"OPRM1, GRIN2B, HDAC2"
"473","MET activates PTK2 signaling",0.230987143168446,0.980533241832259,0.983246213644284,1.43640101532091,1059,18,"LAMC1, HGF"
"474","MET promotes cell motility",0.316866933689364,0.980533241832259,0.976059549356223,1.29674989693033,1423,28,"LAMC1, RAP1A, CRK"
"475","MHC class II antigen presentation",0.718102508178844,0.980533241832259,-0.634701414922902,-0.845929788738904,3950,89,"SEC23A, CLTC, DYNLL1, SPTBN2, KIF3A, KIF3B, AP1M1, RAB7A"
"476","Macroautophagy",0.172457937088515,0.980533241832259,-0.91678798634815,-1.24082542874386,942,100,"PRKAG2, UBB, ATG4B, DYNLL1, HSPA8"
"477","Major pathway of rRNA processing in the nucleolus and cytosol",0.76018779342723,0.980533241832259,-0.573678976227748,-0.822860227860034,4047,149,"RBM28, XRN2, EBNA1BP2, EXOSC10, TBL3, UTP4"
"478","Meiosis",0.428338467113608,0.980533241832259,-0.886618633017242,-1.1114101425265,2363,57,"SYCP3, SYNE1"
"479","Meiotic recombination",0.886840664354809,0.980533241832259,-0.220703989272544,-0.27719570726358,4858,25,"PRDM9, TOP3A, TEX15, RPA3, RPA2, RPA1, RBBP8, RAD51C, RAD51, RAD50, PSMC3IP, NBN, MSH5, MSH4, MRE11, MND1, MLH3, MLH1"
"480","Meiotic synapsis",0.596171211847571,0.980533241832259,-0.886665581356909,-1.08149364430461,3300,33,"SYCP3, SYNE1"
"481","Metabolic disorders of biological oxidation enzymes",0.0141592920353982,0.629804462055302,0.998726285446135,1.37451464080054,63,23,"CYP7B1, ACY1"
"482","Metabolism of amino acids and derivatives",0.438984100763989,0.980533241832259,0.6427981847581,1.00710628682111,2125,296,"PSMA1, IYD, ACAT1, PSMB3, SEPSECS, OGDH, PSMD14, PSME4, PSMD9"
"483","Metabolism of carbohydrates",0.669705760464153,0.980533241832259,0.567140283157157,0.879931957118065,3231,259,"CSGALNACT1, HS6ST3, HS3ST4, NUP93, RANBP2, EXT1, ST3GAL4"
"484","Metabolism of cofactors",0.70265563778842,0.980533241832259,0.288642482389994,0.427944210919467,3227,17,"AKT1, CALM1, COQ2, COQ3, COQ5, COQ6, COQ7, COQ9, DHFR"
"485","Metabolism of fat-soluble vitamins",0.0187249219794918,0.629804462055302,0.997383077232772,1.28694044179051,83,37,"APOE, AGRN"
"486","Metabolism of folate and pterines",0.750544188071397,0.980533241832259,0.23768679219996,0.352396798599308,3447,17,"ALDH1L1, ALDH1L2, DHFR2, DHFR, FOLR2, FPGS, MTHFD1, MTHFD1L, MTHFD2, MTHFD2L, MTHFR, MTHFS, SHMT1, SHMT2, SLC19A1, SLC25A32, SLC46A1"
"487","Metabolism of non-coding RNA",0.439397296698427,0.980533241832259,0.850547200636466,1.10454070918295,1982,49,"NUP93, RANBP2, NCBP2"
"488","Metabolism of nucleotides",0.954198473282443,0.985120736573921,-0.500282685697679,-0.666776560870557,5249,89,"UPP2, APRT, CTPS2"
"489","Metabolism of polyamines",0.49077162552813,0.980533241832259,0.794418393344669,1.03747855123427,2206,56,"PSMA1, PSMB3, PSMD14, PSME4, PSMD9"
"490","Metabolism of porphyrins",0.751424813678211,0.980533241832259,0.421964321622476,0.592398059860315,3427,21,"ABCC1, ABCC2, ABCG2, ALAD, ALAS1, ALAS2, ALB, BLVRA, BLVRB, COX10, CPOX, FECH, FLVCR1, GUSB, HMBS, HMOX1, HMOX2"
"491","Metabolism of steroid hormones",0.862436210339472,0.980533241832259,0.189930276213462,0.258889427070832,3886,24,"AKR1B1, CGA, CYP11A1, CYP19A1, FDX1, HSD11B1, HSD11B2, HSD17B1, HSD17B11, HSD17B12, HSD17B2, HSD17B3, HSD3B2, HSD3B1"
"492","Metabolism of steroids",0.847863616745792,0.980533241832259,0.534168742679194,0.769050483773401,3928,123,"CYP7B1, NCOA6, GGPS1, ABCB11"
"493","Metabolism of vitamins and cofactors",0.887852448590206,0.980533241832259,0.510617563400435,0.757176743475075,4187,159,"APOE, NADK"
"494","Metabolism of water-soluble vitamins and cofactors",0.0880733944954128,0.980533241832259,-0.959727871526815,-1.31226211913734,479,106,"ACACA, LMBRD1, MCCC1"
"495","Metal ion SLC transporters",0.752866242038217,0.980533241832259,-0.665191740412979,-0.842074789898534,4136,24,"SLC41A2, SLC41A1, SLC40A1, SLC39A8, SLC39A7, SLC39A6, SLC39A3, SLC39A2, SLC39A14, SLC39A10, SLC39A1, SLC31A1, SLC30A8, SLC30A7, SLC30A6, SLC30A5, SLC30A3, SLC30A2, SLC30A10, SLC30A1, SLC11A2, SLC11A1"
"496","Metalloprotease DUBs",0.625046313449426,0.980533241832259,-0.830336847362719,-1.13134795677396,3373,16,"UBB"
"497","MicroRNA (miRNA) biogenesis",0.402407880335644,0.980533241832259,-0.968539473569899,-1.23221631586539,2205,23,"AGO2"
"498","Miscellaneous transport and binding events",0.723345588235294,0.980533241832259,-0.698481002291768,-0.898855177488766,3934,21,"NIPA1, TUSC3"
"499","Misspliced GSK3beta mutants stabilize beta-catenin",0.627841524139424,0.980533241832259,0.361139028475712,0.558322466329792,2899,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"500","Mitochondrial Fatty Acid Beta-Oxidation",0.900044722719141,0.980533241832259,0.478492671723191,0.620207753787109,4024,34,"ACAA2, ACAD10, ACAD11, ACADL, ACADM, ACADS, ACADVL, ACBD6, ACBD7, ACOT11, ACOT12, ACOT13, ACOT1, ACOT2, ACOT7, ACOT9, ACSF2, ACSM3"
"501","Mitochondrial biogenesis",0.579158316633267,0.980533241832259,-0.711038530497981,-0.945336734214991,3178,88,"PRKAG2, CRTC3, MEF2D, CREBBP, HSPA9"
"502","Mitochondrial calcium ion transport",0.392810170977641,0.980533241832259,0.973657751860044,1.36692353740251,1791,21,"SLC8A3, VDAC1, MICU1, AFG3L2"
"503","Mitochondrial protein import",0.929464285714286,0.980533241832259,0.513224806254535,0.672299243022576,4163,59,"COX19, VDAC1, ACO2"
"504","Mitochondrial tRNA aminoacylation",0.980850672067759,0.986299304585317,-0.123608901618701,-0.162316139085274,5326,19,"YARS2, WARS2, VARS2, TARS2, SARS2, RARS2, PPA2, PARS2, NARS2, MARS2, LARS2, KARS1, IARS2, HARS2, FARS2, EARS2, DARS2"
"505","Mitochondrial translation",0.66957787481805,0.980533241832259,-0.65937363109527,-0.8814137555277,3679,91,"MRPS21, MRPL4, MRPL21, MRPS33"
"506","Mitochondrial translation elongation",0.68615664845173,0.980533241832259,-0.659384647411909,-0.871284058405195,3766,85,"MRPS21, MRPL4, MRPL21, MRPS33"
"507","Mitochondrial translation initiation",0.68615664845173,0.980533241832259,-0.659384647411909,-0.871284058405195,3766,85,"MRPS21, MRPL4, MRPL21, MRPS33"
"508","Mitochondrial translation termination",0.68615664845173,0.980533241832259,-0.659384647411909,-0.871284058405195,3766,85,"MRPS21, MRPL4, MRPL21, MRPS33"
"509","Mitophagy",0.578036787470406,0.980533241832259,-0.949238664116115,-1.1819717309608,3173,26,"UBB"
"510","Mitotic Anaphase",0.406131718395155,0.980533241832259,-0.712752318960041,-1.03979370964978,2145,166,"PTTG1, UBB, DYNLL1, CENPP, PSMB2, PPP2R2A, BUB3, NUP98"
"511","Mitotic G1 phase and G1/S transition",0.534415221040851,0.980533241832259,-0.680625858416901,-0.965363653180609,2864,136,"UBB, ORC3, CUL1, PSMB2, PPP2R2A, CCND2, MAX, DYRK1A"
"512","Mitotic G2-G2/M phases",0.784090909090909,0.980533241832259,-0.558267996870533,-0.817454932164843,4139,170,"UBB, HSP90AB1, YWHAG, CUL1, DYNLL1, FBXL7, AKAP9, PSMB2, PPP2R2A, PCM1, SDCCAG8"
"513","Mitotic Metaphase and Anaphase",0.402122418040553,0.980533241832259,-0.712750376289904,-1.04133933070313,2121,167,"PTTG1, UBB, DYNLL1, CENPP, PSMB2, PPP2R2A, BUB3, NUP98"
"514","Mitotic Prometaphase",0.734686136923952,0.980533241832259,-0.577646344378289,-0.846465129145346,3873,172,"YWHAG, DYNLL1, AKAP9, CENPP, BUB3, NUP98, PCM1, SDCCAG8, PDS5A"
"515","Mitotic Prophase",0.906836461126005,0.980533241832259,0.521687040753616,0.703878967400134,4058,77,"NUP93, RANBP2, AAAS"
"516","Mitotic Spindle Checkpoint",0.938464931627702,0.980533241832259,0.502564501306848,0.702698587811426,4254,100,"CKAP5, RANBP2, DYNC1I2, AHCTF1"
"517","Molecules associated with elastic fibres",0.115643780732107,0.980533241832259,-0.987930803272093,-1.23015035707623,634,26,"FBLN2"
"518","Muscle contraction",0.048728813559322,0.800979872881356,0.904219408856874,1.34982680243655,229,169,"KCNIP4, KCND2, SLC8A3, CALD1, TRPC1, KCNJ4, ATP1A1"
"519","MyD88 cascade initiated on plasma membrane",0.634556298572203,0.980533241832259,-0.699339107708299,-0.908825268417279,3510,74,"UBB, CUL1, CHUK"
"520","MyD88 dependent cascade initiated on endosome",0.622185911401598,0.980533241832259,-0.699332023812256,-0.916085165934004,3426,79,"UBB, CUL1, CHUK"
"521","MyD88-independent TLR4 cascade",0.747130624886136,0.980533241832259,-0.620168675088375,-0.82452385464946,4100,88,"UBB, CUL1, CHUK"
"522","MyD88:MAL(TIRAP) cascade initiated on plasma membrane",0.612389059952907,0.980533241832259,-0.699329188918963,-0.920152111460848,3380,81,"UBB, CUL1, CHUK"
"523","Myogenesis",0.547588717015469,0.980533241832259,-0.960579243765085,-1.2160096341127,3008,24,"MEF2D, NEO1, MAPK14"
"524","N-Glycan antennae elongation",0.389261744966443,0.980533241832259,0.973802345058627,1.50550254650041,1797,15,"MGAT5, ST3GAL4"
"525","N-glycan antennae elongation in the medial/trans-Golgi",0.388728644331041,0.980533241832259,0.973451327433628,1.32688827429174,1751,24,"MGAT5, ST3GAL4, MAN2A2"
"526","N-glycan trimming in the ER and Calnexin/Calreticulin cycle",0.545421708506411,0.980533241832259,-0.943398948347796,-1.15069310023335,3019,33,"UBB, OS9, UGGT1"
"527","NCAM signaling for neurite out-growth",0.918933623503808,0.980533241832259,-0.532892684633759,-0.663186863419679,5066,53,"FGFR1, CACNA1H, SPTBN2, PTPRA"
"528","NCAM1 interactions",0.714221724524076,0.980533241832259,0.66610914567649,0.86519016415951,3188,33,"GFRA1, AGRN"
"529","NEP/NS2 Interacts with the Cellular Export Machinery",0.531758413193671,0.980533241832259,0.853936386347138,1.12506800917468,2385,30,"NUP93, RANBP2, AAAS"
"530","NIK-->noncanonical NF-kB signaling",0.837238873751135,0.980533241832259,-0.59514939354683,-0.744356256447496,4608,56,"UBB, CUL1, PSMB2, CHUK"
"531","NOD1/2 Signaling Pathway",0.684277879341865,0.980533241832259,-0.80736249178533,-0.998822900653429,3742,27,"CHUK, ITCH, MAPK14"
"532","NOTCH1 Intracellular Domain Regulates Transcription",0.910352382691254,0.980533241832259,-0.540824567276116,-0.661961490969746,4985,46,"MAML3, UBB, FBXW7, NCOR2, CUL1, TLE4, CREBBP, HDAC9"
"533","NOTCH2 Activation and Transmission of Signal to the Nucleus",0.236649597659108,0.980533241832259,-0.979286767663226,-1.25135893295849,1293,22,"UBB, NEURL1, MIB1"
"534","NOTCH3 Activation and Transmission of Signal to the Nucleus",0.224128490600475,0.980533241832259,-0.979349648005364,-1.23002542560274,1227,25,"UBB, NEURL1, YBX1, MIB1"
"535","NOTCH3 Intracellular Domain Regulates Transcription",0.663274336283186,0.980533241832259,0.672300181565989,0.925264966028728,2997,23,"MAML2, DLGAP5"
"536","NOTCH4 Intracellular Domain Regulates Transcription",0.61605775541457,0.980533241832259,0.686619368131031,0.990419264043113,2815,19,"MAML2, ACTA2"
"537","NR1H2 and NR1H3-mediated signaling",0.847596504005827,0.980533241832259,-0.604169084564805,-0.734004882388839,4654,40,"AGO2, NCOR2, KDM1A, APOD"
"538","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux",0.833725348290212,0.980533241832259,-0.60418093352478,-0.738893292122491,4607,32,"AGO2, NCOR2, KDM1A, APOD"
"539","NRAGE signals death through JNK",0.980957562568009,0.986299304585317,-0.476508258739869,-0.593016242518797,5408,53,"ARHGEF12, ARHGEF11, ARHGEF7, ARHGEF18, FGD4"
"540","NRIF signals cell death from the nucleus",0.0304662827419654,0.629804462055302,-0.997185929648241,-1.38057073176504,163,15,"UBB"
"541","NS1 Mediated Effects on Host Pathways",0.499443578900512,0.980533241832259,0.853926583215889,1.10050210360158,2243,39,"NUP93, RANBP2, AAAS"
"542","Neddylation",0.563404417364813,0.980533241832259,-0.622028439145607,-0.9426194471017,2958,217,"UBB, FBXO10, CUL3, FBXW7, CUL1, FBXW4, FBXL7, PSMB2"
"543","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters",0.560133013116571,0.980533241832259,-0.960260018764241,-1.27431429471566,3031,18,"PACS1, AP1M1, ATP6V1H"
"544","Negative epigenetic regulation of rRNA expression",0.268951759158506,0.980533241832259,-0.965278710543989,-1.19245223864047,1482,50,"HDAC2"
"545","Negative regulation of FGFR1 signaling",0.0374001452432825,0.719288660551397,-0.994970493562232,-1.22792052556329,205,28,"UBB, FGFR1"
"546","Negative regulation of FGFR2 signaling",0.390571169537625,0.980533241832259,-0.967002012072435,-1.18705308200242,2153,30,"UBB, FGFR2"
"547","Negative regulation of FGFR3 signaling",0.0210237659963437,0.629804462055302,-0.997183665258499,-1.23365884736015,114,27,"UBB"
"548","Negative regulation of FGFR4 signaling",0.0210237659963437,0.629804462055302,-0.997183665258499,-1.23365884736015,114,27,"UBB"
"549","Negative regulation of MAPK pathway",0.493480622962695,0.980533241832259,-0.954430845134064,-1.15837142728685,2724,38,"UBB"
"550","Negative regulation of MET activity",0.641544117647059,0.980533241832259,-0.873732835818452,-1.12438173785763,3489,21,"UBB, SH3GL1"
"551","Negative regulation of NMDA receptor-mediated neuronal transmission",0.573838737949167,0.980533241832259,0.790569492447053,1.12495215745974,2618,20,"PPM1E, ACTN2"
"552","Negative regulation of NOTCH4 signaling",0.865213442325159,0.980533241832259,-0.576081104922551,-0.71287351922094,4762,51,"UBB, FBXW7, CUL1, PSMB2"
"553","Negative regulation of the PI3K/AKT network",0.459680992467878,0.980533241832259,0.73275875146,1.02023313541286,2074,98,"NRG1, STRN, AKT1"
"554","Negative regulators of DDX58/IFIH1 signaling",0.682122803839884,0.980533241832259,-0.795838631442042,-0.974633969577349,3765,31,"UBB, UBE2K, ITCH"
"555","Nephrin family interactions",0.65234546251644,0.980533241832259,0.662272556084677,0.929768127823623,2975,21,"KIRREL3, CASK, ACTN1, ACTN2"
"556","Netrin-1 signaling",0.711046899310958,0.980533241832259,0.657699748021846,0.852202324805337,3198,48,"UNC5C, TRPC1, TRPC4, ABLIM1"
"557","Neurexins and neuroligins",0.763959390862944,0.980533241832259,-0.654626711127712,-0.817780194346426,4213,55,"NRXN3, SHANK1, APBA2, NLGN1, STXBP1, SHANK2, GRIN2B, EPB41L1, NRXN1"
"558","Neurodegenerative Diseases",0.55393331880584,0.980533241832259,0.798909409800412,1.16710776147662,2541,18,"PRDX1, APP"
"559","Neuronal System",0.795583468395462,0.980533241832259,0.524500955316904,0.834136098009006,3926,352,"LRRTM4, KCND2, PTPRD, NRG1, SLC1A3, IL1RAPL1, ADCY1, PPM1E, ARHGEF9, DLGAP1, RPS6KA2, RIMS1, KCNAB2, CREB1, SYT10, COMT, CASK"
"560","Neurotransmitter receptors and postsynaptic signal transmission",0.773401101228293,0.980533241832259,0.549727829324154,0.818117902753863,3651,164,"NRG1, ADCY1, PPM1E, ARHGEF9, RPS6KA2, CREB1, CASK, KCNJ4, GRIK2"
"561","Neurotransmitter release cycle",0.524800708591674,0.980533241832259,0.798037124715907,1.03453722522935,2369,47,"SLC1A3, RIMS1, CASK, ABAT"
"562","Neutrophil degranulation",0.782451923076923,0.980533241832259,0.522692665743743,0.837333745456495,3905,377,"CST3, TYROBP, VPS35L, CTSS, CDK13, SIRPB1, SIRPA, KCNAB2, GDI2, GALNS, PSAP, CD47, ILF2, ACTR10, PSMD14, RAP1A, VCP, RHOA"
"563","Nicotinamide salvaging",0.719340496480178,0.980533241832259,-0.532833020637899,-0.72599397595691,3882,16,"RNLS, PTGS2, PTGIS, PARP9, PARP8, PARP6, PARP4, PARP16, PARP14, PARP10, NUDT12, NNMT, NAXE, NAXD, NAPRT, NAMPT"
"564","Nicotinate metabolism",0.401241409886943,0.980533241832259,0.972106745339949,1.3100393537966,1809,26,"NADK, CD38"
"565","Nitric oxide stimulates guanylate cyclase",0.0725464923586816,0.906512436285034,-0.99343207559815,-1.30451817662755,393,19,"PDE10A, PRKG1"
"566","NoRC negatively regulates rRNA expression",0.29529711994167,0.980533241832259,-0.96528570469348,-1.18393048480391,1619,47,"HDAC2"
"567","Non-integrin membrane-ECM interactions",0.487361419068736,0.980533241832259,0.856293811072462,1.10407617483205,2197,40,"LAMC1, CASK, ACTN1, AGRN"
"568","Nonhomologous End-Joining (NHEJ)",0.0732766419395694,0.906512436285034,-0.990676147035149,-1.21156415089025,404,32,"SUMO1"
"569","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)",0.966120218579235,0.985120736573921,-0.49524127964583,-0.653172306780128,5303,84,"PPP2R2A, SMG6"
"570","Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)",0.152999325994159,0.980533241832259,0.970691045980102,1.28023868156428,680,64,"ETF1, NCBP2"
"571","Nonsense-Mediated Decay (NMD)",0.966120218579235,0.985120736573921,-0.49524127964583,-0.653172306780128,5303,84,"PPP2R2A, SMG6"
"572","Norepinephrine Neurotransmitter Release Cycle",0.632781889420984,0.980533241832259,0.574065688037064,0.851115490169019,2906,17,"RIMS1, CPLX1"
"573","Notch-HLH transcription pathway",0.738526037069726,0.980533241832259,0.604625616697234,0.812190302848148,3346,27,"MAML2, HDAC1"
"574","Nuclear Envelope Breakdown",0.659871482384223,0.980533241832259,0.693415412993189,0.900485653768251,2977,49,"NUP93, RANBP2, AAAS"
"575","Nuclear Events (kinase and transcription factor activation)",0.451076103838473,0.980533241832259,0.961348437045173,1.31039111322276,2032,24,"RPS6KA2, CREB1, ATF1"
"576","Nuclear Pore Complex (NPC) Disassembly",0.525643896976484,0.980533241832259,0.853933119951961,1.10914936542742,2346,33,"NUP93, RANBP2, AAAS"
"577","Nuclear Receptor transcription pathway",0.0286130854747585,0.629804462055302,-0.992749244712991,-1.2158398367364,156,45,"NR3C2, NCOR2"
"578","Nuclear import of Rev protein",0.530908279401919,0.980533241832259,0.853935297694805,1.12022409112498,2378,31,"NUP93, RANBP2, AAAS"
"579","Nuclear signaling by ERBB4",0.162759544541192,0.980533241832259,0.985557170996755,1.30344827504084,728,29,"NRG1, APOE, GFAP, TAB2"
"580","Nucleobase catabolism",0.677039985525602,0.980533241832259,-0.798920580652684,-0.977053437517426,3741,32,"UPP2"
"581","Nucleosome assembly",0.489535941765241,0.980533241832259,-0.963529096272459,-1.21974389038719,2689,24,"CENPP, RBBP7"
"582","Nucleotide Excision Repair",0.034948224852071,0.693689293290164,-0.968242195401524,-1.32931833937595,188,109,"UBB, SUMO1, SUMO2, RNF111"
"583","Nucleotide salvage",0.801349872309376,0.980533241832259,-0.563868062656367,-0.717376468136729,4392,23,"UPP2, APRT"
"584","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.893131165509682,0.980533241832259,-0.557969251762703,-0.68184455068339,4888,44,"HSP90AB1, CHUK, ITCH, MAPK14"
"585","O-glycosylation of TSR domain-containing proteins",0.0308586762075134,0.629804462055302,0.9962431235744,1.29130025685195,137,34,"ADAMTS17, ADAMTS1"
"586","O-linked glycosylation",0.779741300783385,0.980533241832259,-0.601749836430455,-0.800035723503153,4279,88,"GALNT2, ST6GALNAC3"
"587","O-linked glycosylation of mucins",0.435392746491708,0.980533241832259,-0.95416716527338,-1.16858759311433,2388,45,"GALNT2, ST6GALNAC3"
"588","Olfactory Signaling Pathway",0.0543101877164206,0.83731026498585,-0.988318227593152,-1.21041308153084,297,45,"GNB1"
"589","Oncogene Induced Senescence",0.0199239268248506,0.629804462055302,-0.997182909651888,-1.22121281781417,109,31,"UBB"
"590","Oncogenic MAPK signaling",0.326368876080692,0.980533241832259,-0.926783917309158,-1.17634343609926,1811,63,"SPRED2, SPRED1, AKAP9, IQGAP1, FXR1, CAMK2A, CAMK2G, NF1"
"591","Opioid Signalling",0.833877995642701,0.980533241832259,-0.574401491913037,-0.752433276490652,4592,79,"PDE4A, GNB1, OPRM1, CAMKK1, CAMK2A, CAMK2G, ADCY8, GNAO1"
"592","Orc1 removal from chromatin",0.750224618149146,0.980533241832259,-0.642163782776345,-0.819942806749801,4174,66,"UBB, ORC3, CUL1, PSMB2"
"593","Organelle biogenesis and maintenance",0.200154410345493,0.980533241832259,-0.749766051278136,-1.16313118046446,1036,266,"AHI1, PRKAG2, CRTC3, YWHAG, DYNLL1, MEF2D, AKAP9, TTC26, CREBBP, HSPA9, ARF4, KIF3A, KIF3B, IFT20, PCM1, SDCCAG8"
"594","Other interleukin signaling",0.838536855717717,0.980533241832259,-0.219340570969039,-0.291076187215043,4538,18,"VAMP2, TYK2, TXLNA, STXBP2, STX4, STX3, STX1A, SNAP25"
"595","Other semaphorin interactions",0.48282651498578,0.980533241832259,0.929271461287551,1.34043459812373,2206,19,"TYROBP, TREM2, CD72"
"596","Ovarian tumor domain proteases",0.544398038859633,0.980533241832259,-0.930100308482519,-1.12979703034601,2997,35,"UBB"
"597","Oxidative Stress Induced Senescence",0.277106260147934,0.980533241832259,-0.960551075268817,-1.21230686867426,1535,60,"UBB, SCMH1, RBBP7, MAPK14"
"598","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha",0.98340435075129,0.986440951515286,0.472236658219059,0.618917026772514,4384,60,"PSMA1, PSMB3, UBE2D2, PSMD14, PSME4, PSMD9"
"599","PCNA-Dependent Long Patch Base Excision Repair",0.80066200809121,0.980533241832259,-0.442962466487936,-0.576248565806973,4353,20,"RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, POLE4, POLE3, POLE2, POLE, POLD4, POLD2, POLD1, POLB, PCNA"
"600","PCP/CE pathway",0.487156130442704,0.980533241832259,-0.763675774778886,-1.01531876538809,2673,88,"PRICKLE1, UBB, ROR1, CLTC, PSMB2, DVL2"
"601","PERK regulates gene expression",0.844904316866934,0.980533241832259,0.460568669527897,0.611891328898491,3796,28,"ASNS, ATF3, ATF4, ATF6, CEBPB, CEBPG, DCP2, DDIT3, DIS3, EIF2AK3, EIF2S1, EIF2S2, EIF2S3, EXOSC1, EXOSC2, EXOSC3, EXOSC4, EXOSC5, EXOSC7, EXOSC8, EXOSC9"
"602","PI Metabolism",0.269607843137255,0.980533241832259,0.864984095479124,1.17370496399297,1209,80,"INPP4B, PLEKHA1"
"603","PI-3K cascade:FGFR1",0.0549186390532544,0.83731026498585,-0.994907190243249,-1.33838706278909,296,17,"FGFR1"
"604","PI-3K cascade:FGFR2",0.441171055054318,0.980533241832259,-0.966959319080491,-1.26975566702977,2395,19,"FGFR2"
"605","PI-3K cascade:FGFR3",0.646394439617724,0.980533241832259,0.446378316805146,0.674414912350957,2975,16,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF5, FGF9, FGFR3, FRS2, GAB1, GRB2"
"606","PI-3K cascade:FGFR4",0.650304083405734,0.980533241832259,0.383811310640579,0.579884957848355,2993,16,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF9, FGFR4, FRS2, GAB1, GRB2"
"607","PI3K Cascade",0.343002175489485,0.980533241832259,-0.967053613366436,-1.17378581382333,1891,37,"FGFR1, PDPK1, FGFR2"
"608","PI3K events in ERBB2 signaling",0.0164537778739987,0.629804462055302,0.998592964824121,1.54382894956943,75,15,"NRG1, BTC"
"609","PI3K/AKT Signaling in Cancer",0.665110073382255,0.980533241832259,0.635680299961012,0.879465985815287,2990,93,"NRG1, CREB1, STRN"
"610","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",0.472703062583222,0.980533241832259,0.732766787256438,1.01164011221769,2129,91,"NRG1, STRN, AKT1"
"611","PIP3 activates AKT signaling",0.919028340080972,0.980533241832259,-0.497396251840766,-0.764610756092514,4766,248,"UBB, AGO2, FGFR1, KDM1A, PDPK1, PSMB2, CHUK, CNOT6L, SCMH1, FGFR2, HDAC2, RBBP7"
"612","PIWI-interacting RNA (piRNA) biogenesis",0.887751371115174,0.980533241832259,-0.355372270278728,-0.439646336587521,4855,27,"TDRKH, TDRD9, TDRD6, TDRD12, TDRD1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, PLD6, PIWIL2, PIWIL1"
"613","PKA activation",0.457025330158043,0.980533241832259,0.938346591311085,1.4506878011613,2110,15,"ADCY1, ADCY2"
"614","PKA activation in glucagon signalling",0.457025330158043,0.980533241832259,0.938346591311085,1.4506878011613,2110,15,"ADCY1, ADCY2"
"615","PKA-mediated phosphorylation of CREB",0.473225946887244,0.980533241832259,0.937768083250495,1.3903442732656,2173,17,"ADCY1, CREB1, ADCY2"
"616","PKMTs methylate histone lysines",0.601892285298399,0.980533241832259,-0.830302066648305,-1.01404956831379,3307,42,"DOT1L, ATF7IP, RBBP7, AEBP2"
"617","PLC beta mediated events",0.635138121546961,0.980533241832259,0.723092820678739,0.934695138671313,2873,46,"ADCY1, CREB1, ADCY2"
"618","PPARA activates gene expression",0.415083901899318,0.980533241832259,-0.767541956930041,-1.05247566863409,2250,108,"NCOR2, CREBBP, CLOCK, HMGCR, NRF1"
"619","PTEN Regulation",0.570229434806939,0.980533241832259,-0.666898736812007,-0.944768206302104,3056,135,"UBB, AGO2, KDM1A, PSMB2, CNOT6L, SCMH1, HDAC2, RBBP7, PREX2, NEDD4, VAPA"
"620","Paradoxical activation of RAF signaling by kinase inactive BRAF",0.696486780152119,0.980533241832259,-0.763756781918801,-0.926954569921745,3845,38,"IQGAP1, CAMK2A, CAMK2G"
"621","Pausing and recovery of HIV elongation",0.927187103785546,0.980533241832259,-0.221184865604019,-0.270876877619602,5118,31,"TCEA1, SUPT5H, SUPT4H1, SUPT16H, SSRP1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, NELFE, NELFCD, NELFB, NELFA"
"622","Pausing and recovery of Tat-mediated HIV elongation",0.907658881042911,0.980533241832259,-0.26796463615151,-0.329701979663797,5012,29,"TCEA1, SUPT5H, SUPT4H1, SUPT16H, SSRP1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, NELFE, NELFCD, NELFB, NELFA"
"623","Peptide chain elongation",0.801016702977487,0.980533241832259,-0.621157704980328,-0.779097422535075,4411,58,"RPSA, RPS9, RPS8, RPS7, RPS5, RPS4X, RPS3A, RPS28, RPS27L, RPS27A, RPS25, RPS24, RPS21, RPS20, RPS19, RPS17, RPS16, RPS15A, RPS15, RPS14, RPS13, RPS12, RPS11, RPLP1, RPL8, RPL7A, RPL6, RPL5, RPL4, RPL3L, RPL38, RPL37A, RPL36, RPL35, RPL34, RPL32, RPL30, RPL3, RPL29, RPL28, RPL27, RPL26, RPL23, RPL22L1, RPL19, RPL18A, RPL18, RPL14, RPL13A, RPL12, RPL11, RPL10A, RPL10"
"624","Peptide hormone metabolism",0.275589134736463,0.980533241832259,-0.959537572254335,-1.21649459127491,1531,62,"AOPEP, KIF5A"
"625","Peptide ligand-binding receptors",0.942098469481837,0.980533241832259,-0.503270626185166,-0.690099197855846,5108,108,"OPRM1, CX3CL1, SST, CCK"
"626","Peroxisomal lipid metabolism",0.828993821712268,0.980533241832259,0.371286796754509,0.498747534956938,3756,27,"ABCD1, ACAA1, ACBD4, ACBD5, ACOT6, ACOT8, ACOX1, ACOX2, ACOX3, ACOXL, ALDH3A2, AMACR"
"627","Peroxisomal protein import",0.533646040050514,0.980533241832259,-0.804920072946231,-1.01588573298241,2957,60,"UBB"
"628","Phase 0 - rapid depolarisation",0.448357233617716,0.980533241832259,-0.960472451513321,-1.16539405487237,2469,39,"SCN1B, CAMK2A, CAMK2G, SCN1A"
"629","Phase 2 - plateau phase",0.196643560744254,0.980533241832259,-0.98230207146209,-1.24972566693907,1077,23,"AKAP9, KCNQ1"
"630","Phase I - Functionalization of compounds",0.636424731182796,0.980533241832259,0.680977731637318,0.906842408468931,2840,69,"CYP7B1, ACSS1"
"631","Phase II - Conjugation of compounds",0.733827249728948,0.980533241832259,-0.65221904817435,-0.835345655822687,4060,68,"GSTZ1, CHAC2, PODXL2"
"632","Phospholipid metabolism",0.281493986073011,0.980533241832259,0.741224268758113,1.12009223784313,1333,194,"INPP4B, PLA2G3, PTDSS2, GPCPD1, OSBPL10, PLEKHA1, PLD3, PLA2G4E"
"633","Phosphorylation of the APC/C",0.565273868802771,0.980533241832259,0.634907872696817,0.981570258059575,2610,15,"ANAPC1, ANAPC10, ANAPC15, ANAPC16, ANAPC2, ANAPC4, ANAPC5, ANAPC7, CDC16, CDC23, CDC26, CDC27"
"634","Pink/Parkin Mediated Mitophagy",0.59418155035905,0.980533241832259,-0.949239985275643,-1.24648765143622,3226,19,"UBB"
"635","Plasma lipoprotein assembly, remodeling, and clearance",0.624386981720909,0.980533241832259,0.712000052114509,0.927588267601706,2800,55,"APOE, PCSK5, CLTA, LPA"
"636","Plasma lipoprotein clearance",0.700379549006475,0.980533241832259,0.667723685999518,0.883097716025696,3136,29,"APOE, CLTA, AMN"
"637","Plasma lipoprotein remodeling",0.446514686540991,0.980533241832259,0.970783538366324,1.36288841308026,2036,21,"APOE, PCSK5, LPA"
"638","Platelet Aggregation (Plug Formation)",0.640238396243453,0.980533241832259,-0.839627131289845,-1.02411938070951,3544,33,"PDPK1"
"639","Platelet activation, signaling and aggregation",0.288212927756654,0.980533241832259,-0.725539723513717,-1.10498162960446,1515,225,"DGKZ, DGKB, APLP2, TMSB4X, PDPK1, GNB1, PPIA, MGLL, DGKD, DAGLB, VTI1B, ACTN4, CLU, MANF, MAPK14"
"640","Platelet calcium homeostasis",0.0871579876434245,0.980533241832259,0.991618051364581,1.33203513580336,394,27,"SLC8A3, ATP2A1"
"641","Platelet degranulation",0.524064171122995,0.980533241832259,-0.713582835526081,-0.978485365086789,2841,108,"APLP2, TMSB4X, PPIA, VTI1B, ACTN4, CLU, MANF"
"642","Platelet homeostasis",0.524972855591748,0.980533241832259,-0.763767841964829,-0.997273433523917,2900,77,"PDE10A, PRKG1, GNB1"
"643","Platelet sensitization by LDL",0.553994082840237,0.980533241832259,-0.960463713730483,-1.29205238573153,2995,17,"MAPK14"
"644","Positive epigenetic regulation of rRNA expression",0.333394193901771,0.980533241832259,-0.963542366053444,-1.17936199617872,1825,46,"SF3B1, HDAC2, RBBP7"
"645","Post NMDA receptor activation events",0.865848214285714,0.980533241832259,0.552405225340129,0.723623664156437,3878,59,"NRG1, ADCY1, RPS6KA2, CREB1"
"646","Post-translational modification: synthesis of GPI-anchored proteins",0.211021505376344,0.980533241832259,0.924917656326131,1.23169160477767,941,69,"THY1, CNTN5, CNTN3, PIGB"
"647","Post-translational protein phosphorylation",0.60692871419054,0.980533241832259,0.670669336056251,0.920415505778572,2732,86,"APOE, CST3, MIA3, LAMC1, IGFBP5"
"648","Potassium Channels",0.861346411056621,0.980533241832259,0.544707369071856,0.742369826838615,3863,82,"KCND2, KCNAB2, KCNJ4, KCNG2"
"649","Pre-NOTCH Expression and Processing",0.810451727192205,0.980533241832259,0.582832576469221,0.755556324085032,3659,47,"MAML2, ST3GAL4"
"650","Pre-NOTCH Processing in Golgi",0.723230826231938,0.980533241832259,-0.515104274435244,-0.701838260290138,3903,16,"FURIN, ST3GAL3"
"651","Pre-NOTCH Transcription and Translation",0.786368715083799,0.980533241832259,0.592274388664965,0.77161919596113,3518,32,"MAML2, AGO1"
"652","Prefoldin mediated transfer of substrate  to CCT/TriC",0.564338235294118,0.980533241832259,-0.960252027615792,-1.23572080541139,3069,21,"TUBB2A, PFDN1"
"653","Presynaptic function of Kainate receptors",0.13387573964497,0.980533241832259,-0.988340146083227,-1.32955282475088,723,17,"GNB1"
"654","Presynaptic phase of homologous DNA pairing and strand exchange",0.95970230531857,0.985120736573921,-0.288493802687481,-0.350045399001066,5286,39,"XRCC2, WRN, TOPBP1, TOP3A, RPA3, RPA2, RPA1, RMI2, RMI1, RHNO1, RFC5, RFC4, RFC3, RFC2, RBBP8, RAD9B, RAD9A, RAD51D, RAD51C, RAD51B, RAD51, RAD50, RAD17, RAD1"
"655","Processing of Capped Intron-Containing Pre-mRNA",0.351083982319512,0.980533241832259,0.692103858171887,1.06262868137589,1667,233,"SRSF2, SRSF1, SRSF7, SRSF11, NUP93, LSM7, HNRNPU, POLDIP3, RANBP2, U2AF1, CPSF7, SRSF10, RNPS1, ELAVL1, FYTTD1, SRSF4, TRA2B, NCBP2"
"656","Processing of Capped Intronless Pre-mRNA",0.759606629029321,0.980533241832259,-0.691957401899393,-0.861610592775132,4170,26,"SYMPK"
"657","Processing of DNA double-strand break ends",0.166606302064469,0.980533241832259,-0.968886499563201,-1.21915288249738,919,59,"UBB, SUMO1, SUMO2"
"658","Processing of Intronless Pre-mRNAs",0.697025678921116,0.980533241832259,-0.691965094666522,-0.91827317012801,3772,18,"SYMPK"
"659","Programmed Cell Death",0.842708554447039,0.980533241832259,0.527075066445351,0.781486009277445,3969,158,"BCL2L1, PSMA1, NMT1, YWHAZ, PSMB3, PSMD14, PSME4, ADD1, PSMD9"
"660","Protein folding",0.144990892531876,0.980533241832259,-0.960417367889599,-1.26905645337986,795,85,"FBXW7, FBXW4, GNB1, XRN2, TUBB2A, GNAO1, PFDN1"
"661","Protein localization",0.498965192850423,0.980533241832259,-0.68753733347439,-0.988263518268771,2651,152,"UBB, HSPA9, SGTA, TIMM23"
"662","Protein ubiquitination",0.512617159336698,0.980533241832259,-0.81458281421387,-1.02970071460109,2843,61,"UBB, SELENOS, UBE2K"
"663","Protein-protein interactions at synapses",0.933333333333333,0.980533241832259,-0.515416603217891,-0.6810505394442,5123,85,"NRXN3, SHANK1, APBA2, NLGN1, STXBP1, SHANK2, GRIN2B, EPB41L1, NRXN1"
"664","Purine catabolism",0.688071397474967,0.980533241832259,0.315643834428498,0.46797668360401,3160,17,"ADPRM, DNPH1, GDA, GPX1, ITPA, NT5C, NT5C1A, NT5C2, NT5E, NUDT1, NUDT15, NUDT16, NUDT18, NUDT5, NUDT9"
"665","Pyruvate metabolism",0.66745886654479,0.980533241832259,-0.828378923487394,-1.02482323320247,3650,27,"GSTZ1, LDHB"
"666","Pyruvate metabolism and Citric Acid (TCA) cycle",0.83905540417802,0.980533241832259,-0.599290997576022,-0.74159467968817,4618,51,"GSTZ1, SDHB, LDHB"
"667","RAB GEFs exchange GTP for GDP on RABs",0.589920232052212,0.980533241832259,-0.714740799774684,-0.940856842827006,3253,82,"RAB6B, MADD, RAB7A, CCZ1, CCZ1B"
"668","RAB geranylgeranylation",0.168781725888325,0.980533241832259,-0.970104131676184,-1.21188447072648,930,55,"RAB6B, RAB7A"
"669","RAF activation",0.728951656708311,0.980533241832259,-0.739869163157075,-0.910330300626533,4025,29,"CAMK2A, CAMK2G"
"670","RAF-independent MAPK1/3 activation",0.292944785276074,0.980533241832259,0.979222520107239,1.39339867924587,1336,20,"PEA15, DUSP1"
"671","RAF/MAP kinase cascade",0.712794229309036,0.980533241832259,-0.570101695133108,-0.863783409554808,3754,215,"SPRED2, UBB, CUL3, FGFR1, SPRED1, RASGRF1, SHC3, IQGAP1, PSMB2, SPTBN2, CAMK2A, GRIN2B, RASGEF1A, CAMK2G, FGFR2, NF1, PTPRA"
"672","RET signaling",0.742086491306286,0.980533241832259,0.646099374897017,0.833673073015742,3328,37,"GFRA1, ARTN"
"673","RHO GTPase Effectors",0.839323065221525,0.980533241832259,-0.525117564594232,-0.800204595216121,4413,227,"YWHAG, KDM1A, PDPK1, DYNLL1, CENPP, IQGAP1, SCAI, BUB3, PAK2, LIMK2, DVL2, NUP98"
"674","RHO GTPases Activate Formins",0.924140912038038,0.980533241832259,0.505052835999971,0.718186221773669,4275,113,"CKAP5, DIAPH2, RANBP2, DYNC1I2, RHOA"
"675","RHO GTPases Activate NADPH Oxidases",0.558460688639293,0.980533241832259,-0.960458414315394,-1.2612190507488,3032,19,"MAPK14"
"676","RHO GTPases Activate ROCKs",0.674117864400517,0.980533241832259,-0.750493449421087,-0.995943298689556,3648,18,"LIMK2"
"677","RHO GTPases Activate WASPs and WAVEs",0.196885428253615,0.980533241832259,0.980945991278095,1.26891696524513,884,35,"WIPF3, ABI1"
"678","RHO GTPases activate CIT",0.410982784920462,0.980533241832259,0.972858866103739,1.42122638627411,1885,18,"RHOA, CDKN1B"
"679","RHO GTPases activate PAKs",0.631682734443471,0.980533241832259,0.676786799907893,0.96304344902058,2882,20,"PAK3, CALM1"
"680","RHO GTPases activate PKNs",0.764641885766092,0.980533241832259,-0.69275873555569,-0.850402979372378,4216,30,"YWHAG, KDM1A, PDPK1"
"681","RMTs methylate histone arginines",0.766884531590414,0.980533241832259,-0.683796853007176,-0.843892554157011,4223,28,"DNMT3A, SMARCA4, RBBP7"
"682","RNA Pol II CTD phosphorylation and interaction with CE",0.837599293909974,0.980533241832259,0.261025056438454,0.350633538813263,3795,27,"CCNH, CDK7, ERCC2, ERCC3, GTF2F1, GTF2F2, GTF2H1, GTF2H2, GTF2H3, GTF2H4, GTF2H5, MNAT1, POLR2A, POLR2B, POLR2C, POLR2D, POLR2E, POLR2F, POLR2G, POLR2H, POLR2I, POLR2J, POLR2K, POLR2L, RNGTT, RNMT"
"683","RNA Pol II CTD phosphorylation and interaction with CE during HIV infection",0.837599293909974,0.980533241832259,0.261025056438454,0.350633538813263,3795,27,"CCNH, CDK7, ERCC2, ERCC3, GTF2F1, GTF2F2, GTF2H1, GTF2H2, GTF2H3, GTF2H4, GTF2H5, MNAT1, POLR2A, POLR2B, POLR2C, POLR2D, POLR2E, POLR2F, POLR2G, POLR2H, POLR2I, POLR2J, POLR2K, POLR2L, RNGTT, RNMT"
"684","RNA Polymerase I Promoter Clearance",0.298694232861806,0.980533241832259,-0.963465413028878,-1.19021219060295,1646,50,"HDAC2, RBBP7"
"685","RNA Polymerase I Promoter Escape",0.931427537542971,0.980533241832259,-0.223277770324658,-0.27306132586885,5147,32,"ZNRD1, UBTF, TWISTNB, TBP, TAF1D, TAF1C, TAF1B, TAF1A, RRN3, POLR2L, POLR2K, POLR2H, POLR2F, POLR2E, POLR1E, POLR1D, POLR1C, POLR1B, POLR1A"
"686","RNA Polymerase I Transcription",0.298694232861806,0.980533241832259,-0.963465413028878,-1.19021219060295,1646,50,"HDAC2, RBBP7"
"687","RNA Polymerase I Transcription Initiation",0.335767756070842,0.980533241832259,-0.963475224922788,-1.17927981640058,1838,46,"HDAC2, RBBP7"
"688","RNA Polymerase I Transcription Termination",0.91441523118767,0.980533241832259,-0.262910798122066,-0.322738804372971,5042,30,"ZNRD1, UBTF, TWISTNB, TTF1, TBP, TAF1D, TAF1C, TAF1B, TAF1A, POLR2L, POLR2K, POLR2H, POLR2F, POLR2E, POLR1E, POLR1D, POLR1C, POLR1B, POLR1A"
"689","RNA Polymerase II HIV Promoter Escape",0.975756471017134,0.985120736573921,-0.266275317120281,-0.326588764089938,5352,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1L, TAF1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"690","RNA Polymerase II Pre-transcription Events",0.0932354250111259,0.980533241832259,0.970594172666712,1.31374192479121,418,79,"NCBP2, AFF4"
"691","RNA Polymerase II Promoter Escape",0.975756471017134,0.985120736573921,-0.266275317120281,-0.326588764089938,5352,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1L, TAF1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"692","RNA Polymerase II Transcription Elongation",0.198132088058706,0.980533241832259,0.970639613007256,1.26761639447144,890,56,"NCBP2, AFF4"
"693","RNA Polymerase II Transcription Initiation",0.975756471017134,0.985120736573921,-0.266275317120281,-0.326588764089938,5352,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1L, TAF1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"694","RNA Polymerase II Transcription Initiation And Promoter Clearance",0.975756471017134,0.985120736573921,-0.266275317120281,-0.326588764089938,5352,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1L, TAF1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"695","RNA Polymerase II Transcription Pre-Initiation And Promoter Opening",0.975756471017134,0.985120736573921,-0.266275317120281,-0.326588764089938,5352,47,"TBP, TAF9B, TAF7L, TAF7, TAF6, TAF5, TAF4B, TAF4, TAF3, TAF2, TAF15, TAF13, TAF12, TAF11, TAF10, TAF1L, TAF1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, MNAT1, GTF2H5, GTF2H4, GTF2H3, GTF2H2, GTF2H1, GTF2F2, GTF2F1, GTF2E2, GTF2E1, GTF2B, GTF2A2, GTF2A1"
"696","RNA Polymerase II Transcription Termination",0.249381048840873,0.980533241832259,0.923262174847258,1.21093116737227,1107,62,"SRSF2, SRSF1, SRSF7, SRSF11, POLDIP3, U2AF1, CPSF7, RNPS1, FYTTD1, SRSF4, NCBP2"
"697","RNA Polymerase III Abortive And Retractive Initiation",0.266110001815211,0.980533241832259,-0.970740218777263,-1.17785250165797,1465,39,"NFIX"
"698","RNA Polymerase III Chain Elongation",0.709892552797332,0.980533241832259,-0.567290940766551,-0.772943473207393,3831,16,"POLR3K, POLR3H, POLR3F, POLR3E, POLR3D, POLR3C, POLR3B, POLR3A, POLR2L, POLR2K, POLR2H, POLR2F, POLR2E, POLR1D, POLR1C"
"699","RNA Polymerase III Transcription",0.266110001815211,0.980533241832259,-0.970740218777263,-1.17785250165797,1465,39,"NFIX"
"700","RNA Polymerase III Transcription Initiation",0.935804701627486,0.980533241832259,-0.306351173234623,-0.373303799262619,5174,34,"ZNF143, TBP, SNAPC5, SNAPC4, SNAPC3, SNAPC2, SNAPC1, POU2F1, POLR3K, POLR3H, POLR3F, POLR3E, POLR3D, POLR3C, POLR3B, POLR3A, POLR2L, POLR2K, POLR2H, POLR2F, POLR2E, POLR1D, POLR1C"
"701","RNA Polymerase III Transcription Initiation From Type 1 Promoter",0.821325648414986,0.980533241832259,0.331124085784137,0.446232458983136,3704,26,"BDP1, BRF1, CRCP, GTF3C2, GTF3A, GTF3C1, GTF3C3, GTF3C4, GTF3C5, GTF3C6, POLR1C, POLR1D, POLR2E, POLR2F, POLR2H, POLR2K, POLR2L, POLR3A, POLR3B, POLR3C, POLR3D, POLR3E, POLR3F, POLR3H, POLR3K"
"702","RNA Polymerase III Transcription Initiation From Type 2 Promoter",0.81030289630776,0.980533241832259,0.329560844787127,0.446884282888011,3664,25,"BDP1, BRF1, CRCP, GTF3C2, GTF3C1, GTF3C3, GTF3C4, GTF3C5, GTF3C6, POLR1C, POLR1D, POLR2E, POLR2F, POLR2H, POLR2K, POLR2L, POLR3A, POLR3B, POLR3C, POLR3D, POLR3E, POLR3F, POLR3H, POLR3K"
"703","RNA Polymerase III Transcription Initiation From Type 3 Promoter",0.858859952649791,0.980533241832259,-0.514694504905045,-0.64088661563854,4715,26,"ZNF143, TBP, SNAPC5, SNAPC4, SNAPC3, SNAPC2, SNAPC1, POU2F1, POLR3K, POLR3H, POLR3F, POLR3E, POLR3D, POLR3C, POLR3B, POLR3A, POLR2L, POLR2K, POLR2H, POLR2F, POLR2E, POLR1D, POLR1C"
"704","RNA Polymerase III Transcription Termination",0.371323529411765,0.980533241832259,-0.97077552114753,-1.24926318754525,2019,21,"NFIX"
"705","RNA polymerase II transcribes snRNA genes",0.0242139501264908,0.629804462055302,-0.986070438821233,-1.26912058348581,133,70,"RPRD2"
"706","RORA activates gene expression",0.755403657860706,0.980533241832259,-0.534753604918241,-0.709645460169209,4088,18,"CREBBP"
"707","ROS and RNS production in phagocytes",0.609428830462375,0.980533241832259,-0.885814321791136,-1.08739031319129,3360,30,"ATP6V0C, ATP6V0B, ATP6V1C1"
"708","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known",0.33502538071066,0.980533241832259,-0.967456216869087,-1.17427448402059,1847,37,"YAF2, SCMH1, SMARCA4"
"709","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function",0.957094972067039,0.985120736573921,0.130232090152938,0.169667273505881,4282,32,"AGO1, AGO3, AGO4, ASH2L, CBFB, DPY30, EP300, GATA1, H3-3A, HDAC1, ITGA2B, KAT2B, KMT2A, KMT2B, KMT2C, KMT2D, KMT2E, MOV10, MYL9, NR4A3, PRKCQ, PRMT1, PRMT6, RBBP5, RUNX1, SETD1B, SIN3A, SIN3B"
"710","RUNX1 regulates transcription of genes involved in differentiation of HSCs",0.944104960460101,0.980533241832259,-0.513213684016183,-0.654571341070705,5252,65,"UBB, PSMB2, ITCH"
"711","RUNX2 regulates bone development",0.922686945500634,0.980533241832259,-0.204634856470229,-0.251781422561684,5095,29,"ZNF521, YES1, YAP1, WWTR1, UCMA, SRC, SP7, SMAD6, SMAD4, SMAD1, SATB2, RUNX2, RBM14, RB1, MAPK3, MAPK1, MAF, HEY2, HEY1, HES1, HDAC6, HDAC4, HDAC3, GLI3, GLI2"
"712","RUNX2 regulates osteoblast differentiation",0.918825246260489,0.980533241832259,-0.168582096295152,-0.214477174432565,5036,23,"ZNF521, YES1, YAP1, WWTR1, UCMA, SRC, SP7, SATB2, RUNX2, RB1, MAPK3, MAPK1, MAF, HEY2, HEY1, HES1, HDAC6, HDAC3, GLI3"
"713","Rab regulation of trafficking",0.874213836477987,0.980533241832259,0.524391745246084,0.744626171411938,4030,111,"TBC1D14, GDI2, TBC1D24, TBC1D20, GAPVD1"
"714","Ras activation upon Ca2+ influx through NMDA receptor",0.435463082305284,0.980533241832259,-0.967294417264258,-1.27019569879683,2364,19,"RASGRF1, CAMK2A, GRIN2B, CAMK2G"
"715","Receptor-type tyrosine-protein phosphatases",0.0234084445416758,0.629804462055302,0.997989410897393,1.43955732060735,106,19,"PTPRD, IL1RAPL1"
"716","Recognition and association of DNA glycosylase with site containing an affected pyrimidine",0.71279955415196,0.980533241832259,-0.416013400335008,-0.575956707218245,3836,15,"UNG, TINF2, TERF2IP, TERF2, TERF1, TDG, SMUG1, POT1, OGG1, NTHL1, NEIL3, NEIL2, NEIL1, MBD4"
"717","Recognition of DNA damage by PCNA-containing replication complex",0.0208220170197357,0.629804462055302,-0.997183287505868,-1.22692795848048,114,29,"UBB"
"718","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks",0.696133599564349,0.980533241832259,-0.762963160591928,-0.925745168473616,3834,39,"UBB, SUMO1"
"719","Recruitment of NuMA to mitotic centrosomes",0.907594936708861,0.980533241832259,-0.530905646787227,-0.691054749020705,5018,75,"YWHAG, DYNLL1, AKAP9, PCM1, SDCCAG8"
"720","Recruitment of mitotic centrosome proteins and complexes",0.79477445288075,0.980533241832259,0.586079898404036,0.787970810812463,3558,76,"CKAP5, CDK11A, CDK11B, DYNC1I2, TUBGCP4, ODF2"
"721","Recycling pathway of L1",0.768314210061783,0.980533241832259,0.563788365623025,0.757333845560371,3481,27,"RPS6KA2, CLTA, AP2A1"
"722","Regulation of APC/C activators between G1/S and early anaphase",0.805907937658572,0.980533241832259,-0.597467338484977,-0.770977442079171,4446,71,"UBB, CUL1, PSMB2, BUB3"
"723","Regulation of Apoptosis",0.917301414581066,0.980533241832259,-0.535705728389989,-0.661781398567431,5057,50,"UBB, PSMB2, PAK2"
"724","Regulation of Complement cascade",0.497997329773031,0.980533241832259,0.893078918023204,1.1865054705536,2237,28,"C1QB, C1QA"
"725","Regulation of FZD by ubiquitination",0.0286870172857668,0.629804462055302,-0.997184986595174,-1.29723500712304,155,20,"UBB"
"726","Regulation of Glucokinase by Glucokinase Regulatory Protein",0.530908279401919,0.980533241832259,0.853935297694805,1.12022409112498,2378,31,"NUP93, RANBP2, AAAS"
"727","Regulation of HSF1-mediated heat shock response",0.575774035850081,0.980533241832259,-0.730642230202357,-0.956101256152813,3179,78,"UBB, HSPA8, HSPA4, HSPA9, ST13, NUP98"
"728","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)",0.59511653718091,0.980533241832259,0.670655913388655,0.928938452021089,2680,94,"APOE, CST3, MIA3, LAMC1, IGFBP5"
"729","Regulation of KIT signaling",0.775101889588737,0.980533241832259,-0.264423076923077,-0.360280901360658,4183,16,"YES1, SRC, SOS1, SOCS6, SOCS1, SH2B3, SH2B2, PTPN6, PRKCA, LYN, LCK, KITLG, KIT, GRB2, FYN"
"730","Regulation of MECP2 expression and activity",0.658748866727108,0.980533241832259,-0.827632523017454,-1.01596865874951,3632,30,"AGO2, NCOR2, CAMK2A, CAMK2G, HDAC2"
"731","Regulation of PLK1 Activity at G2/M Transition",0.57272397533551,0.980533241832259,-0.728781224189426,-0.956376944601888,3157,80,"UBB, YWHAG, CUL1, DYNLL1, AKAP9, PCM1, SDCCAG8"
"732","Regulation of PTEN gene transcription",0.245098039215686,0.980533241832259,-0.963580163956458,-1.20858650890948,1349,58,"KDM1A, SCMH1, HDAC2, RBBP7"
"733","Regulation of PTEN stability and activity",0.942857142857143,0.980533241832259,-0.515511742329067,-0.658227941616868,5246,66,"UBB, PSMB2"
"734","Regulation of RAS by GAPs",0.608539001981625,0.980533241832259,-0.742815179265379,-0.944255734027534,3377,64,"SPRED2, UBB, CUL3, SPRED1, PSMB2"
"735","Regulation of RUNX1 Expression and Activity",0.202477810650888,0.980533241832259,-0.983113315017088,-1.32252149243475,1094,17,"AGO2, CCND2"
"736","Regulation of RUNX2 expression and activity",0.735092157571377,0.980533241832259,-0.650737799201177,-0.833448509613303,4067,68,"UBB, FBXW7, CUL1, PSMB2, WWP1"
"737","Regulation of RUNX3 expression and activity",0.92188919164396,0.980533241832259,-0.53093900447988,-0.657012273759819,5074,51,"UBB, PSMB2"
"738","Regulation of TNFR1 signaling",0.280746241622894,0.980533241832259,-0.973237641692937,-1.19188793882314,1549,31,"UBB, MADD, CHUK, SPPL2A"
"739","Regulation of TP53 Activity",0.0208411565903117,0.629804462055302,-0.960581473968898,-1.37895560062332,110,150,"PRKAG2, UBB, JMY, PDPK1, BRD1, HDAC2, RBBP7, MAPK14"
"740","Regulation of TP53 Activity through Acetylation",0.466957153231663,0.980533241832259,-0.963586373390558,-1.18918851734305,2571,28,"BRD1, HDAC2, RBBP7"
"741","Regulation of TP53 Activity through Methylation",0.0546831701459449,0.83731026498585,-0.994839833802439,-1.32020348280089,295,18,"UBB, JMY"
"742","Regulation of TP53 Activity through Phosphorylation",0.00473243538405533,0.629804462055302,-0.990941797745873,-1.32294197984277,25,90,"PRKAG2, UBB"
"743","Regulation of TP53 Degradation",0.0749503341159473,0.906512436285034,-0.990205943516469,-1.20778505107512,414,33,"UBB, PDPK1"
"744","Regulation of TP53 Expression and Degradation",0.0717902350813743,0.906512436285034,-0.990205286461827,-1.20661328495396,396,34,"UBB, PDPK1"
"745","Regulation of actin dynamics for phagocytic cup formation",0.449227974568574,0.980533241832259,-0.876971363619195,-1.09683237236446,2472,56,"HSP90AB1"
"746","Regulation of activated PAK-2p34 by proteasome mediated degradation",0.911228581844696,0.980533241832259,-0.540619822138461,-0.663074450400399,4998,47,"UBB, PSMB2, PAK2"
"747","Regulation of beta-cell development",0.685561258647623,0.980533241832259,0.686618828701397,0.900732122688553,3071,31,"MAML2, AKT1"
"748","Regulation of cholesterol biosynthesis by SREBP (SREBF)",0.596223674655047,0.980533241832259,-0.791778064264373,-0.981296093707686,3283,52,"SEC23A, ACACA, CREBBP, INSIG2, HMGCR"
"749","Regulation of expression of SLITs and ROBOs",0.46100818612667,0.980533241832259,0.696321723325376,1.01071039997007,2139,133,"ROBO2, PSMA1, PSMB3, ETF1, RNPS1, PSMD14, PSME4, PSMD9, NCBP2"
"750","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells",0.548387096774194,0.980533241832259,0.686619547748148,1.06151672652787,2532,15,"MAML2, EP300"
"751","Regulation of insulin secretion",0.382002168413444,0.980533241832259,-0.867997741348901,-1.11715528282335,2113,70,"GNB1, IQGAP1, STXBP1, ADCY8"
"752","Regulation of lipid metabolism by PPARalpha",0.411884487226953,0.980533241832259,-0.767536865061828,-1.05505990591053,2224,110,"NCOR2, CREBBP, CLOCK, HMGCR, NRF1"
"753","Regulation of mRNA stability by proteins that bind AU-rich elements",0.988631297369594,0.989571955121611,0.478698761449551,0.652408131086405,4434,82,"PSMA1, YWHAZ, PSMB3, ELAVL1, PSMD14, PSME4, PSMD9"
"754","Regulation of mitotic cell cycle",0.4457111834962,0.980533241832259,-0.808324785522667,-1.05545270430199,2462,77,"PTTG1, UBB, CUL1, PSMB2, BUB3"
"755","Regulation of ornithine decarboxylase (ODC)",0.529673260724606,0.980533241832259,0.794433588298818,1.02937267786396,2382,48,"PSMA1, PSMB3, PSMD14, PSME4, PSMD9"
"756","Regulation of pyruvate dehydrogenase (PDH) complex",0.14099944268995,0.980533241832259,-0.987470686767169,-1.36712030133395,758,15,"GSTZ1"
"757","Regulation of signaling by CBL",0.915758359504896,0.980533241832259,-0.166666666666667,-0.221175214666609,4956,18,"YES1, VAV1, SYK, RAPGEF1, PIK3R3, PIK3R2, PIK3R1, PIK3CD, PIK3CB, PIK3CA"
"758","Reproduction",0.906905278380333,0.980533241832259,-0.533372259450471,-0.69026411754299,5016,72,"SYCP3, SYNE1"
"759","Resolution of AP sites via the multiple-nucleotide patch replacement pathway",0.850409463148317,0.980533241832259,-0.420957361222848,-0.532895344262537,4672,24,"RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, POLE4, POLE3, POLE2, POLE, POLD4, POLD2, POLD1, POLB, PCNA, PARP2, PARP1, PARG"
"760","Resolution of Abasic Sites (AP sites)",0.15514935354436,0.980533241832259,0.983426155807556,1.2689315873844,695,37,"PNKP, ADPRHL2"
"761","Resolution of D-Loop Structures",0.942748780928301,0.980533241832259,-0.188392274526305,-0.229787928865454,5219,33,"XRCC3, XRCC2, WRN, TOP3A, SPIDR, SLX4, SLX1A, RTEL1, RMI2, RMI1, RBBP8, RAD51D, RAD51C, RAD51B, RAD51AP1, RAD51, RAD50"
"762","Resolution of D-loop Structures through Holliday Junction Intermediates",0.943187986249322,0.980533241832259,-0.173195599678025,-0.211812488157534,5212,32,"XRCC3, XRCC2, WRN, TOP3A, SPIDR, SLX4, SLX1A, RMI2, RMI1, RBBP8, RAD51D, RAD51C, RAD51B, RAD51AP1, RAD51, RAD50"
"763","Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)",0.902021489710435,0.980533241832259,-0.211654511506999,-0.263547681725054,4952,26,"XRCC3, XRCC2, WRN, TOP3A, RTEL1, RMI2, RMI1, RBBP8, RAD51D, RAD51C, RAD51B, RAD51AP1, RAD51, RAD50"
"764","Resolution of Sister Chromatid Cohesion",0.950266429840142,0.984906683932837,0.496792326942221,0.689485134977072,4279,96,"CKAP5, RANBP2, DYNC1I2, AHCTF1"
"765","Respiratory electron transport",0.841918294849023,0.980533241832259,0.548155909559722,0.760771313875832,3791,96,"NDUFS1, NDUFS4, COX19, SDHA, COX7C, ACAD9"
"766","Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",0.901579061215661,0.980533241832259,0.514431830487819,0.732589339627294,4167,114,"ATP5MG, NDUFS1, NDUFS4, COX19, SDHA, COX7C"
"767","Response of EIF2AK1 (HRI) to heme deficiency",0.60142888071011,0.980533241832259,0.529313232830821,0.818320497960177,2777,15,"ASNS, ATF3, ATF4, ATF5, CEBPB, CEBPG, CHAC1, DDIT3, EIF2AK1, EIF2S1, EIF2S2, EIF2S3"
"768","Response of EIF2AK4 (GCN2) to amino acid deficiency",0.995650598042769,0.995650598042769,-0.467739384047915,-0.603575276244186,5493,71,"TRIB3, RPSA, RPS9, RPS8, RPS7, RPS5, RPS4X, RPS3A, RPS28, RPS27L, RPS27A, RPS25, RPS24, RPS21, RPS20, RPS19, RPS17, RPS16, RPS15A, RPS15, RPS14, RPS13, RPS12, RPS11, RPLP1, RPL8, RPL7A, RPL6, RPL5, RPL4, RPL3L, RPL38, RPL37A, RPL36, RPL35, RPL34, RPL32, RPL30, RPL3, RPL29, RPL28, RPL27, RPL26, RPL23, RPL22L1, RPL19, RPL18A, RPL18, RPL14, RPL13A, RPL12, RPL11, RPL10A, RPL10"
"769","Response of Mtb to phagocytosis",0.563643013899049,0.980533241832259,-0.960249363185414,-1.22703242621879,3081,22,"UBB, RAB7A, ATP6V1H"
"770","Response to elevated platelet cytosolic Ca2+",0.595906976744186,0.980533241832259,-0.67205012478533,-0.926897569338789,3202,113,"APLP2, TMSB4X, PPIA, VTI1B, ACTN4, CLU, MANF"
"771","Retinoid metabolism and transport",0.0215005599104143,0.629804462055302,0.997383779432481,1.29547333414984,95,33,"APOE, AGRN"
"772","Retrograde transport at the Trans-Golgi-Network",0.694186258429014,0.980533241832259,-0.740728627509511,-0.907185151067542,3808,45,"GOLGA1, VPS54, RAB6B"
"773","Rev-mediated nuclear export of HIV RNA",0.525643896976484,0.980533241832259,0.853933119951961,1.10914936542742,2346,33,"NUP93, RANBP2, AAAS"
"774","Rho GTPase cycle",0.983627906976744,0.986440951515286,-0.48134095412666,-0.679034305270295,5286,131,"ARHGEF12, RHOF, ARHGEF11, ARHGEF7, ARHGEF18, FGD4"
"775","Ribosomal scanning and start codon recognition",0.821733599854625,0.980533241832259,-0.618478574756323,-0.760437694390884,4521,48,"EIF4E, EIF5, EIF4A2"
"776","Role of phospholipids in phagocytosis",0.250221238938053,0.980533241832259,0.981095394516324,1.35024981662746,1130,23,"PLD3, AHCYL1"
"777","S Phase",0.630422535211268,0.980533241832259,-0.632019927388921,-0.90654195641443,3356,149,"UBB, ORC3, CUL1, PSMB2, MAX"
"778","S33 mutants of beta-catenin aren't phosphorylated",0.627841524139424,0.980533241832259,0.361139028475712,0.558322466329792,2899,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"779","S37 mutants of beta-catenin aren't phosphorylated",0.627841524139424,0.980533241832259,0.361139028475712,0.558322466329792,2899,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"780","S45 mutants of beta-catenin aren't phosphorylated",0.627841524139424,0.980533241832259,0.361139028475712,0.558322466329792,2899,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"781","SCF(Skp2)-mediated degradation of p27/p21",0.845594913714805,0.980533241832259,-0.588488886820447,-0.736025928118759,4654,56,"UBB, CUL1, PSMB2"
"782","SCF-beta-TrCP mediated degradation of Emi1",0.863289760348584,0.980533241832259,-0.576874975534661,-0.714954335816083,4754,52,"UBB, CUL1, PSMB2"
"783","SHC-mediated cascade:FGFR1",0.0549186390532544,0.83731026498585,-0.994907190243249,-1.33838706278909,296,17,"FGFR1"
"784","SHC-mediated cascade:FGFR2",0.441171055054318,0.980533241832259,-0.966959319080491,-1.26975566702977,2395,19,"FGFR2"
"785","SHC-mediated cascade:FGFR3",0.651172893136403,0.980533241832259,0.370661350844278,0.560017216406711,2997,16,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF5, FGF9, FGFR3, GRB2, HRAS, KRAS"
"786","SHC-mediated cascade:FGFR4",0.651172893136403,0.980533241832259,0.370661350844278,0.560017216406711,2997,16,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF9, FGFR4, GRB2, HRAS, KLB, KRAS"
"787","SHC1 events in ERBB2 signaling",0.631302060499781,0.980533241832259,0.695712458564879,0.976714593048504,2879,21,"NRG1, BTC"
"788","SLC transporter disorders",0.133378016085791,0.980533241832259,0.948459429919444,1.2796956642592,596,77,"SLC1A3, NUP93, SLC4A4, RANBP2, AAAS"
"789","SLC-mediated transmembrane transport",0.0662433862433862,0.906512436285034,0.870100256109583,1.32013028119575,312,204,"AHCYL2, SLC1A3, SLC4A3, SLC24A2, SLC8A3, SLC4A4, SLC6A15, SLC4A10"
"790","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription",0.373528879232301,0.980533241832259,-0.968345516732613,-1.19144614920302,2062,29,"UBB, SMAD7, RNF111"
"791","SRP-dependent cotranslational protein targeting to membrane",0.107324147933285,0.980533241832259,-0.965136626733073,-1.27046811908743,591,82,"SRP9, SRP14"
"792","SUMO E3 ligases SUMOylate target proteins",0.534460093896714,0.980533241832259,-0.674982037036108,-0.96816494208856,2845,149,"NR3C2, NCOR2, SUMO1, CREBBP, SMC6, DNMT3A, NUP98, SCMH1, SUMO2, HDAC2"
"793","SUMOylation",0.524645892351275,0.980533241832259,-0.673782014818823,-0.971551765072951,2777,155,"NR3C2, NCOR2, SUMO1, CREBBP, SMC6, DNMT3A, NUP98, SCMH1, SUMO2, HDAC2"
"794","SUMOylation of DNA damage response and repair proteins",0.944182674882204,0.980533241832259,-0.511636220675602,-0.660220164824036,5209,71,"SUMO1, SMC6, NUP98, SCMH1, SUMO2"
"795","SUMOylation of DNA methylation proteins",0.391626528343831,0.980533241832259,-0.96978021978022,-1.32134190317208,2113,16,"SUMO1, DNMT3A, SCMH1"
"796","SUMOylation of DNA replication proteins",0.900618374558304,0.980533241832259,0.518156509867461,0.668403667294831,4077,44,"NUP93, RANBP2, AAAS"
"797","SUMOylation of RNA binding proteins",0.94828729281768,0.983824686434121,0.483886999108543,0.625489304828751,4290,46,"NUP93, RANBP2, AAAS"
"798","SUMOylation of SUMOylation proteins",0.864490161001789,0.980533241832259,0.518167408815585,0.671632950092733,3865,34,"NUP93, RANBP2, AAAS"
"799","SUMOylation of chromatin organization proteins",0.978426395939086,0.985923916214482,-0.484221851150062,-0.604905105167684,5396,55,"SUMO1, NUP98, SCMH1, SUMO2, HDAC2"
"800","SUMOylation of intracellular receptors",0.378255326898561,0.980533241832259,-0.968955343972107,-1.20652252002909,2076,26,"NR3C2, SUMO1, SUMO2"
"801","SUMOylation of transcription cofactors",0.822780203784571,0.980533241832259,-0.624260231439647,-0.762410264450151,4521,42,"NCOR2, SUMO1, CREBBP, SCMH1, SUMO2, DDX5"
"802","SUMOylation of transcription factors",0.405164406464797,0.980533241832259,-0.96891122278057,-1.34142534113111,2180,15,"SUMO1, SUMO2"
"803","SUMOylation of ubiquitinylation proteins",0.840392331698618,0.980533241832259,0.553950600473313,0.714771933449265,3769,37,"NUP93, RANBP2, AAAS"
"804","Scavenging by Class A Receptors",0.0308427454387489,0.629804462055302,0.997386759581881,1.50691124259301,141,16,"APOE, APOA1"
"805","Selective autophagy",0.451396445411679,0.980533241832259,-0.907494471271218,-1.12106876697961,2488,50,"PRKAG2, UBB, DYNLL1, HSPA8"
"806","Selenoamino acid metabolism",0.0415549597855228,0.74094606261644,0.981093991791698,1.32372739193834,185,77,"SEPSECS, AHCY"
"807","Selenocysteine synthesis",0.0742741390952059,0.906512436285034,0.981113052829681,1.28680715700692,329,62,"SEPSECS, EEFSEC"
"808","Sema3A PAK dependent Axon repulsion",0.640163477614713,0.980533241832259,-0.738813562894759,-1.02286278901203,3445,15,"HSP90AB1, PAK2"
"809","Sema4D in semaphorin signaling",0.60251732944181,0.980533241832259,-0.934158087796765,-1.18847488284401,3302,23,"ARHGEF12, ARHGEF11, LIMK2"
"810","Sema4D induced cell migration and growth-cone collapse",0.602467317252808,0.980533241832259,-0.934165240391906,-1.22669235874143,3271,19,"ARHGEF12, ARHGEF11, LIMK2"
"811","Semaphorin interactions",0.908616657672243,0.980533241832259,-0.53806132079176,-0.682150137153687,5050,62,"HSP90AB1, ARHGEF12, ARHGEF11, PAK2, LIMK2, SEMA7A"
"812","Senescence-Associated Secretory Phenotype (SASP)",0.675009134088418,0.980533241832259,-0.761094188024203,-0.930065452570501,3694,44,"UBB"
"813","Separation of Sister Chromatids",0.44674835061263,0.980533241832259,-0.705362402122756,-1.01853354082653,2369,156,"PTTG1, UBB, DYNLL1, CENPP, PSMB2, BUB3, NUP98"
"814","Serotonin Neurotransmitter Release Cycle",0.651340161255175,0.980533241832259,0.574064866233699,0.838637713805087,2988,18,"RIMS1, CPLX1"
"815","Sialic acid metabolism",0.581508956034015,0.980533241832259,-0.909719073865474,-1.11255632890228,3213,32,"ST3GAL5, ST6GALNAC3, ST3GAL3"
"816","Signal amplification",0.543712356269392,0.980533241832259,-0.960509554140127,-1.20636299357739,2978,25,"GNB1, MAPK14"
"817","Signal transduction by L1",0.0481617647058824,0.800979872881356,-0.994905824787184,-1.28031578352096,261,21,"FGFR1"
"818","Signaling by BMP",0.170740605618387,0.980533241832259,-0.98411208688074,-1.25202844405006,935,23,"BMPR1A, SMAD7"
"819","Signaling by BRAF and RAF fusions",0.480290644868302,0.980533241832259,-0.85784547590851,-1.07291153109011,2643,56,"AKAP9, IQGAP1, FXR1, CAMK2A, CAMK2G"
"820","Signaling by EGFR",0.462267590229676,0.980533241832259,-0.918882481227473,-1.12701656741401,2535,47,"UBB, PTPN12, ARHGEF7, SH3GL1"
"821","Signaling by EGFR in Cancer",0.0279809802487198,0.629804462055302,-0.997184609196943,-1.27422927556236,152,22,"UBB"
"822","Signaling by ERBB2",0.935341009743135,0.980533241832259,0.496680143887175,0.64387242393826,4223,47,"NRG1, RHOA"
"823","Signaling by ERBB2 KD Mutants",0.0161504424778761,0.629804462055302,0.998592210229939,1.3743301174228,72,23,"NRG1, BTC"
"824","Signaling by ERBB2 in Cancer",0.653649877967606,0.980533241832259,0.695712175459279,0.948308664114336,2945,24,"NRG1, BTC"
"825","Signaling by ERBB4",0.57673487544484,0.980533241832259,0.745082302196057,0.97063937164968,2592,54,"NRG1, APOE, GFAP, TAB2"
"826","Signaling by Erythropoietin",0.860269974461875,0.980533241832259,-0.238817106831715,-0.30383308432557,4715,23,"VAV1, STAT5B, SOS1, SHC1, RAPGEF1, PLCG2, PLCG1, PIK3R1, PIK3CG, PIK3CD, PIK3CB, PIK3CA, NRAS, LYN, KRAS, JAK2, IRS2, HRAS, GRB2, GAB1, EPOR, EPO"
"827","Signaling by FGFR",0.0562997827661115,0.846105306713562,-0.975478951578333,-1.27146123457129,310,76,"SPRED2, UBB, FGFR1, SPRED1"
"828","Signaling by FGFR in disease",0.2260348583878,0.980533241832259,-0.96504606706066,-1.21042514235315,1244,58,"FGFR1, ZMYM2, LRRFIP1, MYO18A, FGFR2"
"829","Signaling by FGFR1",0.0179028132992327,0.629804462055302,-0.994629430719656,-1.21544808274479,97,44,"SPRED2, UBB, FGFR1, SPRED1"
"830","Signaling by FGFR1 in disease",0.320433996383363,0.980533241832259,-0.969274117804911,-1.18110763828014,1771,34,"FGFR1, ZMYM2, LRRFIP1, MYO18A"
"831","Signaling by FGFR2",0.194284687275341,0.980533241832259,-0.964360520826535,-1.22998037475003,1080,65,"UBB, FGFR2"
"832","Signaling by FGFR2 IIIa TM",0.608359418155036,0.980533241832259,-0.923884245894571,-1.213191944848,3303,19,"FGFR2"
"833","Signaling by FGFR2 in disease",0.517516790706117,0.980533241832259,-0.9238398989636,-1.12094576394119,2850,39,"FGFR2"
"834","Signaling by FGFR3",0.0143064107207533,0.629804462055302,-0.997181586364246,-1.21025704832357,78,38,"UBB"
"835","Signaling by FGFR3 in disease",0.73510078878177,0.980533241832259,0.33230563002681,0.472859045290968,3354,20,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF5, FGF9, FGFR3, FRS2, GAB1, GRB2, HRAS, KRAS, NRAS, PIK3CA, PIK3R1, PLCG1"
"836","Signaling by FGFR3 point mutants in cancer",0.73510078878177,0.980533241832259,0.33230563002681,0.472859045290968,3354,20,"FGF1, FGF16, FGF18, FGF2, FGF20, FGF23, FGF4, FGF5, FGF9, FGFR3, FRS2, GAB1, GRB2, HRAS, KRAS, NRAS, PIK3CA, PIK3R1, PLCG1"
"837","Signaling by FGFR4",0.0143219724437999,0.629804462055302,-0.997181775481447,-1.2103546335851,78,37,"UBB"
"838","Signaling by Hedgehog",0.812476722532588,0.980533241832259,-0.563771051049682,-0.789634484315046,4362,126,"UBB, CUL3, OS9, CUL1, PSMB2, SPOP, KIF3A, ITCH, ADCY8"
"839","Signaling by Hippo",0.357852151526296,0.980533241832259,-0.97171581769437,-1.26410224044023,1945,20,"DVL2, WWC1"
"840","Signaling by Insulin receptor",0.320744488615829,0.980533241832259,-0.914353956248587,-1.17108141409628,1774,68,"ATP6V0C, FGFR1, ATP6V0B, PDPK1, ATP6V1C1, FGFR2"
"841","Signaling by Interleukins",0.15677879714577,0.980533241832259,0.757810159506883,1.20205439765984,768,340,"IL12B, IL1RAPL1, BCL2L1, PSMA1, CEBPD, YWHAZ, RPS6KA2, PSMB3, IL1R1, CREB1, PSMD14, PSME4, TAB2"
"842","Signaling by Ligand-Responsive EGFR Variants in Cancer",0.0310363938666174,0.629804462055302,-0.99718536389224,-1.3233161215276,167,18,"UBB"
"843","Signaling by MET",0.617975504322767,0.980533241832259,-0.739520259774214,-0.938654401744032,3430,63,"UBB, SH3GL1"
"844","Signaling by NODAL",0.507152145643693,0.980533241832259,-0.962747068676717,-1.33289127492655,2729,15,"FURIN"
"845","Signaling by NOTCH",0.839454751987883,0.980533241832259,-0.534995812069092,-0.783034506739132,4433,169,"MAML3, UBB, AGO2, NEURL1, FBXW7, NCOR2, YBX1, CUL1, PSMB2, TLE4, CREBBP, MIB1, HDAC9, WWC1, ITCH, HDAC2, FURIN, ST3GAL3"
"846","Signaling by NOTCH1",0.831887201735358,0.980533241832259,-0.581838114197881,-0.752986240535766,4601,72,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, TLE4, CREBBP, MIB1, HDAC9, ITCH, HDAC2"
"847","Signaling by NOTCH1 HD Domain Mutants in Cancer",0.249674902470741,0.980533241832259,-0.97929648241206,-1.355803387454,1343,15,"UBB, NEURL1, MIB1"
"848","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer",0.866098930965755,0.980533241832259,-0.572778423693031,-0.717999516146413,4779,57,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, CREBBP, MIB1, HDAC9"
"849","Signaling by NOTCH1 PEST Domain Mutants in Cancer",0.866098930965755,0.980533241832259,-0.572778423693031,-0.717999516146413,4779,57,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, CREBBP, MIB1, HDAC9"
"850","Signaling by NOTCH1 in Cancer",0.866098930965755,0.980533241832259,-0.572778423693031,-0.717999516146413,4779,57,"MAML3, UBB, NEURL1, FBXW7, NCOR2, CUL1, CREBBP, MIB1, HDAC9"
"851","Signaling by NOTCH2",0.863829787234043,0.980533241832259,0.511053071611373,0.663792253554208,3856,33,"MAML2, CREB1"
"852","Signaling by NOTCH3",0.939664600802042,0.980533241832259,-0.515575161141335,-0.632356977333197,5154,47,"MAML3, UBB, NEURL1, YBX1, CREBBP, MIB1, WWC1"
"853","Signaling by NOTCH4",0.866266132621273,0.980533241832259,0.542256214915459,0.733967649481913,3892,79,"MAML2, PSMA1, YWHAZ, PSMB3, PSMD14, PSMD9"
"854","Signaling by NTRK1 (TRKA)",0.971862438588656,0.985120736573921,0.488337395959327,0.656558286492953,4351,76,"RPS6KA2, CREB1, CLTA, RAP1A, RHOA"
"855","Signaling by NTRK2 (TRKB)",0.568870218881274,0.980533241832259,0.819718056970324,1.11153713147007,2572,25,"NTF3, BDNF"
"856","Signaling by NTRK3 (TRKC)",0.593164997823248,0.980533241832259,0.678057878997089,1.00529534523985,2724,17,"NTF3, BAX"
"857","Signaling by NTRKs",0.79809185711116,0.980533241832259,0.570993265416675,0.793404133570114,3596,97,"NTF3, PCSK5, RPS6KA2, CREB1, CLTA, RAP1A, RHOA"
"858","Signaling by Non-Receptor Tyrosine Kinases",0.744294261023709,0.980533241832259,0.634238722781776,0.823637404400899,3358,49,"NRG1, RHOA"
"859","Signaling by Nuclear Receptors",0.417505221188532,0.980533241832259,-0.683275568426766,-1.02406219034443,2198,201,"HSP90AB1, AGO2, NCOR2, KDM1A, PDPK1, GNB1, CREBBP, APOD"
"860","Signaling by PDGF",0.340320816624134,0.980533241832259,-0.962734170415631,-1.18080100800768,1866,47,"PTPN12, FURIN"
"861","Signaling by PTK6",0.744294261023709,0.980533241832259,0.634238722781776,0.823637404400899,3358,49,"NRG1, RHOA"
"862","Signaling by RAS mutants",0.696486780152119,0.980533241832259,-0.763756781918801,-0.926954569921745,3845,38,"IQGAP1, CAMK2A, CAMK2G"
"863","Signaling by ROBO receptors",0.359163851351351,0.980533241832259,0.712085623938441,1.06788737679488,1700,177,"ROBO2, PSMA1, PAK6, PAK3, PSMB3, ETF1, RNPS1, PSMD14, PSME4, RHOA, PSMD9, NCBP2"
"864","Signaling by Receptor Tyrosine Kinases",0.77082079068834,0.980533241832259,-0.524228360979226,-0.857001265162828,3840,409,"SPRED2, ATP6V0C, UBB, PTPN12, FGFR1, SPRED1, ATP6V0B, CLTC, PDPK1, SHC3, ARHGEF7, PTPRO, PAK2, SH3GL1, WWP1, MAP2K5, ATP6V1C1, GRIN2B, FGFR2, ITCH"
"865","Signaling by Retinoic Acid",0.875027895559027,0.980533241832259,0.284190757260715,0.372812007675417,3920,31,"ADH4, ALDH1A2, ALDH1A1, ALDH8A1, CPT1A, CYP26B1, DHRS3, DHRS4, DLAT, DLD, FABP5, PDHA1, PDHB, PDHX, PDK1, PDK2, PDK3, PDK4, PPARD, RARA, RARB, RARG, RDH10, RDH11, RDH13, RDH14, RDH16, RDH5, RXRA, RXRB, RXRG"
"866","Signaling by Rho GTPases",0.844518795512694,0.980533241832259,-0.510454768903567,-0.819250578641092,4290,348,"YWHAG, ARHGEF12, KDM1A, PDPK1, DYNLL1, RHOF, CENPP, ARHGEF11, IQGAP1, SCAI, ARHGEF7, ARHGEF18, BUB3, PAK2, LIMK2, DVL2, NUP98, FGD4"
"867","Signaling by SCF-KIT",0.963219227967953,0.985120736573921,-0.26248322147651,-0.318890805622219,5289,40,"YES1, VAV1, TEC, STAT5B, STAT3, STAT1, SRC, SOS1, SOCS6, SOCS1, SH2B3, SH2B2, RAC1, PTPRU, PTPN6, PTPN11, PRKCA, PIK3R3, PIK3R2, PIK3R1, PIK3CA, NRAS, MMP9, LYN, LCK, KRAS, KITLG, KIT, JAK2, HRAS, GRB7, GRB2, GRB10, GRAP2, GAB2, FYN, FES, FER"
"868","Signaling by TGF-beta Receptor Complex",0.248644741597398,0.980533241832259,-0.950128888725196,-1.22286206154513,1375,70,"UBB, PMEPA1, NCOR2, SKIL, SMAD7, ARHGEF18, RNF111, ZFYVE9, FURIN, PARD3"
"869","Signaling by TGF-beta family members",0.138601271571299,0.980533241832259,-0.951649086487617,-1.27583645701485,762,93,"UBB, PMEPA1, BMPR1A, NCOR2, SKIL, SMAD7, ARHGEF18, RNF111, ZFYVE9, FURIN, PARD3"
"870","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)",0.290281329923274,0.980533241832259,-0.96703813104189,-1.18173121165893,1588,44,"FGFR1, PDPK1, FGFR2"
"871","Signaling by VEGF",0.865248226950355,0.980533241832259,-0.54750612602206,-0.736329038685691,4757,95,"PDPK1, PAK2"
"872","Signaling by WNT",0.184464148033924,0.980533241832259,-0.766946124576565,-1.17850120893939,956,247,"PRICKLE1, UBB, AGO2, CUL3, ROR1, PRKG1, CLTC, CUL1, GNB1, PSMB2, TLE4, CREBBP, DVL2, CAMK2A, SMARCA4, CHD8, GNAO1"
"873","Signaling by WNT in cancer",0.899888268156425,0.980533241832259,0.204965454789375,0.267030421120994,4026,32,"AMER1, APC, AXIN1, CSNK1A1, CTBP1, CTBP2, CTNNB1, DKK2, FZD4, FZD5, FZD6, FZD8, GSK3B, KREMEN1, KREMEN2, LRP5, LRP6, PORCN, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"874","Signaling by cytosolic FGFR1 fusion mutants",0.402181952662722,0.980533241832259,-0.96924210949541,-1.30386141821118,2174,17,"ZMYM2, LRRFIP1, MYO18A"
"875","Signaling by high-kinase activity BRAF mutants",0.761378059836809,0.980533241832259,-0.697663520510695,-0.856423897658701,4198,30,"IQGAP1"
"876","Signaling by moderate kinase activity BRAF mutants",0.696486780152119,0.980533241832259,-0.763756781918801,-0.926954569921745,3845,38,"IQGAP1, CAMK2A, CAMK2G"
"877","Signaling by the B Cell Receptor (BCR)",0.806416131989001,0.980533241832259,-0.57553881251061,-0.782603631671477,4398,103,"UBB, CUL1, PSMB2, PPIA, CHUK"
"878","Signaling downstream of RAS mutants",0.696486780152119,0.980533241832259,-0.763756781918801,-0.926954569921745,3845,38,"IQGAP1, CAMK2A, CAMK2G"
"879","Signalling to ERKs",0.690998007607318,0.980533241832259,-0.785123366402979,-0.961511383053531,3814,31,"SHC3, MAPK14"
"880","Signalling to RAS",0.553809171597633,0.980533241832259,-0.960530724385177,-1.29214253101763,2994,17,"SHC3, MAPK14"
"881","Smooth Muscle Contraction",0.672452158433467,0.980533241832259,0.696611966508196,0.925488097899096,3021,28,"CALD1, ACTA2"
"882","Sphingolipid de novo biosynthesis",0.322759538598048,0.980533241832259,0.965208478934046,1.24251678974921,1454,41,"ACER3, ACER1"
"883","Sphingolipid metabolism",0.0729862038273253,0.906512436285034,0.973993836572033,1.31834351949309,327,79,"PSAP, ACER3, ACER1"
"884","Spry regulation of FGF signaling",0.0305668766209707,0.629804462055302,-0.99718574108818,-1.35868238810246,164,16,"UBB"
"885","Stabilization of p53",0.937908496732026,0.980533241832259,-0.518931375250755,-0.643141499391038,5165,52,"UBB, PSMB2"
"886","Stimuli-sensing channels",0.778121587186021,0.980533241832259,-0.602398760647344,-0.799848442636066,4274,87,"UBB, WNK2, TTYH1, WWP1, TRPM7, UNC80"
"887","Striated Muscle Contraction",0.154980877800036,0.980533241832259,-0.984578248625453,-1.2259758275626,850,26,"TMOD1"
"888","Sulfur amino acid metabolism",0.190536851683348,0.980533241832259,-0.982367927058193,-1.24359220886749,1046,24,"GOT2"
"889","Surfactant metabolism",0.64748045178106,0.980533241832259,0.406693915840257,0.614457358879293,2980,16,"ABCA3, ADGRF5, ADORA2A, ADORA2B, ADRA2A, ADRA2C, CCDC59, CKAP4, CSF2RA, CTSH"
"890","Switching of origins to a post-replicative state",0.718880610576049,0.980533241832259,-0.642145781393089,-0.845855641772229,3955,83,"UBB, ORC3, CUL1, PSMB2"
"891","Synaptic adhesion-like molecules",0.459886014905743,0.980533241832259,0.958799177543862,1.34606350221435,2097,21,"PTPRD, DLG1"
"892","Syndecan interactions",0.246458923512748,0.980533241832259,0.982240986462941,1.43493250283251,1130,18,"CASK, ACTN1, FGF2"
"893","Synthesis of DNA",0.669634576145428,0.980533241832259,-0.642116042082251,-0.883810442729972,3609,111,"UBB, ORC3, CUL1, PSMB2"
"894","Synthesis of IP3 and IP4 in the cytosol",0.149699508286287,0.980533241832259,-0.984980555183049,-1.22647677110424,821,26,"SYNJ1"
"895","Synthesis of Leukotrienes (LT) and Eoxins (EX)",0.646394439617724,0.980533241832259,0.462962342535513,0.699471044869719,2975,16,"ABCC1, ALOX5, ALOX5AP, CYP4A22, CYP4F11, CYP4A11, CYP4B1, CYP4F8, CYP4F2, CYP4F3, CYP4F22"
"896","Synthesis of PA",0.322737944735416,0.980533241832259,-0.969477426712283,-1.18250183308297,1786,33,"LCLAT1"
"897","Synthesis of PC",0.235079394050009,0.980533241832259,-0.978679182031512,-1.22918334617124,1287,25,"LPIN2"
"898","Synthesis of PIPs at the Golgi membrane",0.505634583410309,0.980533241832259,-0.963342715453693,-1.27840519132791,2736,18,"PI4KA, SACM1L"
"899","Synthesis of PIPs at the early endosome membrane",0.00673327541268462,0.629804462055302,0.99953095684803,1.51015082336311,30,16,"INPP4B, FIG4"
"900","Synthesis of PIPs at the plasma membrane",0.365864527629233,0.980533241832259,0.890995101700435,1.15644355711924,1641,50,"INPP4B, PLEKHA1"
"901","Synthesis of active ubiquitin: roles of E1 and E2 enzymes",0.691902687000726,0.980533241832259,-0.792892509951851,-0.97853051305021,3810,28,"UBB, UBE2K"
"902","Synthesis of bile acids and bile salts",0.562680275127579,0.980533241832259,0.829255296101098,1.13033810503062,2535,24,"CYP7B1, ABCB11"
"903","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol",0.0149382983329725,0.629804462055302,0.998726968174204,1.54403611931575,68,15,"CYP7B1, ABCB11"
"904","Synthesis of glycosylphosphatidylinositol (GPI)",0.303866203301477,0.980533241832259,0.978759045832217,1.47876738465274,1398,16,"PIGB, DPM2"
"905","Synthesis of substrates in N-glycan biosythesis",0.359776938298255,0.980533241832259,-0.909641707295126,-1.15323698510608,1999,62,"ST3GAL5, ST6GALNAC3, ST3GAL3"
"906","Synthesis of very long-chain fatty acyl-CoAs",0.776388378080177,0.980533241832259,-0.547230928763913,-0.711891100764429,4221,20,"TECR, HACD1"
"907","Synthesis, secretion, and deacylation of Ghrelin",0.785234899328859,0.980533241832259,0.214405360134003,0.331471594110452,3626,15,"ACHE, SPCS3, BCHE, CRHR2, GHRL, IGF1, INS, KLF4, MBOAT4, PCSK1, PLA2G7, SEC11A, SEC11C, SPCS1, SPCS2"
"908","T41 mutants of beta-catenin aren't phosphorylated",0.627841524139424,0.980533241832259,0.361139028475712,0.558322466329792,2899,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"909","TAK1 activates NFkB by phosphorylation and activation of IKKs complex",0.694454578620941,0.980533241832259,-0.771061719437509,-0.980976880300118,3806,23,"CHUK"
"910","TBC/RABGAPs",0.811529933481153,0.980533241832259,0.586706339622921,0.756479239747501,3659,40,"TBC1D14, TBC1D24, TBC1D20, ARF6"
"911","TCF dependent signaling in response to WNT",0.807000946073794,0.980533241832259,-0.553490012211617,-0.801282708174696,4264,159,"UBB, CUL3, PSMB2, TLE4, CREBBP, DVL2, SMARCA4, CHD8"
"912","TCR signaling",0.86517058930852,0.980533241832259,-0.546103416290667,-0.738430499424724,4741,99,"UBB, PDPK1, CUL1, PSMB2, CHUK, PAK2"
"913","TGF-beta receptor signaling activates SMADs",0.454857969965623,0.980533241832259,-0.962972900456131,-1.17768399689758,2513,32,"UBB, PMEPA1, SMAD7, ZFYVE9, FURIN"
"914","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)",0.584660985550204,0.980533241832259,-0.946971589730449,-1.29026476009986,3155,16,"UBB, ARHGEF18"
"915","TICAM1, RIP1-mediated IKK complex recruitment",0.642566568047337,0.980533241832259,-0.808773740658579,-1.08799325387962,3474,17,"UBB, CHUK"
"916","TNF signaling",0.47542773935202,0.980533241832259,-0.946509170253904,-1.15417643811897,2611,41,"UBB, MADD, CHUK, SPPL2A"
"917","TNFR1-induced NFkappaB signaling pathway",0.696269335759782,0.980533241832259,-0.77106030371972,-0.976095167463708,3825,24,"CHUK"
"918","TNFR2 non-canonical NF-kB pathway",0.817802755620014,0.980533241832259,-0.58313868380891,-0.767620962944475,4510,82,"UBB, CUL1, PSMB2, CHUK"
"919","TNFs bind their physiological receptors",0.362824144693833,0.980533241832259,0.975606487066077,1.42524032040907,1664,18,"EDA, CD27"
"920","TP53 Regulates Metabolic Genes",0.675308194343727,0.980533241832259,-0.667337794478256,-0.87845738008783,3724,82,"PRKAG2, AGO2, YWHAG, COX8A, SESN1"
"921","TP53 Regulates Transcription of Cell Cycle Genes",0.84825327510917,0.980533241832259,-0.597441409000483,-0.729656383170655,4661,42,"CNOT6L, CNOT4"
"922","TP53 Regulates Transcription of Cell Death Genes",0.134953745692001,0.980533241832259,-0.982487922705314,-1.1927111447768,743,36,"CREBBP"
"923","TP53 Regulates Transcription of DNA Repair Genes",0.0283482142857143,0.629804462055302,0.990054431825818,1.29692259017101,126,59,"CDK13, ATF2"
"924","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release",0.210613905325444,0.980533241832259,-0.982510219124841,-1.32171018485981,1138,17,"CREBBP"
"925","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest",0.873490618614156,0.980533241832259,-0.192562814070352,-0.266596807303146,4701,15,"ZNF385A, TP53, TFDP2, TFDP1, SFN, RBL2, RBL1, PRMT1, PCNA"
"926","TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain",0.734158507297247,0.980533241832259,-0.597488478840844,-0.792897855410696,3973,18,"CNOT6L, CNOT4"
"927","TRAF6 mediated NF-kB activation",0.24770136079441,0.980533241832259,-0.978887399463807,-1.27343173000618,1346,20,"CHUK"
"928","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation",0.622668839398877,0.980533241832259,-0.69933344097278,-0.915131310160598,3438,78,"UBB, CUL1, CHUK"
"929","TRAF6-mediated induction of TAK1 complex within TLR4 complex",0.576444361879993,0.980533241832259,-0.956765192615874,-1.32460956660606,3102,15,"UBB"
"930","TRIF(TICAM1)-mediated TLR4 signaling",0.747130624886136,0.980533241832259,-0.620168675088375,-0.82452385464946,4100,88,"UBB, CUL1, CHUK"
"931","TRP channels",0.573445081605646,0.980533241832259,0.8011004010902,1.11395193801811,2599,22,"TRPC1, TRPC4"
"932","Tat-mediated HIV elongation arrest and recovery",0.907658881042911,0.980533241832259,-0.26796463615151,-0.329701979663797,5012,29,"TCEA1, SUPT5H, SUPT4H1, SUPT16H, SSRP1, POLR2L, POLR2K, POLR2J, POLR2I, POLR2H, POLR2G, POLR2F, POLR2E, POLR2D, POLR2C, POLR2B, POLR2A, NELFE, NELFCD, NELFB, NELFA"
"933","Tat-mediated elongation of the HIV-1 transcript",0.313442768411713,0.980533241832259,0.97066917242768,1.24954636263176,1412,41,"NCBP2, CCNH"
"934","Telomere C-strand (Lagging Strand) Synthesis",0.840569135352061,0.980533241832259,-0.462646936235576,-0.588598729191048,4607,23,"RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, PRIM2, PRIM1, POLE4, POLE3, POLE2, POLE, POLD4, POLD2, POLD1, POLA2, POLA1, PCNA"
"935","Telomere Maintenance",0.941528963137825,0.980533241832259,-0.428581013082858,-0.520599285289664,5184,35,"WRAP53, TINF2, TERT, TERF2IP, TERF2, TERF1, RUVBL2, RUVBL1, RPA3, RPA2, RPA1, RFC5, RFC4, RFC3, RFC2, RFC1, PRIM2, PRIM1, POT1, POLE4, POLE3, POLE2, POLE, POLD4, POLD2, POLD1, POLA2, POLA1"
"936","Termination of O-glycan biosynthesis",0.608768344789151,0.980533241832259,-0.848399057595865,-1.17458025925723,3276,15,"ST6GALNAC3, ST3GAL3"
"937","Termination of translesion DNA synthesis",0.0201269265639166,0.629804462055302,-0.997183098591549,-1.2241021794432,110,30,"UBB"
"938","The canonical retinoid cycle in rods (twilight vision)",0.736939607261949,0.980533241832259,-0.370359823103726,-0.504621504477846,3977,16,"TTR, STRA6, RPE65, RLBP1, RDH5, RDH16, RDH12, RDH11, RDH10, RBP4, RBP1"
"939","The citric acid (TCA) cycle and respiratory electron transport",0.974761399787911,0.985120736573921,0.481095831430381,0.713976242283741,4595,161,"ATP5MG, NDUFS1, NDUFS4, COX19, FAHD1, SDHA, OGDH, COX7C, VDAC1, HAGH"
"940","The phototransduction cascade",0.740658854742428,0.980533241832259,0.586125886486731,0.794786306103539,3349,25,"NMT1, CALM1"
"941","The role of GTSE1 in G2/M progression after G2 checkpoint",0.774211099020675,0.980533241832259,-0.64886380620395,-0.807513341487689,4268,53,"UBB, HSP90AB1, PSMB2"
"942","The role of Nef in HIV-1 replication and disease pathogenesis",0.546450082131776,0.980533241832259,-0.960308414347972,-1.20611036974794,2993,25,"PACS1, PAK2, AP1M1, ATP6V1H"
"943","Thrombin signalling through proteinase activated receptors (PARs)",0.11218357311965,0.980533241832259,-0.98833310982969,-1.23065130061787,615,26,"GNB1"
"944","Thromboxane signalling through TP receptor",0.13387573964497,0.980533241832259,-0.988340146083227,-1.32955282475088,723,17,"GNB1"
"945","Tie2 Signaling",0.87753323164088,0.980533241832259,0.173703256936068,0.253758957995625,4026,18,"ANGPT1, ANGPT2, ANGPT4, DOK2, GRB14, GRB2, GRB7, HRAS, KRAS, NRAS, PIK3CA, PIK3CB, PIK3R1, PIK3R2, PTPN11, SHC1, SOS1, TEK"
"946","Tight junction interactions",0.491392460230987,0.980533241832259,0.907966105899634,1.32642609581718,2254,18,"MPP5, CLDN1"
"947","Toll Like Receptor 10 (TLR10) Cascade",0.634556298572203,0.980533241832259,-0.699339107708299,-0.908825268417279,3510,74,"UBB, CUL1, CHUK"
"948","Toll Like Receptor 2 (TLR2) Cascade",0.612389059952907,0.980533241832259,-0.699329188918963,-0.920152111460848,3380,81,"UBB, CUL1, CHUK"
"949","Toll Like Receptor 3 (TLR3) Cascade",0.752823315118397,0.980533241832259,-0.620172931150862,-0.819471291130352,4132,85,"UBB, CUL1, CHUK"
"950","Toll Like Receptor 4 (TLR4) Cascade",0.717981651376147,0.980533241832259,-0.620143102562459,-0.847938593929101,3912,106,"UBB, CUL1, CHUK"
"951","Toll Like Receptor 5 (TLR5) Cascade",0.634556298572203,0.980533241832259,-0.699339107708299,-0.908825268417279,3510,74,"UBB, CUL1, CHUK"
"952","Toll Like Receptor 7/8 (TLR7/8) Cascade",0.622185911401598,0.980533241832259,-0.699332023812256,-0.916085165934004,3426,79,"UBB, CUL1, CHUK"
"953","Toll Like Receptor 9 (TLR9) Cascade",0.611484644739233,0.980533241832259,-0.699326353262423,-0.921175780464897,3364,83,"UBB, CUL1, CHUK"
"954","Toll Like Receptor TLR1:TLR2 Cascade",0.612389059952907,0.980533241832259,-0.699329188918963,-0.920152111460848,3380,81,"UBB, CUL1, CHUK"
"955","Toll Like Receptor TLR6:TLR2 Cascade",0.612389059952907,0.980533241832259,-0.699329188918963,-0.920152111460848,3380,81,"UBB, CUL1, CHUK"
"956","Toll-like Receptor Cascades",0.914120715350224,0.980533241832259,-0.515341259231244,-0.719132660672895,4906,123,"UBB, CUL1, CHUK"
"957","Trafficking of AMPA receptors",0.384587488667271,0.980533241832259,-0.967270288397049,-1.18738240731301,2120,30,"MYO6, CAMK2A, EPB41L1, CAMK2G"
"958","Trafficking of GluR2-containing AMPA receptors",0.698084457988681,0.980533241832259,0.295461801955923,0.438054601831038,3206,17,"AP2A1, AP2A2, AP2B1, AP2M1, AP2S1, GRIA1, GRIA2, GRIA3, GRIA4, GRIP1, GRIP2, NSF, PICK1, PRKCA, PRKCB, PRKCG"
"959","Transcription of E2F targets under negative control by DREAM complex",0.391826923076923,0.980533241832259,-0.969778194732963,-1.30458258050001,2118,17,"MAX"
"960","Transcription of the HIV genome",0.134064458370636,0.980533241832259,0.970615922538999,1.29099013841559,598,68,"NCBP2, TAF9"
"961","Transcription-Coupled Nucleotide Excision Repair (TC-NER)",0.00217155266015201,0.629804462055302,-0.997174190943955,-1.30203875390436,11,77,"UBB"
"962","Transcriptional Regulation by E2F6",0.442373801338882,0.980533241832259,-0.963576603166085,-1.1784223053381,2444,32,"YAF2, MAX, RBBP7"
"963","Transcriptional Regulation by MECP2",0.790360572567494,0.980533241832259,-0.630799276483347,-0.790730859553607,4361,57,"AGO2, NCOR2, OPRM1, SST, CAMK2A, GRIN2B, CAMK2G, HDAC2"
"964","Transcriptional Regulation by TP53",0.171434169278997,0.980533241832259,-0.737878269368184,-1.17688218071161,874,333,"PRKAG2, UBB, AGO2, JMY, YWHAG, PDPK1, BRD1, CREBBP, COX8A, CNOT6L, CNOT4, SESN1, HDAC2, RBBP7"
"965","Transcriptional Regulation by VENTX",0.893169092945129,0.980533241832259,0.367429578538454,0.477243796209844,3987,33,"AGO1, AGO3, AGO4, ANAPC1, ANAPC10, ANAPC15, ANAPC16, ANAPC2, ANAPC4, ANAPC5, ANAPC7, CCND1, CDC16, CDC23, CDC26, CDC27, CEBPB, CSF1R, CTNNB1, EHMT1, EHMT2"
"966","Transcriptional activation of mitochondrial biogenesis",0.678273485672833,0.980533241832259,-0.724574846915946,-0.901736004068499,3739,53,"CRTC3, MEF2D, CREBBP"
"967","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer",0.287586457954132,0.980533241832259,-0.968454258675079,-1.18093635211046,1579,41,"UBB, NCOR2, SKIL, SMAD7, RNF111"
"968","Transcriptional regulation by RUNX1",0.491958372753075,0.980533241832259,-0.685073509474,-0.991775000196741,2599,159,"UBB, AGO2, PSMB2, CCND2, CREBBP, YAF2, SCMH1, SMARCA4, ITCH"
"969","Transcriptional regulation by RUNX2",0.654585798816568,0.980533241832259,-0.650668278259314,-0.893314998301221,3539,109,"UBB, FBXW7, CUL1, PSMB2, WWP1"
"970","Transcriptional regulation by RUNX3",0.705190771960958,0.980533241832259,0.618136709872681,0.852428196997559,3178,90,"MAML2, PSMA1, ITGA4, PSMB3, PSMD14, PSMD9"
"971","Transcriptional regulation by small RNAs",0.911995618039072,0.980533241832259,-0.53929993049034,-0.66009535747477,4994,46,"AGO2, NUP98"
"972","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors",0.733867378727192,0.980533241832259,0.630425448967473,0.83755559433851,3297,28,"APOE, CDKN1A"
"973","Transcriptional regulation of granulopoiesis",0.169585457769896,0.980533241832259,0.985919270484109,1.32865351484516,764,26,"CREB1, CBFB"
"974","Transcriptional regulation of pluripotent stem cells",0.548261834319527,0.980533241832259,-0.960865777658648,-1.29259325744816,2964,17,"FOXP1"
"975","Transcriptional regulation of white adipocyte differentiation",0.879919499105546,0.980533241832259,0.538286705118384,0.723910571875023,3934,75,"CEBPD, NCOA6"
"976","Transferrin endocytosis and recycling",0.60639070442992,0.980533241832259,-0.898766697523584,-1.10919276774806,3339,28,"ATP6V0C, ATP6V0B, TFRC, ATP6V1C1"
"977","Translation",0.479410074698334,0.980533241832259,-0.646317952417258,-0.990532882373955,2502,240,"SRP9, EIF4E, EIF5, MRPS21, MRPL4, MRPL21, MRPS33, SRP14, EIF4A2"
"978","Translation initiation complex formation",0.96718920889537,0.985120736573921,-0.487313642398628,-0.597694003020351,5305,47,"EIF4E, EIF4A2"
"979","Translesion Synthesis by POLH",0.439497506004064,0.980533241832259,-0.967129483711907,-1.28343042702233,2378,18,"UBB"
"980","Translesion synthesis by POLI",0.407914201183432,0.980533241832259,-0.968974066876633,-1.30350083706676,2205,17,"UBB, REV3L"
"981","Translesion synthesis by POLK",0.407914201183432,0.980533241832259,-0.968974066876633,-1.30350083706676,2205,17,"UBB, REV3L"
"982","Translesion synthesis by REV1",0.407187847350871,0.980533241832259,-0.968976145805414,-1.32024633882204,2197,16,"UBB, REV3L"
"983","Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template",0.524396880101578,0.980533241832259,-0.940840846282069,-1.14215283148924,2890,36,"UBB, REV3L"
"984","Translocation of SLC2A4 (GLUT4) to the plasma membrane",0.67835725967654,0.980533241832259,-0.742618992797715,-0.913072008867033,3732,48,"PRKAG2, YWHAG, KIF3A, KIF3B"
"985","Transmission across Chemical Synapses",0.588359342049768,0.980533241832259,0.60369529050482,0.923284080328879,2789,225,"NRG1, SLC1A3, ADCY1, PPM1E, ARHGEF9, RPS6KA2, RIMS1, CREB1, COMT, CASK, KCNJ4, GRIK2"
"986","Transport of Mature Transcript to Cytoplasm",0.282205849519982,0.980533241832259,0.864434333078535,1.16727210024253,1263,78,"SRSF2, SRSF1, SRSF7, SRSF11, NUP93, POLDIP3, RANBP2, U2AF1, RNPS1, FYTTD1, SRSF4, NCBP2"
"987","Transport of Mature mRNA Derived from an Intronless Transcript",0.954297159504734,0.985120736573921,-0.489233366381977,-0.594369504706725,5240,40,"EIF4E, SYMPK, NUP98"
"988","Transport of Mature mRNA derived from an Intron-Containing Transcript",0.147269471799463,0.980533241832259,0.957449656331609,1.2782987738892,657,70,"SRSF2, SRSF1, SRSF7, SRSF11, NUP93, POLDIP3, RANBP2, U2AF1, RNPS1, FYTTD1, SRSF4, NCBP2"
"989","Transport of Mature mRNAs Derived from Intronless Transcripts",0.95376774663269,0.985120736573921,-0.489231433906891,-0.596570441732771,5239,41,"EIF4E, SYMPK, NUP98"
"990","Transport of Ribonucleoproteins into the Host Nucleus",0.530908279401919,0.980533241832259,0.853935297694805,1.12022409112498,2378,31,"NUP93, RANBP2, AAAS"
"991","Transport of bile salts and organic acids, metal ions and amine compounds",0.0815866576515664,0.943177624719207,0.977611940298508,1.2934774749754,361,66,"SLC6A15, BSG"
"992","Transport of inorganic cations/anions and amino acids/oligopeptides",0.182343784745386,0.980533241832259,0.88737726787508,1.22768964797194,819,93,"AHCYL2, SLC1A3, SLC4A3, SLC24A2, SLC8A3, SLC4A4, SLC6A15, SLC4A10"
"993","Transport of the SLBP Dependant Mature mRNA",0.804004449388209,0.980533241832259,0.58637972077188,0.758520022895126,3613,35,"NUP93, RANBP2, NCBP2"
"994","Transport of the SLBP independent Mature mRNA",0.800536672629696,0.980533241832259,0.586380810008588,0.760049101127468,3579,34,"NUP93, RANBP2, NCBP2"
"995","Transport of vitamins, nucleosides, and related molecules",0.189914746961727,0.980533241832259,-0.977724100912507,-1.18692800667128,1046,36,"APOD"
"996","Transport to the Golgi and subsequent modification",0.58083705120034,0.980533241832259,0.628225248016648,0.928169547577545,2733,155,"MGAT5, LMAN2L, TMED9, MIA3, TBC1D20, DYNC1I2, TFG, ACTR10, ST3GAL4, MAN2A2, SEC23IP"
"997","Triglyceride catabolism",0.541496850685439,0.980533241832259,-0.961136424551059,-1.30956458640919,2922,16,"MGLL, LIPE"
"998","Triglyceride metabolism",0.526315789473684,0.980533241832259,-0.9611774171919,-1.19683761155747,2889,26,"MGLL, LPIN2, LIPE"
"999","Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",0.648566463944396,0.980533241832259,0.397631332082552,0.600765068280657,2985,16,"DCP1A, DCP2, DIS3, EXOSC1, EXOSC2, EXOSC3, EXOSC4, EXOSC5, EXOSC7, EXOSC8, EXOSC9"
"1000","UCH proteinases",0.865482233502538,0.980533241832259,-0.552936203126791,-0.72786359827594,4773,82,"UBB, PSMB2, SMAD7, ASXL1"
"1001","Ub-specific processing proteases",0.699133383571967,0.980533241832259,-0.598720554962429,-0.861680284365542,3710,153,"UBB, USP47, PSMB2, SMAD7"
"1002","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A",0.937693568956094,0.980533241832259,-0.51893456879571,-0.639239529582098,5146,49,"UBB, PSMB2"
"1003","Ubiquitin-dependent degradation of Cyclin D",0.937693568956094,0.980533241832259,-0.51893456879571,-0.639239529582098,5146,49,"UBB, PSMB2"
"1004","Unblocking of NMDA receptors, glutamate binding and activation",0.431408606105186,0.980533241832259,-0.967225201072386,-1.25826041052511,2345,20,"CAMK2A, GRIN2B, CAMK2G"
"1005","Unfolded Protein Response (UPR)",0.687431693989071,0.980533241832259,-0.658879395733521,-0.870616439384052,3773,85,"PREB"
"1006","Uptake and actions of bacterial toxins",0.652340193043161,0.980533241832259,-0.851444909779547,-1.06020103465443,3581,26,"HSP90AB1, SV2A, FURIN"
"1007","VEGFA-VEGFR2 Pathway",0.871132144157262,0.980533241832259,-0.547518280614783,-0.72697965645531,4785,87,"PDPK1, PAK2"
"1008","VEGFR2 mediated cell proliferation",0.109187994844412,0.980533241832259,-0.990148113397225,-1.30020586531036,592,19,"PDPK1"
"1009","VEGFR2 mediated vascular permeability",0.802001819836215,0.980533241832259,-0.57802514031933,-0.731729468390995,4406,24,"PDPK1, PAK2"
"1010","Vasopressin regulates renal water homeostasis via Aquaporins",0.666592128801431,0.980533241832259,0.714837313809808,0.926550542821416,2980,34,"ADCY1, ADCY2"
"1011","Vif-mediated degradation of APOBEC3G",0.937693568956094,0.980533241832259,-0.51893456879571,-0.639239529582098,5146,49,"UBB, PSMB2"
"1012","Viral Messenger RNA Synthesis",0.472598180607943,0.980533241832259,0.853922222466538,1.10153353372037,2129,43,"NUP93, RANBP2, AAAS"
"1013","Viral mRNA Translation",0.8163708801159,0.980533241832259,-0.605650021241966,-0.762091297086524,4507,59,"RPSA, RPS9, RPS8, RPS7, RPS5, RPS4X, RPS3A, RPS28, RPS27L, RPS27A, RPS25, RPS24, RPS21, RPS20, RPS19, RPS17, RPS16, RPS15A, RPS15, RPS14, RPS13, RPS12, RPS11, RPLP1, RPL8, RPL7A, RPL6, RPL5, RPL4, RPL3L, RPL38, RPL37A, RPL36, RPL35, RPL34, RPL32, RPL30, RPL3, RPL29, RPL28, RPL27, RPL26, RPL23, RPL22L1, RPL19, RPL18A, RPL18, RPL14, RPL13A, RPL12, RPL11, RPL10A, RPL10"
"1014","Visual phototransduction",0.374132915641083,0.980533241832259,0.81778239563359,1.09895777056366,1671,74,"APOE, NMT1, ABCA4"
"1015","Vitamin B5 (pantothenate) metabolism",0.742584975102836,0.980533241832259,0.236113902847571,0.365033093014135,3429,15,"AASDHPPT, COASY, ENPP1, ENPP2, ENPP3, FASN, PANK1, PANK2, PANK3, PANK4, PDZD11, PPCDC, PPCS, SLC25A16, SLC5A6"
"1016","Voltage gated Potassium channels",0.608502114400178,0.980533241832259,0.76159819690822,0.981513439528057,2733,39,"KCND2, KCNAB2, KCNG2"
"1017","Vpr-mediated nuclear import of PICs",0.53072625698324,0.980533241832259,0.853934208896422,1.11251143098995,2374,32,"NUP93, RANBP2, AAAS"
"1018","Vpu mediated degradation of CD4",0.936943485371616,0.980533241832259,-0.518935633024765,-0.638046704318098,5155,48,"UBB, PSMB2"
"1019","VxPx cargo-targeting to cilium",0.25925243969803,0.980533241832259,-0.978553716238858,-1.28498076617006,1407,19,"ARF4"
"1020","WNT ligand biogenesis and trafficking",0.687936741449062,0.980533241832259,-0.759919571045576,-0.988577128025339,3740,20,"WNT9A, WNT7B, WNT7A, WNT5B, WNT5A, WNT4, WNT3A, WNT3, WNT2B, WNT2, WNT16, WNT10A, WNT1, WLS, VPS35, VPS29, VPS26A"
"1021","WNT5A-dependent internalization of FZD4",0.653167378785064,0.980533241832259,-0.694063981882234,-0.960908483432897,3515,15,"CLTC, DVL2"
"1022","XBP1(S) activates chaperone genes",0.781625956981407,0.980533241832259,-0.658963559435718,-0.808223972029686,4287,47,"PREB"
"1023","ZBP1(DAI) mediated induction of type I IFNs",0.258636615555145,0.980533241832259,-0.978890229191797,-1.29903753945925,1399,18,"CHUK"
"1024","Zinc transporters",0.63551922719673,0.980533241832259,-0.757788944723618,-1.04913357362512,3420,15,"SLC39A8, SLC39A7, SLC39A6, SLC39A3, SLC39A2, SLC39A14, SLC39A10, SLC39A1, SLC30A8, SLC30A7, SLC30A6, SLC30A5, SLC30A3, SLC30A2, SLC30A1"
"1025","activated TAK1 mediates p38 MAPK activation",0.570309098824554,0.980533241832259,0.735900678291369,1.09105365391431,2619,17,"TAB2, IKBKG"
"1026","cGMP effects",0.0746795467211592,0.906512436285034,-0.993433835845896,-1.37537608277097,401,15,"PDE10A, PRKG1"
"1027","mRNA 3'-end processing",0.293594306049822,0.980533241832259,0.92327579270422,1.20277697195118,1319,54,"SRSF2, SRSF1, SRSF7, SRSF11, POLDIP3, U2AF1, CPSF7, RNPS1, FYTTD1, SRSF4, NCBP2"
"1028","mRNA Capping",0.407903549899531,0.980533241832259,0.97069277714439,1.28378937640303,1826,29,"NCBP2, CCNH"
"1029","mRNA Splicing",0.385572663994938,0.980533241832259,0.697935977955346,1.04986606198299,1827,184,"SRSF2, SRSF1, SRSF7, SRSF11, LSM7, HNRNPU, U2AF1, CPSF7, SRSF10, RNPS1, ELAVL1, SRSF4, TRA2B, NCBP2"
"1030","mRNA Splicing - Major Pathway",0.392608236536431,0.980533241832259,0.697950886777616,1.04615375437696,1858,176,"SRSF2, SRSF1, SRSF7, SRSF11, LSM7, HNRNPU, U2AF1, CPSF7, SRSF10, RNPS1, ELAVL1, SRSF4, TRA2B, NCBP2"
"1031","mRNA Splicing - Minor Pathway",0.475205692684012,0.980533241832259,0.819158861209426,1.06539481836227,2136,51,"SRSF2, SRSF1, SRSF7, NCBP2"
"1032","mRNA decay by 3' to 5' exoribonuclease",0.624377570902793,0.980533241832259,0.376750418760469,0.582457741775959,2883,15,"DCPS, DIS3, EXOSC1, EXOSC2, EXOSC3, EXOSC4, EXOSC5, EXOSC7, EXOSC8, EXOSC9"
"1033","mRNA decay by 5' to 3' exoribonuclease",0.097207187702966,0.980533241832259,0.991959798994975,1.53357404712664,448,15,"LSM7, DCP1A"
"1034","mTOR signalling",0.355704697986577,0.980533241832259,-0.966610735307302,-1.17343671104618,1960,36,"PRKAG2, STRADA, EIF4E"
"1035","mTORC1-mediated signalling",0.123574843692534,0.980533241832259,-0.988471849865952,-1.28590011325787,671,20,"EIF4E"
"1036","p53-Dependent G1 DNA Damage Response",0.938300559263937,0.980533241832259,-0.518922852835358,-0.654930024026354,5200,60,"UBB, PSMB2"
"1037","p53-Dependent G1/S DNA damage checkpoint",0.938300559263937,0.980533241832259,-0.518922852835358,-0.654930024026354,5200,60,"UBB, PSMB2"
"1038","p53-Independent DNA Damage Response",0.937693568956094,0.980533241832259,-0.51893456879571,-0.639239529582098,5146,49,"UBB, PSMB2"
"1039","p53-Independent G1/S DNA damage checkpoint",0.937693568956094,0.980533241832259,-0.51893456879571,-0.639239529582098,5146,49,"UBB, PSMB2"
"1040","p75 NTR receptor-mediated signalling",0.7282489989079,0.980533241832259,-0.628385197462736,-0.838916230121958,4000,90,"UBB, ARHGEF12, ARHGEF11, ARHGEF7, ARHGEF18, FGD4, HDAC2"
"1041","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex",0.627841524139424,0.980533241832259,0.361139028475712,0.558322466329792,2899,15,"AMER1, APC, AXIN1, CSNK1A1, CTNNB1, GSK3B, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E"
"1042","rRNA modification in the nucleus and cytosol",0.302273740526081,0.980533241832259,0.913516904159598,1.19012289400506,1355,55,"NOL11, FCF1, UTP11, BMS1"
"1043","rRNA processing",0.739674118984464,0.980533241832259,-0.572702940748387,-0.843045044482146,3903,178,"RBM28, XRN2, EBNA1BP2, EXOSC10, TBL3, UTP4"
"1044","rRNA processing in the mitochondrion",0.800845899227657,0.980533241832259,-0.409450402144772,-0.532652820171705,4354,20,"TRMT10C, TFB1M, PRORP, NSUN4, MTERF4, MT-ND5, MT-ND4, MT-ND3, MT-ND2, MT-ND1, MT-CYB, MT-CO3, MT-CO1, MT-ATP8, MT-ATP6, MRM3, MRM2, MRM1"
"1045","rRNA processing in the nucleus and cytosol",0.758457758457758,0.980533241832259,-0.572751425733742,-0.828398166193989,4012,158,"RBM28, XRN2, EBNA1BP2, EXOSC10, TBL3, UTP4"
"1046","snRNP Assembly",0.439397296698427,0.980533241832259,0.850547200636466,1.10454070918295,1982,49,"NUP93, RANBP2, NCBP2"
"1047","tRNA Aminoacylation",0.29594324983374,0.980533241832259,0.977739037146306,1.31762959422417,1334,26,"FARSA, AARS2"
"1048","tRNA modification in the nucleus and cytosol",0.849445676274945,0.980533241832259,0.550885063922991,0.710292502740902,3830,40,"TRMT1, ADAT1"
"1049","tRNA processing",0.239522258414767,0.980533241832259,0.826530799719736,1.17313635475408,1102,112,"NUP93, RANBP2, TRMT1, AAAS"
"1050","tRNA processing in the mitochondrion",0.735457576880326,0.980533241832259,-0.392823639774859,-0.535228833506965,3969,16,"TRNT1, TRMT10C, PRORP, MT-ND6, MT-ND5, MT-ND4, MT-ND3, MT-ND2, MT-ND1, MT-CYB, MT-CO3, MT-CO1, MT-ATP8, MT-ATP6"
"1051","tRNA processing in the nucleus",0.40414623272403,0.980533241832259,0.853909126156277,1.1124663329283,1812,55,"NUP93, RANBP2, AAAS"
"1052","trans-Golgi Network Vesicle Budding",0.722161966738973,0.980533241832259,-0.650305171762715,-0.841592935453584,3994,72,"CLTC, TFRC, HSPA8, PUM1, AP1M1"
